ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000082.1|Kijanimicin_2 # 1026 # 1850 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AAGGA;rbs_spacer=5bp;gc_cont=0.670	BGC0000082.1|Kijanimicin_2 	1026	1850	-	Loose	500	24.6386	OXA-33	28.0	3001427	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGCGACCAAGGACACCCCGGACGAGCGGAAGAAACCGGCTCCGGAGATCTCGAACCCGACGGAGCTGGCCGATGCCTATCTCGGCCTTCTGAAGAAATGCCTGCTGCGTTTCCACGACGGCGCCGCCTTTCCCTACTCGCCCGACTCGGATCCCGTCGACGCGCGCATGAGCACCCTGCTGAGCAAGGGGATCATGCCGTCGCCGGGCGCGGACACCATGGTCAGCCAGGAACGGCTGGACAACATCCACCACGCCGCCGCGACGGTCATCCGGGAGGGCGTTCCGGGCGACTTCATCGAGACGGGCGTCTGGCGCGGCGGCTCGTGCATCCTCATGCGCGCCGCGCTCACGGCGTACGGGGACCGCACCCGCAAGGTCTGGGTCGCCGACTCCTTCGACGGGTTCCCGCCGCCGACCGACAAGTACCCGTCGGACCCGTGGCAGGGACGCAGCCAGGACATCATCGGCACGCTCGGCGTCTCGCTCAAGGTCACCTTCGAGGAGGTGAAGGAGCGTTTCGCCCGGTACGGACTGCTCGACGAGCGGGTGGAGTTCCTGACCGGGTTCTTCGAGCACACCCTGCCGTCGGCGCCGATCGACAGGCTGGCGATCCTCCGCCTGGACGGCGACCTGTACCAGTCCACCTACGAGGCGCTCGAAGCGCTCTACCCGAAGCTGTCGGTCGGCGGCTACTGCATCATCGACGACTACTTCTACACGATGTGCAGCAAGGCCGTGGACGACTACCGCCGCAAGCACAACATCGACGAGCCCATCGAGGCCGTCGACTGGACGTGCGTGCAGTGGCGGAAGGCCGGGTGA	MATKDTPDERKKPAPEISNPTELADAYLGLLKKCLLRFHDGAAFPYSPDSDPVDARMSTLLSKGIMPSPGADTMVSQERLDNIHHAAATVIREGVPGDFIETGVWRGGSCILMRAALTAYGDRTRKVWVADSFDGFPPPTDKYPSDPWQGRSQDIIGTLGVSLKVTFEEVKERFARYGLLDERVEFLTGFFEHTLPSAPIDRLAILRLDGDLYQSTYEALEALYPKLSVGGYCIIDDYFYTMCSKAVDDYRRKHNIDEPIEAVDWTCVQWRKAG	ANIIYSSASASTDISTVASPLFEGTEGCFLLYDVSTNAEIAQFNKAKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVVWVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLRKIINHNLPVKNSAIENTIENMYLQDLENSTKLYGKTGAGFTANRTLQNGWFEGFIISKSGHKYVFVSALTGNLGSNLTSSIKAKKNAITIL	107.03	gnl|BL_ORD_ID|1396|hsp_num:0	1517			471	612	cloxacillin; oxacillin; cefalotin
BGC0000082.1|Kijanimicin_3 # 1974 # 2954 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AAG;rbs_spacer=10bp;gc_cont=0.706	BGC0000082.1|Kijanimicin_3 	1974	2954	-	Loose	550	27.335	TER-2	34.09	3007007	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	TER beta-lactamase	ATGGAGTACATCCGACTGGGATCGGCCGGTCTGAAGGTGAGCCGGCTCGCGCTCGGCTGCATGAGCTTCGGCACCCCCTCTCCGCTGAGCCCGTGGGTGCTCGACGACGAGGCGGCCGAGCCGCTGTTCCGGCAGGCGGTCGAGCTGGGCATCACCTTCTGGGACACCGCCAACATCTACGGGATGGGCACCTCGGAGGAGATCGTCGGGCGCGCGTTGCGGAAGTACGCCAGCCGCGAGGAGATCGTCCTGGCGACCAAGGTGCTCTTCCCGATGCGGCAGGGCCCCTCCCGTCCCGGGCTGTCCCGCAAGGCGATCATCGAGCAGCTCGACGCCTCGCTGACCCGGCTCGGCACCGACCACGTCGACCTCTACCAGATCCACCGGTTCGACCCCGAGACACCGGTGGAGGAGACGATGGAGGCGCTGCATGACGTCATCAAGGCGGGCAAGGTCCGCTACATCGGCGCGTCGTCGATGTGGGCCTGGCAGTTCGCCAAGATGCAGCACGCCGCGCAGGCGAACGGGTGGACCCGGTTCGTCTCCATGCAGGACCAGTACAGCCTGCTCCAGCGCGAGGAGGAGCGGGAGATGTTCGGCCTGCTCGCCGACCAGGGCGTGGGCAGCCTGCCGTGGAGTCCGCTGGCCGGGGGACGGCTCGCCCGCCCGTGGGGCGAGGGCGGCACGGCCCGCGCCGAGGTCAGCCCGCCCACCGATCCGTGGGGCCGGCCGCTGTTCCTCGACAGCGACAAGGCGATCGTGCAGGCGGTGCAGCGGATCGCCGAGGAGAGGGGCGTCTCGATGGCGACGGTGGCCATGGCCTGGGTGCTGAGGAACCCGGTCGTGACCGCCCCGATCGTCGGCGCCACCAAGCCGCACCACCTGGCCGACGCCGCCGCGGCCCTGGAGATCCGGCTCACCGACGAGGAGGTCTCCGCGCTCGAATCCCCCTACGCCCCGCGCCTGCCCACGCATTTCTGA	MEYIRLGSAGLKVSRLALGCMSFGTPSPLSPWVLDDEAAEPLFRQAVELGITFWDTANIYGMGTSEEIVGRALRKYASREEIVLATKVLFPMRQGPSRPGLSRKAIIEQLDASLTRLGTDHVDLYQIHRFDPETPVEETMEALHDVIKAGKVRYIGASSMWAWQFAKMQHAAQANGWTRFVSMQDQYSLLQREEEREMFGLLADQGVGSLPWSPLAGGRLARPWGEGGTARAEVSPPTDPWGRPLFLDSDKAIVQAVQRIAEERGVSMATVAMAWVLRNPVVTAPIVGATKPHHLADAAAALEIRLTDEEVSALESPYAPRLPTHF	MRHSLFAPILLLALFALPAWAHEATVNQVKAAERQLEARVGYAELDLASGRLLASYRPDERFPMMSTFKVPLCAAVLARVDAGEEKLDRRVRYRQQDLVEYSPVTEKHLADGMTVAELCAAAITLSDNTAANLLLASVGGPQGLTAFLRRSGDQTSRLDRWETELNEALPGDARDTTTPQAMAKTLRNLLTGSVLSAASRQQLRSWMVDDKVAGPLLRSALPHGWFIADKTGAGNRGSRGIIAALGPDGQPARIVIIYLTGTEASMDERNRQIAEIGETLVKHW	114.79	gnl|BL_ORD_ID|4600|hsp_num:0	5671			582	705	
BGC0000082.1|Kijanimicin_5 # 4339 # 5619 # -1 # ID=1_5;partial=00;start_type=TTG;rbs_motif=AAGG;rbs_spacer=7bp;gc_cont=0.766	BGC0000082.1|Kijanimicin_5 	4339	5619	-	Loose	700	43.1282	oleI	22.64	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	TTGCGAATCCTGTTCACCGTGCCCCCCTTCCCGACCACCCTGTTCCACGCGGTGCCGTTGGCCTGGGCGTGCCGGGCGGCCGGACACGAGGTGCGCATCGCCGCCCAGCCGGAGCTCACCCCGACGACCACCGGCATCGGGCTGATCGCGGTCGAGGTCGGCCACGGCTACGACCTGCTGGACGGCATCCTGCGGGCGCGCGGCGGCCGGCAGGTCGTCGAGTCCCCCGCCGCGGACTGGAAGCGGACGGAGCTGGCCGACTCCCCGCCGGAACCCGGCTCCGCGTCCGCCGGGCTGCCCGCCGACGAGAGGCGCAGGGCCCACGACCGGCTGCTCGCCCCGCACGTCGCGGCGTCCGCCGCGGTCGCGGACGACCTGATGCGGTTCGCCGAACGCTGGCGGCCGGACCTGGTGATCTCCGATCCGCTGCTGTTCGCCGCCCCGCTGGTGTCGGCGGCACTCGGCGTCCCGCTGCTGCGCCACCTGGTCGGGCCCGACATCTGGGGGCGGTTCTGCCCCCTGCAGGGCCAGCCGGACGACGGCGGCGCGCGGGAGCGGTGGCCGGCGGAACTCGTCGCCCTGTACGACCGCTTCGGCGTCGAGGTCCGCGACGACCATCCGGTGGGCGCGATCGACCCCTGGCCGACCAGCCTCCAGCTGCCCGGCGTCGCCGGCCGCGTCCCCGTGCGCTTCGTCCCCTACAACGGATCGGCGGCCGCGCCGGACTGGGTGCTCGACCGGCCCGGCCGGCCGCGCGTGTGCGTCACCTGGGGGACCACGACCGCCGTGCTCGGCGGTGACGACACCTTCGTCCTCCCCCGCGTCCTGGAAGCGCTCGCCGAACTCGACGTCGAGATCGTCCTGGCGGTGACCGCCGCCGAGCGGACGAGGCTCGACTGGATCCCCGGCAACGCGCGGGTCGCCGACAGCGTGCCGCTCCACCTGCTCATGCCCACCTGCGACGCGATCGTGGACCAGGGCGGCGCGGGCTCGGTCCTCACCGCGGCGGCGCACGGCGTGCCCCAGGTGATCATGCCGCGCACCGCGGACACCCCGATCGTCGCCGCCAGCTTCGGCCGCGGCGGGGCGGCCGTCACCCTGGACGCCGACGACGCGACCCGGGAGGCGATCGGCGCGGCGGTGACGCGGACGCTCACCGACGACGCGGTCCGGAACGCGGCGCTGAAGCTGGCCGACGAGATCGCCGCGACCCCGTCGCCCGCCGCCGTGGTGGGCGCGCTGGAGGACCTGGTCGCCCGGCGCCCCGGCGCCCGCGCGTGA	MRILFTVPPFPTTLFHAVPLAWACRAAGHEVRIAAQPELTPTTTGIGLIAVEVGHGYDLLDGILRARGGRQVVESPAADWKRTELADSPPEPGSASAGLPADERRRAHDRLLAPHVAASAAVADDLMRFAERWRPDLVISDPLLFAAPLVSAALGVPLLRHLVGPDIWGRFCPLQGQPDDGGARERWPAELVALYDRFGVEVRDDHPVGAIDPWPTSLQLPGVAGRVPVRFVPYNGSAAAPDWVLDRPGRPRVCVTWGTTTAVLGGDDTFVLPRVLEALAELDVEIVLAVTAAERTRLDWIPGNARVADSVPLHLLMPTCDAIVDQGGAGSVLTAAAHGVPQVIMPRTADTPIVAASFGRGGAAVTLDADDATREAIGAAVTRTLTDDAVRNAALKLADEIAATPSPAAVVGALEDLVARRPGARA	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	100.47	gnl|BL_ORD_ID|1684|hsp_num:0	1824			210	1266	oleandomycin
BGC0000082.1|Kijanimicin_6 # 5842 # 7383 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AAGGA;rbs_spacer=5bp;gc_cont=0.724	BGC0000082.1|Kijanimicin_6 	5842	7383	+	Loose	900	148.288	lmrB	26.42	3002813	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGCGCAGGCGAAGTTGGACGACTCTCCGGCGGGCGACGGCCAGCGTCTCTCGCCGGAGCTGCTGAAGGTCACCGGCGTGGTGCTGCTCGGCATGCTGCTGATGCAGCTCGACGGGACGATGGTCAGCATCGCGCTGGACAAGTTCGTGCGCGAGCTGTCGGTGCCGGTGTCCACGGTGCAGTGGGTGATGACCGCCTACCTGCTCGCGTTGATGGCCGGGATGCCGGTCGCCGGATGGGCGGCCGACCGGTTCGGCACCCGGACGATGTGGAACGTCTCCCTCGCCGCGTTCCTCGTCGGGTCGCTGCTGTGCGGCGTGGCGGACTCGATCTGGACGCTCATCGCGGCGCGGGTGCTGCAGGGCCTCGGCGGCGGCATGATGGTGCCGGTCGGCCAGGCCATGCTCATCCAGCTCAGCGGCGTCGAGCGGCGGGCCCGGCTGGTGTCGCTCATGGCGGTGCCCGCGCTGATCGGCCCCACCCTCGGCCCGGTGCTCGGCGGGGTCATCGTCGACCATCTGAGCTGGCGGTGGATGTTCTTCGTCAACCTTCCGATCGGGCTGGTCGCCTTCCTGGTGGCGAGCCGGGCCATGCCCAACATCAGGGCGCGGAGCGGCGCCGCGCTGGACGTGCTCGGGGTCGCGCTGCTGGTGCCCGGGCTGGTGGCGGTCGTCTACGGCTTCTCCGCGGCCCCCTCCACCGGGTTCGACGGCGCCGGGGCCATCGTGCCGCTCGCGGTGGGGGCGGTCCTGGTCGCCGCGTTCGCGCTGCACGCGTCGCGGCCGAACATCGACGCGCTGGTGTCGATGCGGATGTTCCGGTACCGGGGGTTCGCGACCTCCAGCGCGCTCCTGCTGCTGTCCGGGCTCACCATGGGGGCCGGGTACGTGGATCCGCTGTTCCTCCAGCAGGTCCACGCCGAGAGCGCGTCGGGCACCGGGCTGCTGCTGGTGGCCACGGGCGTCGGATCGGCGCTCGCCTCGCTGGTCATGGGGAAGGCGTTCAACCGGCTCGGGCCGCGCAAGGTCGGCCTCGCGGGCCTCGCCTGCGCCCTTCTCGGCCGCTTCCTGTTCACGCAGTTCGACGCCGGCACCGGCCACCTCGTCATCCTGGTCGCCATGTTCGCGACCGGGGTGGGGCTCGGCATGATGGTGCTGTCCATGACGACCGCGCTCTACATCGGCCTGCCGCCGGACCAGATCGCCCGGGCGGCGAGCGGCTCGCGGATCTTCCAGCAGGTCGGGCTGTCGGCGGGCACCGCGGTGATCGGCGTGGTGCTGCAGTTCCAGCTGGCCGCGCACGGGTCCGCCGGTGGCACGGCCGGGCTCGCCCGCGCCTACGACAACACGTTCTGGTGGAGCGTCGGTTTCCTCGCGCTCGCCGTCGTGCCGACGCTTCTCCTGCCGACGACGGTGCTGGGGGCGAAGACCGGGCCGAAGACAGGGCCGAAGACCGGGCCGGAGCCCGGCAAGGAGTCCGGCAGGGAGCTCGGCAAGGAGCCCGGGCAGGCCGCGGACGTCCCCCGCCCCAGGGAGTCCTGA	MAQAKLDDSPAGDGQRLSPELLKVTGVVLLGMLLMQLDGTMVSIALDKFVRELSVPVSTVQWVMTAYLLALMAGMPVAGWAADRFGTRTMWNVSLAAFLVGSLLCGVADSIWTLIAARVLQGLGGGMMVPVGQAMLIQLSGVERRARLVSLMAVPALIGPTLGPVLGGVIVDHLSWRWMFFVNLPIGLVAFLVASRAMPNIRARSGAALDVLGVALLVPGLVAVVYGFSAAPSTGFDGAGAIVPLAVGAVLVAAFALHASRPNIDALVSMRMFRYRGFATSSALLLLSGLTMGAGYVDPLFLQQVHAESASGTGLLLVATGVGSALASLVMGKAFNRLGPRKVGLAGLACALLGRFLFTQFDAGTGHLVILVAMFATGVGLGMMVLSMTTALYIGLPPDQIARAASGSRIFQQVGLSAGTAVIGVVLQFQLAAHGSAGGTAGLARAYDNTFWWSVGFLALAVVPTLLLPTTVLGAKTGPKTGPKTGPEPGKESGRELGKEPGQAADVPRPRES	METTAKASQQYKVMPIMISLLLAGFIGMFSETALNIALTDLMKELNITAATVQWLTTGYLLVLGILVPVSGLLLQWFTTRQLFTVSLIFSILGTFIAALAPSFSFLLAARIVQALGTGLLLPLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPFLVLALVFGIAYMQNVSETTKPKIDVLSIILSTIGFGGIVFGFSNAGEGSGGWSSPTVIVSLIVGVVGLILFSIRQLTMKQPMMNLRAFKYPMFILGVIMVFICMMVILSSMLLLPMYLQGGLVLTAFASGLVLLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVIVTVVLWFFSNVTTTSTAVLIIILHTCLMIGISMIMMPAQTNGLNQLPREFYPDGTAIMNTLQQMAGAIGTAVAVSIMAAGQHDYMSTVKNPADPAVIPQALTAGVQHAFVFAMIVAIIGLIGAFFMKRVKVDH	107.55	gnl|BL_ORD_ID|540|hsp_num:0	592			93	1248	
BGC0000082.1|Kijanimicin_7 # 7444 # 7755 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GAGG;rbs_spacer=10bp;gc_cont=0.705	BGC0000082.1|Kijanimicin_7 	7444	7755	-	Loose	400	25.7942	IMP-12	52.17	3002203	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	GTGGCGACCGCCACCAAGCTCACGCTCAAGCCGCTCGAAGACCGCATCGTGGTCCAGCAGTCCACGCCCGAGCAGGTCACCGCGTCGGGGCTGGTGATCCCCGACACCGCCCAGGAGAAGCCCCAGGAGGGGACCGTCCTCGCCGTCGGCCCCGGCCGGTGGGAGGAGGGCGGCTCGAAGCGCGTCCCGCTCGACGTGAAGGTCGGCGACACCGTTCTCTACAGCAAGTACGGCGGCACCGAGGTGCGGCACGGCGGCGAGGAGTACCTCGTGCTGTCCGCCCGTGACGTGCTCGCCGTCATCGAGAAGTGA	MATATKLTLKPLEDRIVVQQSTPEQVTASGLVIPDTAQEKPQEGTVLAVGPGRWEEGGSKRVPLDVKVGDTVLYSKYGGTEVRHGGEEYLVLSARDVLAVIEK	MKKLFVLCIFLFLSITASGEVLPDLKIEKLEEGVYLHTSFEEVSGWGVVTKHGLVVLVNNDAYLIDTPFTNKDTEKLVAWFVGRGFTIKGSVSSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKNGKVQATNSFSGVSYWLVKNKIEIFYPGPGHTQDNVVVWLPENKILFGGCFVKPDGLGNLDDANLKAWPKSAKILMSKYGKAKLVVSGHSEIGNASLLKLTWEQAVKGLKESKKPLLPSN	41.87	gnl|BL_ORD_ID|123|hsp_num:0	144			39	108	
BGC0000082.1|Kijanimicin_8 # 7905 # 9533 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=4bp;gc_cont=0.685	BGC0000082.1|Kijanimicin_8 	7905	9533	-	Loose	500	28.8758	OXA-542	33.33	3005768	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGCTGCAAAGATGATCGCGTTCGACGAGGAGGCCCGGCGCGGTCTCGAGCGCGGCATGAACCAGCTCGCCGACGCCGTCAAGGTCACCCTTGGCCCCAAGGGCCGCAACGTCGTGCTGGAGAAGAAGTGGGGCGCCCCCACCATCACCAACGACGGCGTGTCCATCGCCAAGGAGATCGAGCTCGAGGACGCCTGGGAGAAGATCGGCGCCGAGCTGGTCAAGGAAGTAGCCAAGAAGACCGACGACGTCGCCGGTGACGGCACCACCACCGCCACCGTGCTGGCCCAGGCGCTGGTCCGCGAGGGCCTGCGCAACGTCGCCGCCGGCGCCAACCCGATGTCCCTCAAGCGCGGTATCGAGGCGGCGGTCGAACGGGTCAGCCAGGAGCTGCTGAAGCTCGCCAAGGACGTGGAGACCAAGGAGCAGATCGCCTCCACCGCCTCCATCTCCGCCGGTGACGTCCAGATCGGCGAGATGATCGCCGAGGCGATGGACAAGGTCGGCAAGGAAGGCGTCATCACCGTCGAGGAGAGCAACACCTTCGGGCTGGAGCTGGAGCTCACCGAGGGCATGCGCTTCGACAAGGGCTACATCTCGCCCTACTTCATCACCGACAGCGACCGCATGGAGGCCGTGTTCGAGGACCCCTACCTGCTGATCGTCCAGAGCAAGGTCTCGGCCAACAAGGACCTGGTCCCGGTGCTGGAGCAGGTCATGCAGACCGGCAAGCCGCTGGTCATCATCGCCGAGGACGTCGACTCCGAGGCGCTCGCCACGCTGCTGGTGAACCGGATCAAGGGCGTGTTCAAGTCCGTGGCCGTCAAGGCCCCGGGCTTCGGCGACCGCCGCAAGGCCATGCTCGGCGACATCGCCACCCTGACCGGCGGCCAGGTCGTCTCCGAGGACATCGGGCTGAGGCTGGAGTCCACCACCCTGGACATGCTGGGCCACGCCCGCAAGGTCGTGGTGGCCAAGGACGAGACCACCATCGTGGACGGCGCCGGTGACGCCAACGAGATCGCGGGCCGGGTCAACCAGATCCGCGCCGAGATCGAACGGAGCGACTCCGACTACGACCGCGAGAAGCTCCAGGAGCGTCTGGCCAAGCTGGCCGGCGGCGTGGCCGTCATCAAGGCCGGCGCGGCCACCGAGGTGGAGCTCAAGGAGCGCAAGCACCGCATCGAGGACGCCGTCCGCAACGCCAAGGCGGCCGTCGAGGAGGGCATCATCCCCGGCGGCGGCGTGGCGCTGCTGCAGGCCTCGAACGGGGCGTTCGAGAAGCTCGACCTGGAGGGCGACGAGGCCACCGGCGCCAACATCGTCAAGCGCGCCCTGGAGGAGCCGCTGAAGCAGATCGCCGTGAACGCCGGCCTGGAGGGCGGCGTCGTGGTGGAGAAGGTCCGCAACCTGACCCCGGGCCACGGCCTCAACGCCGCCACCGGCGAGTACGTCGACATGTTCGAGGCGGGCATCATCGACCCGGCCAAGGTGACGCGTTCGGCGCTGCAGAACGCCGCCTCCATCGCGGCGCTGTTCCTCACCACCGAGGCCGTCATCGCCGACAAGCCGGAGAAGAACGCCGCTCCGGCCGGCGGCGGCGGCGACATGGGCGGCATGGACTTCTGA	MAAKMIAFDEEARRGLERGMNQLADAVKVTLGPKGRNVVLEKKWGAPTITNDGVSIAKEIELEDAWEKIGAELVKEVAKKTDDVAGDGTTTATVLAQALVREGLRNVAAGANPMSLKRGIEAAVERVSQELLKLAKDVETKEQIASTASISAGDVQIGEMIAEAMDKVGKEGVITVEESNTFGLELELTEGMRFDKGYISPYFITDSDRMEAVFEDPYLLIVQSKVSANKDLVPVLEQVMQTGKPLVIIAEDVDSEALATLLVNRIKGVFKSVAVKAPGFGDRRKAMLGDIATLTGGQVVSEDIGLRLESTTLDMLGHARKVVVAKDETTIVDGAGDANEIAGRVNQIRAEIERSDSDYDREKLQERLAKLAGGVAVIKAGAATEVELKERKHRIEDAVRNAKAAVEEGIIPGGGVALLQASNGAFEKLDLEGDEATGANIVKRALEEPLKQIAVNAGLEGGVVVEKVRNLTPGHGLNAATGEYVDMFEAGIIDPAKVTRSALQNAASIAALFLTTEAVIADKPEKNAAPAGGGGDMGGMDF	MKKVVFPILSIFTLFSLNACSSVQTASESTISAYNQQSKETIKKYFDDAQTQGVIVIKDNNHLAIYGNNLTRAHTQYVPASTFKMLNALIGLENNKVTTDELFKWDGNKKAFPIWEKDMNLDEAMKLSAVPVYQELAKRIGIDLMQKEVKRVNFGNANIGTKVDNFWLVGPLKITPIQEVKFADDLAHNKLPFKIETQETVKNMLLIKEINGSKIYAKSGWGMDVTPQVGWLTGWVEQPTGKIISFSLNLEMKNNMTGSIRNEITYKALENLGII	197.09	gnl|BL_ORD_ID|3803|hsp_num:0	4873			69	195	cloxacillin; oxacillin; cefalotin
BGC0000082.1|Kijanimicin_9 # 9904 # 10536 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AAG;rbs_spacer=8bp;gc_cont=0.763	BGC0000082.1|Kijanimicin_9 	9904	10536	+	Loose	390	31.5722	MexZ	36.07	3003709	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGGACGCGCAACAAGCAGGCCACCCGCGAGGCGATCAGCGCCGCGGCGCTGCGGCTGGCGCTGGAGAAGGGCCCCGAGGGGCTGGCTCTGGTGCGGGTCCGTGACATCGCCGAGGCGGCCGGGGTCGCCCCCCGGACCTACAACAACTACTTCTCCAGCCGGGAGGAGGCGATCTGCGCCTTCCAGGCCGACCAGGCCCGGCGGCTGGGCCGCGCGCTGAGCGCCCGGCCCGCCGGGGAGCCGCTGGACGAGGCCGTCGTCGCGGCGGCGATCGAGGTCTTCGCCGATCCCGAGCCGGACCGGGGCGGGCTGAAGATGATCATGTCCACGCCGTCGTTGCAGGGCGAGGCGCTGAAGGCGTTCGCCATGGCCGAGGAGCCGCTGGCCCTCGCGATCGCCGAACGCGTGGGCGATGACGCCGACGAGCTGCGCCCGGCGGTGCTGGCCGCGGCCGTCGCGGGGGCAGTCCGGGTGGCGGGCCGGCACTGGCTCGACAGCACCGACCCGCAGCCCTTCGCCGAGGTGCTGGACGAGGCGCTGCGGCAGGTGATGCGCCCCGGCACGCTGGCCCCGTCCGCCGAACCGGCCCTGACCCGACCGGCCCTGACCCGGCCGGCCCGGCGGTCCTGA	MRTRNKQATREAISAAALRLALEKGPEGLALVRVRDIAEAAGVAPRTYNNYFSSREEAICAFQADQARRLGRALSARPAGEPLDEAVVAAAIEVFADPEPDRGGLKMIMSTPSLQGEALKAFAMAEEPLALAIAERVGDDADELRPAVLAAAVAGAVRVAGRHWLDSTDPQPFAEVLDEALRQVMRPGTLAPSAEPALTRPALTRPARRS	MARKTKEESQKTRDGILDAAERVFLEKGVGTTAMADLADAAGVSRGAVYGHYKNKIEVCLAMCDRAFGQIEVPDENARVPALDILLRAGMGFLRQCCEPGSVQRVLEILYLKCERSDENEPLLRRRELLEKQGQRFGLRQIRRAVERGELPARLDVELASIYLQSLWDGICGTLAWTERLRDDPWNRAERMFRAGLDSLRSSPYLLLADA	100.00	gnl|BL_ORD_ID|4693|hsp_num:0	2223			27	198	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; chloramphenicol; arbekacin; norfloxacin; ofloxacin; gentamicin
BGC0000082.1|Kijanimicin_10 # 10561 # 22326 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=4bp;gc_cont=0.769	BGC0000082.1|Kijanimicin_10 	10561	22326	-	Loose	660	89.7373	MexS	30.89	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCCCCGGCCCCGCCGAGCTCGAACCGACGGCCAACGAGGAGCGGCTGCGCGACTATCTGAAGCGGACGACGGCCAGCCTCCGGCAGGTCCGCCGGCGTCTCCAGGAGGCCGAGGACCGGGAGCACGAGCCGATCGCCGTGGTGTCGATGGCCTGCCGGTTCCCCGGCGGGGTCGCCTCGCCGGAGGACCTGTGGGACCTGCTGGTGGCCGAGAAGGACACCGTCGGGGACGTCCCCGCCGAACGCGGCTGGAACATCGACGACATCTACGACCCCGACCCCGACGCGGTGGGCAGGACCTACACCCGCGAGGGCTCCTTCCTCGCCGACGCCGACCGGTTCGACGCCGGGTTCTTCGGGATCAGCCCGCGCGAGGCGCTGTCGATGGACCCCCAGCAGCGGCAGATCCTCGAGGTCGCGTGGGAGGCGTTCGAACGGGCGGGACTGCCGCCCTCGACCCTGCGCGGCACCCGCACCGGGGTGTTCGTCGGCAGCGTCGGCCAGACCTACAACATGAGCCTGCTGCCCACGCGGGAACAGGTCGAGGGCTACATCCTGACCGGCACCCAGGCCAGCATCATGTCCGGCCGCATCGCCTACTCCTACGGGCTGGAGGGCCCGACGATCACGGTGGACACCGCCTGCTCCTCGTCGATGGTGGCGATCCACCTGGCGGCCAGGGCGCTGCGTAACCGCGAGTGCGAACGGGCGCTGGCGGGCGGCGTCACCATCATGGCCACCTCCGCGTGGTTCACCGAGTTCAGCCGGCAGCGGGGACTGGCGCCCGACGGGCGGAGCAAGCCGTTCGCGGCGGCCGCGGACGGCATCGGCTGGGGCGAGGGCGTCGGGCTGCTGCTGCTGCGGCGGCTGTCGGACGCGCAGCGCGACGGCGACCGGATCCTGGCCGTGCTGCGCGGGTCGGCGGTCAACTCCGACGGCACCAGCAACGGCCTGACCGCGCCCAACGGCCCCTCCCAGCAGCGGGTCATCGAGCAGGCGCTGGCCGACGCCCGGCTGACCGCCGACGACGTCGACGCGGTGGAGGCGCACGGCACCGGCACCACCCTCGGCGACCCGATCGAGGCGCACGCGCTGCTGGCCACCTACGGGCGGGACCGGCCCGCGGACCGGCCGCTGTGGCTCGGCTCGGTGAAGTCCAACCTCAACCATCCGCAGGGCGCCGCCGGGGTGGCGGGCGTCATCAAGATGGTGCTGGCCCTCCGCCACGGCCTGCTCCCCAGAACGCTGCACGTCGACGAGCCGACCCCGCACGTCAACTGGGACCTGGGGAACGTGCGCCTGCTCACCTCCGCGCGGCCCTGGCCCGAGACCGGGCGGCCGCGCCGCGCGGCCGTGTCGTCGTTCGGCGTCGGCGGCACCAACGCGCACGTCGTCCTGGAGGCCGCGCCGCCGCGCCCGGAGACGCCGCCGCGCCCGGCGGACCCCGCGCCGCCGGTGGTCTCGGCGGGCCCGCCGCCGTGGCTGGTCTCCGCCCGGACCGAGCCGGCCCTGCGCGGCCAGGCGCGGCGGCTGCTGGACTTCGCCGCGGCGCACCCCGACGTCGAGCCCGCCGACATCGCCCACGCGCTGGTCCACGAACGCGACCACCACGAGCACCGCGCGGCCGTCGTCGCCGACACGCGCGAGGACCTCCTGGCGGGCCTGCGCGCGCTGGCGGAGGGCGAGGCGGCGGCGAACGTCGTCCGGGGACGGGGTTCCTCGGCCCGGACCGTGTTCGTGTTCCCGGGCCAGGGCTCCCAGTGGGAACGGATGGCCGTCGACCTGCTGGAGACCTCCGCCGTCTTCCGCGACCACCTGCACGCCTGCGCCGACGCGCTCGCGCCGCACACCGGCTGGTCGCTGGTCGACGTGCTGCGCGGCGCGCCGGACGCCCCGTCGCTGGACCGGGTGGACGTGGTGCAGCCCGCGCTGTTCGCGATGATGGTGTCCCTGGCCCGGGTGTGGCAGGCCGCCGGGATCCGGCCGGACGCGGTGGTCGGCCACTCCCAGGGGGAGATCGCGGCCGCGCACGTCGCCGGGGCGCTCACGCTCGACGACGCCGCCCGGATCGTCGCCCTGCGCAGCCGGGCCCTGCTCGACCTGGCCGGCAGCGGCGGCATGGCCTCGGTGCCGCTGCCCCCGGCCGAGGTCGAGGCGCTGCTGGACCGCCCGGACCGGCGGAACCTCGGCGTCGCCGCCGTCAACTCCCCCGGCTCCACCGTCGTCGCGGGCGCGGCCGGGGAGCTGCGCGAGCTCGTCGACTCCTGCCAGGCGGACGGCGTTCCGGCCCGGCTGATCCCGGTCGACTACGCCTCGCACACCCCGCACGTGGAGCCCGTCCGGGACCGGATCGCGCGGGACCTCGCCGGGATCGTCCCGCGCCCGGCCGACGTCCCGTTCTACTCGACCGTCACCGCCGGGCCGATCGACACCGGCGGCCTCGACGGCGACTACTGGTACACCAACCTGCGCCACCGGGTCAGGTTCGAGGAGACCACCCGCGCCCTGCTCGCCGATGGCCACACCCTGTTCATCGAGGTGAGCCCGCATCCGGTCCTCACCGTCCCGATCCAGGAGACCGTCGAGGACGACGGCGGCGCGGCGGTGGCGGTCGGCACGCTCCGCCGCGACCGGGGCGACCGGACCCGGCTGCTCACCGCCCTGGCCGAGGCGCACGTCAACGGCGCGTCACCGGACTGGTCGCGGACCGTGCCGGACCGCGAGGCGGTCCCCGTCGACCTGCCGACCTACGCGTTCGCCGGGGAACGGTACTGGCCCGACACCACGGAGCGGGCCGGGGACGTCCGGTCGGCCGGGCTGGGCCCGGCCGACCCACCCCGGCCTCTGGCCGCCGAGACGATGCTCGCCGACGGCACCGGCCACCTGTTCTCCGGGCGGCTCTCCCTGGGCACCCACGGCTGGCTCGCCGACCACACCGTGCACGGCTCGGTGATCGTCCCGGCCACCGCCTTCGCCGAGCTGGCCCTGCACGCCGCGCACCGCGCCGGCTGCGCCCGGCTGGAGGAGCTGACGCTGCGGACGCCGCTGACCCTGCCGGACGGGGACGCGGTGCGGATCCAGGTGATCGTCGGCGTGCCGGGGCCGGACGGTGAGCGCCCCGTCGGCATCCACTCCCGGCCGGAGGACGCCGACGAGGCCCCGTGGGTGACGCACGCGACCGGCGTCCTGAGCCCGCGCGCCCCGGCCCCGCCGGAGCCCGGCGGGGCCTGGCCGCCCGAGGGGGCGACGCGGCTGGACACGGCCGAGGTCTACCCGCGGCTCGGCGGCATCGGACTGGACTACGGGCCCGCCTTCCGGGGGCTGCGCGCCGCCTGGCGGCACGGCGACGACCTCTACGCCGAGGTCGAGCTGCCCGACGACGTCGACACCGGGGGCTTCGCGCTGCACCCGGCGCTGTTCGACGCCGCGCTGCACGTGACCGCGCTGGCCGGGGACGGCCACGACGGCCGGACCCGGCTGCCGTTCGCCTGGAGCGGCGTGTCCGTGCACGCCGTCGGCGCCACCGCCGTCCGGGTACGGCTCGCCCTGACCGGGCCGGACACCGTCGGCCTGACGCTGTTCGACACGGGCGGCGCCCCGGTGGCGACGGTCGACGCGCTCACCGTCCGCCCGCTCACCGCCCGGCAGGCCGGCCGGGCCTCCGCGGTCCGGCGCGACACGCTCTACCGTCTCTCCTGGCGGCCGGTCACCGCCGACGGCCCGGCCGGGGAGCCGGGAGACTGGGCCGTTCTCGGGGCCGCCCCCGAAGGGCTCGGGGACGGCGTCCGGCGCGTCACCGACCTGGAGTCACTGCCCGCCGAGGTCCCGGCCACGGTCGTGACCTTCGTCGGCTCCGGCGACACCGGCGGGACCCCGGTCGAGGACGCCCACGCGACGACGCACCGCGTGCACGGGCTCGTCCGGCGCTGGCTCGCCGACGAACGGTTCGAGAACAGCAGGCTCGTCGTGGTGACCGAACGGGCCGTCGCCGTCCGCGCCGGGGAACACGTCACCGGGCTGGCCGCCGCACCGGCGTGGGGGTTCCTGCGGGTCGCCCAGTCGGAGCACCCGGACCGGTTCGGCCTCGTGGACCTCGACGGCCGCGACGGCTCCCTCCGGCGGCTGCGGGAGGCCCTCGCCACCGACGAGCCGCAGCTCGCGCTGCGGGACGGCGAGATGTTCGCGGCGCGGCTGGTCCACGCCGACACCGAGACGCCGCTGGCACCGCCGGACACCCCGGCGTGGCGGCTGGCGAGCACCGGTCCGGGCAGCATCGAGAACCTCGTCCTGGAGCCCTGCGCCGCCCACGACCGGCCGCTGGAGGGCGGCGAGGTCCGGGTCGCGGTACGCGCCGGCGGGGCCAACTTCCGCGACGTGCTCCTCGCGCTCGGCCTGTACCCCGGCGAGGCCCACATCGGCAGCGAGGCCGCCGGGGTCGTCGTCGAGACCGGGGCGGACGTCACCGACCTCGCGCCCGGCGACGCCGTCATGGGCCTGTTCCCCGAGGGGGCCGTCGGGCCGGTCGCGGTGGCCGACCGGCGGGCGCTGACCCGGGTGCCGCCCGGCTGGACGTTCGTCCAGGCGGCCGCCGCGCCGGTCGCGTTCCTCACCGCCTACTACGCCCTGCGCGACCTGGGCGGGCTCCGGGCGGGCCAGCGGCTGCTGGTGCACGCCGCGACCGGCGGCGTCGGCATGGCCGCCGTCCAGCTCGCGCGGCACTGGGGCGCGGAGGTCTACGCCACCGCCAGCACCCCCAAGTGGGGGACGCTGCGCGCGATGGGCTTCGACGACGACCACATCGCGGACTCGCGGACCCTCGCGTTCGAGGACGAGTTCCGCGCCGCCACCGGCGGCGAGGGGATGGACGTGGTCCTGGACTCCCTCGCCGGTGAGTTCGTGGACGCGTCGCTGCGGCTGCTGCCCCGGGGCGGGCGCTTCCTGGAGATGGGCAAGACCGACGTCCGCGACGCCGACGAGGTCGCGCGGCGGCATCCCGGCGTCGCCTACCGCGCGTTCGAGACGGTCGAGGCCGGACCCGACCACGTCGGGCGGATGCTGGCGGAACTGGACGCGCTGTTCGCCGAGGGCGCGCTGCGCCCCCTGCCCGTGACGGCCTTCGACGTCCGGCACGCGCCCCAGGCGTTCCGGCTCATGAGCCAGGCCCGCCACACCGGCAAGCTCGTCCTCACCCTCCCCCGGCCGCTCGCGGCCGACGGCACGGTGCTGGTCACCGGCGGCACCGGCACGCTCGGCGCGGCCGTCGCCCGGCACCTGGTCGTCGAGCACGGCGTCGGGCACCTGCTGCTGGCCAGCCGGAGCGGACCGGACGCCGCCGGGGCGGCCGAACTCCGGGCCGAGCTGGCCGGGCTCGGCGCCACGGTCACCGTCCGGGCGTGCGACACCTCCGACCGCGACGACCTGCGCCGGCTGCTCGACGCGATCCCGCCGGAACACCCCCTCACCGCCGTCGTCCATTCGGCGGGCGTGACCGACGACGCCGCCGTCGGCGTGCTGGAGGCCGAGCAGCTCGACCCCGTGCTGCGGCCCAAGATCGACGCGGCATGGCACCTCCACGAGCTGACCCAGGACCACGACCTCAGCGCGTTCGTGCTGTTCTCCTCCCTCGCCGGGACCCTCGGCAACCCCGGGCAGGCCAACTACGCGGCGGGCAACACCTTCCTGGACGCGCTGGCCGCGCACCGCCGCGCCCGGGGTCTTCCGGCGGTCTCGCTCGCCTGGGGACTCTGGCGGCGGGCCAGCGGCATCACCGCCGAGCTGTTCGAGGAGAAACGCCACGCCGTCGCGCACGACGTGCTCACCACCCTGTCCGACGCCGAGGCGCTCGCGCTCTTCGACATCGGCCTCGACGACGGGCGGCCCGACCTCGTGCCCGCCGGGCTCGACCTCGCCGCGATCCGCGCGGCGGCCGAGGAGCGGCCCGCGCCGGCCGTGCTGCGCGGCTTCCTGCGCGCCCCCCGGCGGCGGGCGGGCGGCCGGACGGGCGGGCAGGGCGCGCTCCAGCGGGAGCTGGCCGGTCGCTCCGAGGCCGAGCGGTTCGACTTCCTGCTGGATCTGGTGCGCGGCGACATCGGCGTCGTGCTGGGCCATCCCGCGCCGGAGACGATCGATCCCCGGCGGCCCCTCCAGGAGATCGGCTTCGACTCGCTCACCGCCGTCGAGCTGCGCAACCGGCTCAACGCCGCGACCGGGCTGCGGCTCCCGGCGACCCTGGTCTTCGACCACCCCAACGCCGCCGCGCTCGCCGAACACCTGCGCGAACGGCTCAGCGGCCAGGTCCGCGCCGCACCCGTCCGCCCGGCGGCGGCCGGGGCCGGGGGCGACGACCCGATCGTGATCGTCGCGATGGCGTGCCGGTTCCCCGGCGGCGTGCGGTCCCCGGAGGACCTGTGGGACGTCGCCGACCTCGGCCGGGAGACGGTGTCGGGGTTCCCCGACGACCGGGGCTGGGACCTGGACGCCCTGTTCGATCCCGACCCCGACCGTCCCGGCACCTCCTACGTCGACCGGGGCGGGTTCCTCGACGAGGCGGGGCACTTCGACGCCGAGTTCTTCGGGATGAGCCCCCGGGAGGCGCTGGGCACCGACCCGCAGCAGCGCGTCCTGCTCGAAACCGCCTGGGAGGCCCTCGAACGGGCCGGGATCCCGCCCGCGTCGCTCCGCGACAGCCGCACCGGCGTCTTCGTCGGCATGACCGCCTACGGCTATCCCGGCGGGGCGGCGCGCACCTCGGAGGCGGTGGAGGGGTACCTGCTGACCGGCGCGGCGAGCAGCGTCGCGTCCGGCCGCATCGCCTACGTCCTCGGCCTGGAGGGACCCGCCGTCACGGTCGACACCGCCTGCTCCTCCTCCCTGGTCTCCCTGCACCTGGCCGCCCAGGCACTGCGCAACGGCGACTGCGACCTCGCGCTGGCGGGCGGGGTGACCGTGATGCCCTCGCCGAGCGTCTTCGTCGGGTTCAGTCGCCAGCGCGGGCTGGCGCCGGACGGGCGGTGCAAACCGTTCGACGCCGCCGCCGACGGCACGGTGTTCTCCGAGGGCGTCGGGTTGCTGCTGGTGGAGCGGATGTCGGACGCCCGCCGCAACGGCCACCAGATCCTCGCCACCGTCCGCGGCACCGCCATCAACTCCGACGGCGCCAGCAACGGCCTCACCGCCCCCAACGGACCCTCCCAACAACGCGTCATCCACCAAGCCCTCACCAACGCCCACCTCACCCCCACCGACATCGACGCCATCGAAGCCCACGGCACCGGCACCACCCTCGGCGACCCCATCGAAGCCCAAGCCCTCATCGCCACCTACGGACAAAACCGCCCCACCGACCAACCCCTCTGGATCGGCTCCATCAAATCCAACATCGGGCACACGCAGCAGGCGGCGGGCGCGGCGAGCCTGATCAAGATGGTGCAGGCCATGCGGCACGGGCGGCTGCCCGGCATCCCGCACACCGACACGCCGACGCCGCACGTCGAGTGGGAGTCCAGCGGCGTCGCGGTGCTGACCGAGACCGTGCCCTGGCCCGAGACCGGGCGGCCGCGCCGCGCGGCCGTCTCGGCGTTCGGCATCAGCGGCACCAACGCCCACGTCATCCTCGAACAGCCGCCCGCCGCCGACCCGGTGCCCGCGCCCGCCCCCGCCGGACCGGCGGTCCTCGCGCCGGACGCGCCCGCCGTCGCCTGGCCGGTGTCGGGCCGGTCCGAGGCCGCGCTCCGGGAGCAGGCCGCCCGCCTCGCCGAGCGCGCCGACGACCTGCCCTCCCCCACCGAGGTGGCCTGGGCGCTCGCCACGACGCGTTCGACGTTCGACCACCGCGCCGTCGTCGTCGGCCGCGACCGCGCCGAGCTCCGCGCCGGGCTCGCGGCCGTCGCCGCGGGCGAGCCGCACCCGGCGGTGGTGCGGGGCGCGGCCCCCGCCGGTCCGGTCCGGACCGTCCTGGTGTTCCCGGGGCAGGGCTCGCAGTGGGAGGGCATGGCGCTCGACCTGCTGGAGCGGTCGCCGGTGTTCGCCGAGCACCTGCGCGCCTGCACCGACGCCCTCGCGCCGCACACCGGCTGGTCCCTGCTCGACGTGCTGCGCGGCGCGCCCGGCGCGCCGGGCCTGGACCGCGTGGACGTGGTCCAGCCCGCGCTGTTCGCCGTCATGACGTCGCTGGCCGAGCTCTGGAAGGCCGCGGGCGTCGTCCCGGATGCGGTCGCGGGCCACTCCCAGGGGGAGATCGCCGCCGCGTACGTGGCGGGGGCGCTGTCGCTCCCGGACGCCGCCCTGGTGGTGGCGCTCCGCAGCCGGATCCTGACCCGGCTCGCCGGGACCGGGACGATGGCCTCGGTGCCGCTGCCCGCCGACGCCGTCGCCGGACGGCTGGCGGCCGGGGCGGACGCCGACGTCCACCTCGCCGCGATCAACGGGCCGGACAGCTCCGTGGTCGCGGGCGGCGCCGACGCCGTCCGCGCGTTCGTGGCGCGGTGCGAGGCCGACGGCGTCCGCGCCCGGCTGATCGCCGTGGACTACGCCTCGCACACCCCGCACATCGAGACGCTCCGCGACGAGCTGGCGCGGGCCCTCGCCCCGGTGCGGCCGCGCGCGGGGACGGTGCCNTTCTACTCCGCCGTCACCGGCGGGATCGTGGACGGCGCCGAGCTGGACGCCGGGTACTGGTACCGCAACCTGCGGCACACCGTCCAGTTCGGCATCACCACCGAGGCGCTGCTGGACGCCGGTCACCGCCTGTTCGTCGAGGCGGCCCCGCACCCCGTCCTGACGGTGGGCGTGCGGCAGACCCTGGAACGCGCCGGGGCCGGGGCCGCGGCGATCGGCACGCTGCGGCGCGACGAGGGTGACGCCCGCGCCCTGCTCACCGCCTTCGCCGAGGCCCATGTCCACGGGGCCCCGCTGGACTGGACGAGGGTGCTCACCCCGGGGACCGGGAAGGTCGACCTGCCGACCTACGCGTTCCAGCGCGACCGGTACTGGCTGAGCCCCGCGGCCGCGACCGGCGACGTGACGGCGGGCGGGCTGACCGACACCGGCCACCCCCTGGCGGCGGCGAGCCTGCCGGTCGCCGGGGACGACCGGCGGGTCCTCAGCGGCCGGATCTCGCTGCGCACCCATCCCTGGCTCGCCTACCACCAGGTGAACGACGTGGTGCTGGTGCCTGGGACGGCGTTCGTCGAACTGGCGCTGCACGCCGCCCGTGAGGTCGGCTGCGCCGCGGTGGAGGAGCTCACCCTGCTCACCCCGCTGGTGGTGCCCGAGCGGGGCGGCGTCCGGATCCAGGTCGTCGTGGGGGCGCCCGAGGCGACCGGCGCGCGCCCCGTCACGGTGCACTCCCGCCCGGACTCCGACGACGACGCCGAGTGGACCCTGAACGCCACCGGCGCGCTGGCCCCGGAGGGCGCGGCGACCGCGGACGCGCTGCCCGAGTGGCCGCCCGCCGGAGCCGAACGGGTCGACGCCGGAGCCGTCTACGACCGGTTCACCACCAACGGCCAGACCTACGGCCCGGTCTTCCAGGGCCTGCGGGCCGCCTGGCTCCACGGCGACGACGTCTACGCCGAGGTGACCCTCCCCGAGGACGTCGGCATCGAGGGGTTCGGCGTCCATCCGGCCCTGCTGGACGCCGCCCTGCACGCCCTGATGGCGCGGCGGCCCGCGACCGACCCGTCCGAGGCGGCGGTGCTGCTGCCGTTCTCCTGGACGGGGCTGTCCCTCACCGCGACCGCGGGCCGGACGCTCCGCGCCCGGCTCCGGCCCACCGCCGACGGCGACGGCCTGACCGTGGACCTGGCCGACGGCGCGGGGCGGCCCCTCGCACGCGTCGGATCGCTCCGGCTGCGGCCGCTCGACCCCCGTCGTCTCACCGCCGACCAGGGGCGCGGCGCGGCGCTGACGACCGAGTGGGTCGAGGCCGGACCGGCCGCGGCCCCCGCCCCGACGCTGGCGTTCGTCGGCGACACCGGCGTCCCGGACGTCCGGTCCGAACGCCACGAGGACCTGGACGCGCTCCGCGCGGCCGTCGCCGACGGCGCTCCCCCGCCGCAGGCCGTCGTCATGGCCTGCCCCGGCGGGGTCACGGCCGACCCCGCCGCCGACGCGCACGCGGCGACCCGCCGCGCCCTGGAGCTGGTCCAGCGCTGGTCGGCCGACGAGACGTTCGCCGCGTCGTCCCTGGTCCTGGTGTCGCGCGGCGCTGTCCCCGGCGGCGGCCGGGAGGACGTCACGGACTTGGCGGCCGCGGCCGTGTGGGGCCTGGTGCGCAGCGCGCAGTCGGAGAACCCGTTCCGCTTCCAGCTCGTCGACGTCGACGCCGGGACCACCGAGGACGCGCTCGCCGCCGCGCTCGCGCTCGGCGAACCGCAGGCGGCGATCCGCGGCGGGAAGGTCCGCCTGCCCCGCCTGGCGCGGCGGCCCGCGGGCGATCCCGGGCAGGGCCCGGAGGTGTTCCGGGCGGACGGGACGGTGCTGGTCACCGGCGGCACCGGCACGCTCGGCGGCCTCGTCGCCCGGCACCTGGTCACCGCCCACGGCGTCCGGCACCTGGTCCTGGTCAGCCGCGCGGGACTGGCGGCGGACGGCGCGCCGGACCTGGCGGCCGAGCTGGCCGGGCTCGGCGCGACGGTCACCGTCACCGCCTGCGACACCGCCGACCGCGACGCGCTGGCCGGGGTGCTCGCCGCGATCCCCGGCGAGCACCCCCTCACCGGGGTCGTGCACGCCGCCGGGACGCTGGACGACGCGACGGTGCCCAACCTCACCCCGGACCGGCTGGACACCGTCCTGCGGCCCAAGGCCGACGCCGCCTGGAACCTGCACGTGCTCACCGCGGGGCTCGACCTGGCGGCGTTCGTCCTGTTCTCCTCCGCCGCCGGGACCCTCGGCGCCCCCGGCCAGGCCAACTACGCCGCCGCCAACGCGTTCCTCGACGCGCTCGCCGCGCACCGCCGTGCCCTCGGGCTGCCCGCCGTGTCCATGGCCTGGGGCCCGTGGGAGCCGGCGAGCGCGCTGACCCGGGGGCTGGCGGAGCAGGACCAGGCCCGGGTGACCGCCCGCCGCGGCCTGGTCCCGCTGTCCACCGGCGACGCGCTCGCCCGCTTCGACGCCGCCGTCGGCGCGGAACACGCGGTCCCGGTGCTCGCCGAACTCGACATGCGGCACCTGCGCGCGCAGGTCGTCGCCGACGCCCTGCCGCCGGTGCTGCGTGGCCTGGTGCGGGTCCCGCCGCGCCGGGCGGACGACGCCGGTGGCTCCGTCGCCGAACGGCTCGCCGGGCATGACCGCGAGGAGCAGCTGGAGATCGTGGCGGACCTGGTGCGCGGTCAGATCGCCGCCGTGCTCGGCCACGGGTCACCGGCCGGGATCGCCGTCGATCGCGCCTTCCAGGACCTGGGGTTCGACTCGCTCACCGCGGTGGAGCTGCGCAACCGGCTCGGCGGGGCGACCGGGCTCCGGCTCCCGGCCACCCTCGTCTTCGACTACCCGACGGTGCGGGCACTGTCGGAGTACGTCCTGGGCCTTCTCGCCGCGCCCGAGCCGTCGCCCGCCGACACCGTCCTGGCCTGCCTCGACCAGCTGGAGGCGGCCCTGGCGACGCTTCCGGACGGCTCCGCCCGCGAACCGGTCGACCGGCGGTTGCGGCTCCTGCTCGGGCGGACGGACGGGACGGCCGGAGCGGACGGCGCGGAGATCGAGGGCGCCTCGGCCGACGAGCTCATGGACTTCATCGACCGGGAGCTCCGGCAGGCGTGA	MTPGPAELEPTANEERLRDYLKRTTASLRQVRRRLQEAEDREHEPIAVVSMACRFPGGVASPEDLWDLLVAEKDTVGDVPAERGWNIDDIYDPDPDAVGRTYTREGSFLADADRFDAGFFGISPREALSMDPQQRQILEVAWEAFERAGLPPSTLRGTRTGVFVGSVGQTYNMSLLPTREQVEGYILTGTQASIMSGRIAYSYGLEGPTITVDTACSSSMVAIHLAARALRNRECERALAGGVTIMATSAWFTEFSRQRGLAPDGRSKPFAAAADGIGWGEGVGLLLLRRLSDAQRDGDRILAVLRGSAVNSDGTSNGLTAPNGPSQQRVIEQALADARLTADDVDAVEAHGTGTTLGDPIEAHALLATYGRDRPADRPLWLGSVKSNLNHPQGAAGVAGVIKMVLALRHGLLPRTLHVDEPTPHVNWDLGNVRLLTSARPWPETGRPRRAAVSSFGVGGTNAHVVLEAAPPRPETPPRPADPAPPVVSAGPPPWLVSARTEPALRGQARRLLDFAAAHPDVEPADIAHALVHERDHHEHRAAVVADTREDLLAGLRALAEGEAAANVVRGRGSSARTVFVFPGQGSQWERMAVDLLETSAVFRDHLHACADALAPHTGWSLVDVLRGAPDAPSLDRVDVVQPALFAMMVSLARVWQAAGIRPDAVVGHSQGEIAAAHVAGALTLDDAARIVALRSRALLDLAGSGGMASVPLPPAEVEALLDRPDRRNLGVAAVNSPGSTVVAGAAGELRELVDSCQADGVPARLIPVDYASHTPHVEPVRDRIARDLAGIVPRPADVPFYSTVTAGPIDTGGLDGDYWYTNLRHRVRFEETTRALLADGHTLFIEVSPHPVLTVPIQETVEDDGGAAVAVGTLRRDRGDRTRLLTALAEAHVNGASPDWSRTVPDREAVPVDLPTYAFAGERYWPDTTERAGDVRSAGLGPADPPRPLAAETMLADGTGHLFSGRLSLGTHGWLADHTVHGSVIVPATAFAELALHAAHRAGCARLEELTLRTPLTLPDGDAVRIQVIVGVPGPDGERPVGIHSRPEDADEAPWVTHATGVLSPRAPAPPEPGGAWPPEGATRLDTAEVYPRLGGIGLDYGPAFRGLRAAWRHGDDLYAEVELPDDVDTGGFALHPALFDAALHVTALAGDGHDGRTRLPFAWSGVSVHAVGATAVRVRLALTGPDTVGLTLFDTGGAPVATVDALTVRPLTARQAGRASAVRRDTLYRLSWRPVTADGPAGEPGDWAVLGAAPEGLGDGVRRVTDLESLPAEVPATVVTFVGSGDTGGTPVEDAHATTHRVHGLVRRWLADERFENSRLVVVTERAVAVRAGEHVTGLAAAPAWGFLRVAQSEHPDRFGLVDLDGRDGSLRRLREALATDEPQLALRDGEMFAARLVHADTETPLAPPDTPAWRLASTGPGSIENLVLEPCAAHDRPLEGGEVRVAVRAGGANFRDVLLALGLYPGEAHIGSEAAGVVVETGADVTDLAPGDAVMGLFPEGAVGPVAVADRRALTRVPPGWTFVQAAAAPVAFLTAYYALRDLGGLRAGQRLLVHAATGGVGMAAVQLARHWGAEVYATASTPKWGTLRAMGFDDDHIADSRTLAFEDEFRAATGGEGMDVVLDSLAGEFVDASLRLLPRGGRFLEMGKTDVRDADEVARRHPGVAYRAFETVEAGPDHVGRMLAELDALFAEGALRPLPVTAFDVRHAPQAFRLMSQARHTGKLVLTLPRPLAADGTVLVTGGTGTLGAAVARHLVVEHGVGHLLLASRSGPDAAGAAELRAELAGLGATVTVRACDTSDRDDLRRLLDAIPPEHPLTAVVHSAGVTDDAAVGVLEAEQLDPVLRPKIDAAWHLHELTQDHDLSAFVLFSSLAGTLGNPGQANYAAGNTFLDALAAHRRARGLPAVSLAWGLWRRASGITAELFEEKRHAVAHDVLTTLSDAEALALFDIGLDDGRPDLVPAGLDLAAIRAAAEERPAPAVLRGFLRAPRRRAGGRTGGQGALQRELAGRSEAERFDFLLDLVRGDIGVVLGHPAPETIDPRRPLQEIGFDSLTAVELRNRLNAATGLRLPATLVFDHPNAAALAEHLRERLSGQVRAAPVRPAAAGAGGDDPIVIVAMACRFPGGVRSPEDLWDVADLGRETVSGFPDDRGWDLDALFDPDPDRPGTSYVDRGGFLDEAGHFDAEFFGMSPREALGTDPQQRVLLETAWEALERAGIPPASLRDSRTGVFVGMTAYGYPGGAARTSEAVEGYLLTGAASSVASGRIAYVLGLEGPAVTVDTACSSSLVSLHLAAQALRNGDCDLALAGGVTVMPSPSVFVGFSRQRGLAPDGRCKPFDAAADGTVFSEGVGLLLVERMSDARRNGHQILATVRGTAINSDGASNGLTAPNGPSQQRVIHQALTNAHLTPTDIDAIEAHGTGTTLGDPIEAQALIATYGQNRPTDQPLWIGSIKSNIGHTQQAAGAASLIKMVQAMRHGRLPGIPHTDTPTPHVEWESSGVAVLTETVPWPETGRPRRAAVSAFGISGTNAHVILEQPPAADPVPAPAPAGPAVLAPDAPAVAWPVSGRSEAALREQAARLAERADDLPSPTEVAWALATTRSTFDHRAVVVGRDRAELRAGLAAVAAGEPHPAVVRGAAPAGPVRTVLVFPGQGSQWEGMALDLLERSPVFAEHLRACTDALAPHTGWSLLDVLRGAPGAPGLDRVDVVQPALFAVMTSLAELWKAAGVVPDAVAGHSQGEIAAAYVAGALSLPDAALVVALRSRILTRLAGTGTMASVPLPADAVAGRLAAGADADVHLAAINGPDSSVVAGGADAVRAFVARCEADGVRARLIAVDYASHTPHIETLRDELARALAPVRPRAGTVPFYSAVTGGIVDGAELDAGYWYRNLRHTVQFGITTEALLDAGHRLFVEAAPHPVLTVGVRQTLERAGAGAAAIGTLRRDEGDARALLTAFAEAHVHGAPLDWTRVLTPGTGKVDLPTYAFQRDRYWLSPAAATGDVTAGGLTDTGHPLAAASLPVAGDDRRVLSGRISLRTHPWLAYHQVNDVVLVPGTAFVELALHAAREVGCAAVEELTLLTPLVVPERGGVRIQVVVGAPEATGARPVTVHSRPDSDDDAEWTLNATGALAPEGAATADALPEWPPAGAERVDAGAVYDRFTTNGQTYGPVFQGLRAAWLHGDDVYAEVTLPEDVGIEGFGVHPALLDAALHALMARRPATDPSEAAVLLPFSWTGLSLTATAGRTLRARLRPTADGDGLTVDLADGAGRPLARVGSLRLRPLDPRRLTADQGRGAALTTEWVEAGPAAAPAPTLAFVGDTGVPDVRSERHEDLDALRAAVADGAPPPQAVVMACPGGVTADPAADAHAATRRALELVQRWSADETFAASSLVLVSRGAVPGGGREDVTDLAAAAVWGLVRSAQSENPFRFQLVDVDAGTTEDALAAALALGEPQAAIRGGKVRLPRLARRPAGDPGQGPEVFRADGTVLVTGGTGTLGGLVARHLVTAHGVRHLVLVSRAGLAADGAPDLAAELAGLGATVTVTACDTADRDALAGVLAAIPGEHPLTGVVHAAGTLDDATVPNLTPDRLDTVLRPKADAAWNLHVLTAGLDLAAFVLFSSAAGTLGAPGQANYAAANAFLDALAAHRRALGLPAVSMAWGPWEPASALTRGLAEQDQARVTARRGLVPLSTGDALARFDAAVGAEHAVPVLAELDMRHLRAQVVADALPPVLRGLVRVPPRRADDAGGSVAERLAGHDREEQLEIVADLVRGQIAAVLGHGSPAGIAVDRAFQDLGFDSLTAVELRNRLGGATGLRLPATLVFDYPTVRALSEYVLGLLAAPEPSPADTVLACLDQLEAALATLPDGSAREPVDRRLRLLLGRTDGTAGADGAEIEGASADELMDFIDRELRQA	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	1156.64	gnl|BL_ORD_ID|1039|hsp_num:0	1041			84	1005	ciprofloxacin; trimethoprim; chloramphenicol
BGC0000082.1|Kijanimicin_11 # 22540 # 23979 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=8bp;gc_cont=0.716	BGC0000082.1|Kijanimicin_11 	22540	23979	+	Loose	350	27.7202	vanB	43.59	3000013	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGAGCGCCATCCTCGGCCGGTCCGGGCCTCGGCCGCAGACCCTTCCGGACGGGGCCCGCGTCCTGCGGTCGGCCCTGGCGACCGAGGGCGTGGCGACCACCGACGAACGGTTCGCCGCCTGGCTCGCCGAGTGCGAGCGGACCAACCGGATGCTGGTCGAGCGGGTGCCGCTCACCGAGCTGCGCGGCTGGCGCTTCACCGAGGGCGACGGCTCGCTGGTGCACGAGAGCGGGAGGTTCTTCAGCGTCGACGGGGTGCGGGTGACCCGGACCGGGCGGGATCCGCGTTCCTGGGGGCAGCCGCTCATCGACCAGCCCGAGGTCGGCATCCTCGGCCTGCTGGCGAAGGAGTTCGACGGCGTCCTGCACTTCCTGATGCAGGCCAAGATCGAGCCGGGCAACCGGCGGCGGTTGCAGCTCTCCCCGACGGTGCAGGCCACCAAGAGCAACTACACCAAGGTGCACGGCGGCGCCGCCACCCCGTACCTGGAGCACTTCCTGCGGCCGGGCCGGGGCCGGGTGATCACCGATGTGCTCCAGTCCGAGCAGGGCACCTGGTTCCTGGGCAAGCGCAACCGCAACATGGTCGTCGAGACGACCGGCCCGGTGCCGGTCCTGGACAGCTTCTGCTGGCTGACCCTCGGGCAGATCCGGCGGCTGCTGACCGTGCCGAACCTGATCAACATGGACTCCCGGACGGTGCTGGCCTGCCTGCCGGTCGCGGCGTCCGGCTGGCCGGACGAGCCGTCCGGCCCGGGGTTCGCGGCCGACCTGCGGCGGTCGGTCCAGGCGGGGGAGGCGGACGGCCCGCACACCGACGTCGAGATCCTGAGCTGGCTCAACGACGTGCGGACCGAGACCGGGCAGAGCGTCGAGCGGGTCCCGCTGTCGGCGCTGGAGGACTGGCGGGTGTCGCGGGACGACATCGCGCACCGGGACGGCCGGTACTTCCGGGTCATCGGCGTCTCGGTGGAGAGCGGCCACCGCGAGGTCAAGGCGTGGTCCCAGCCGCTGCTGGCCCCCTGCGGCACCGGGGTGGTCGCCTTCCTGACCAGGCGGGTCGACGGCGTGCTCCAGGTGCTGATGCGGGCCTCGGTCGAGCCGGGGTTCCTGGACGTCGTCGAGCTCGGCCCCACCCTCCAGTGCGATCCGGCCAACTACGCCGACGCGCCGCCCGAGAGGCGCCCGCGCTTCCTCGACCGCGTGCTCGGCGCGACCGGCGACGTCCGCTACGACGTGGTCCTGTCGGAGGAGGGCGGCCGGTTCCACCACGCCGAATGCCGCTACATGGTGGTCGAGTGCGACGACGCGGAGGCGGTGGAACCGCATCCGGATTTCCGCTGGATGACCGTCCGGCAAATCCTGTCGCTGCAACGGCACACCAATTATCTCAACGTTCAGACGCGCAGTCTTCTCGCCTGCCTGAGTTCTCTCTGGTGA	MSAILGRSGPRPQTLPDGARVLRSALATEGVATTDERFAAWLAECERTNRMLVERVPLTELRGWRFTEGDGSLVHESGRFFSVDGVRVTRTGRDPRSWGQPLIDQPEVGILGLLAKEFDGVLHFLMQAKIEPGNRRRLQLSPTVQATKSNYTKVHGGAATPYLEHFLRPGRGRVITDVLQSEQGTWFLGKRNRNMVVETTGPVPVLDSFCWLTLGQIRRLLTVPNLINMDSRTVLACLPVAASGWPDEPSGPGFAADLRRSVQAGEADGPHTDVEILSWLNDVRTETGQSVERVPLSALEDWRVSRDDIAHRDGRYFRVIGVSVESGHREVKAWSQPLLAPCGTGVVAFLTRRVDGVLQVLMRASVEPGFLDVVELGPTLQCDPANYADAPPERRPRFLDRVLGATGDVRYDVVLSEEGGRFHHAECRYMVVECDDAEAVEPHPDFRWMTVRQILSLQRHTNYLNVQTRSLLACLSSLW	MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWEADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVGCDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGVTKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIFRIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGIVLNEVNTLPGFTSYSRYPRMMAAAGITLPALIDSLITLALKR	140.06	gnl|BL_ORD_ID|1005|hsp_num:0	1098			780	897	vancomycin
BGC0000082.1|Kijanimicin_14 # 26565 # 27770 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=6bp;gc_cont=0.778	BGC0000082.1|Kijanimicin_14 	26565	27770	+	Loose	700	52.7582	oleI	23.66	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGCGTTCTGTTCACCCTGCCCGCCGCGTCGACGCACCTGTTCATGGCGGCCCCCCTGGCCTGGGCGTTCCGGGCCGCCGGACACGAGGTGCGGATCGCCGCGCAGCCCGGCCTCACCCGGGCGGTCCTCGGCGCGGGACTGCCCGCCGTGGAGGTCGGCGGCGCGGGCGACCCGGCCGGGTCGCCCGGCGCCCGGCAGACCGCCGCCAGCGGCATGATCCGGCCCGACGGCGGGTGGGGCGACGAGGCGTCGTCGCCCGAGGAGCGGCGCGCGCTCCGTGACCGGGTGTTCGCCCCCTGGGTGTCGGCGGCCCGGGCGATGGCCCCCGACCTGCTCCGGTTCGCCGAGCGCTGGCGGCCCGACCTCGTGGTCACCGACCCGTTCGTGTTCGCCGCCCCGCTGGTCTCGACCCGGCTGGACGTCCCGCTCGTGCGCTGCGTGTGGGGACCGGACGTCCTGCACCGGGTCAGCCACCCCATGCGGGGGACCACGGAGGACACGGGCGAGCGGTGGCCGGAAGGTCTGGCCGAGCTGTTCGGCGAGCACGGGGCGGAGGTCCGCGACGACCACCCGGCGCGGACGGTGGACCCCTGGCCGACCAGCCTGCAACTGCCCGGTACGCCCGGCCGCGTTCCGATGCGGTTCGTCCCCTACAACGGCACCGCGGCCGCGCCGGACTGGGTGCTCGACCGCCCCGGACGGCCCCGGGTCTGCGTCACCTGGGGCCGGACGGCGGCGGGCACGGCCGAGGGCGAGGCGCTGCCGCGGGTCGTCGCGGCGCTCGCCGACCTCGACGTGGAGGCCGTCCTGGCCGTCGCGCCGTCCGAGCGGGAACGGCTCGGGACGCTGCCGGGGAACGCGCGGGTCGCCGAGAACCTGCCGCTGCACCTGCTGATGCCGACCTGCGACGCGATCGTCAACCAGGCCGGGTCCAGCACACTGCTGACGGCGGCCTGCCACGGCGTCCCGCAGGTGCTCGTCCCGAAGACGGCGGACTCCCCGTTCCACGCGTCCGCCTTCGGCGCGGCGGGCGTCGCCGTCCCGCTGGACGCCCGGGAGGTCACGGCCGAGGCCGTCGGCGCGGCGGTCACGCGCGCGCTGACCGACGAGGCGGTGCGGGCGGCGGTGCGCAAGCTCCACGACGAGATCGCGGGCACGCCGTCCCCGGCCGAGGTGGCGTCCGCGCTGGAGCGGCTGGTCTGA	MRVLFTLPAASTHLFMAAPLAWAFRAAGHEVRIAAQPGLTRAVLGAGLPAVEVGGAGDPAGSPGARQTAASGMIRPDGGWGDEASSPEERRALRDRVFAPWVSAARAMAPDLLRFAERWRPDLVVTDPFVFAAPLVSTRLDVPLVRCVWGPDVLHRVSHPMRGTTEDTGERWPEGLAELFGEHGAEVRDDHPARTVDPWPTSLQLPGTPGRVPMRFVPYNGTAAAPDWVLDRPGRPRVCVTWGRTAAGTAEGEALPRVVAALADLDVEAVLAVAPSERERLGTLPGNARVAENLPLHLLMPTCDAIVNQAGSSTLLTAACHGVPQVLVPKTADSPFHASAFGAAGVAVPLDAREVTAEAVGAAVTRALTDEAVRAAVRKLHDEIAGTPSPAEVASALERLV	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	94.58	gnl|BL_ORD_ID|1684|hsp_num:0	1824			324	1260	oleandomycin
BGC0000082.1|Kijanimicin_15 # 27782 # 28777 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GAGGA;rbs_spacer=7bp;gc_cont=0.769	BGC0000082.1|Kijanimicin_15 	27782	28777	-	Loose	700	28.8758	vanS gene in vanA cluster	34.04	3002931	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGAGGCTCGCAGCGACCCCGGACGACCGTCCCCTGATCACGGTGCTGGGCGCGTCGGGCTTCGTCGGCTCGGCCGTCACCGCGGCCCTGGCCCGCAGGCGCTGCCGCGTCCGGGCGGTGGCCAGGCGGCCGGGCGCGCCGGTCCGGCCGGGGGCCGCCGAGATGGAGTGGTGCGCCGCGGACCTGACCGACACCGCGCAGCTCGCCCGTGCCCTCGCGGGCTCGGACGCCGTGCTCCACCTGCTCCTCAACGACGGCGGATGGCGGGCCGCCGAGAACGACCCCGGCAGCGAGCGCCTCAACGTCGGGGTGATGCGCGCCCTGCTGGAGGAGCTCGCGGCCCGCGACGGCCGGCGGCCGCCCGCCCTCGTCGTGTACGCGGGCGCGGCCTCGCAGATCGGAGTGCCGCCCGACGGGCCGATCGACGGCAGCGAACCCGACGCTCCCCTGGCCCGCTATGACCGGCAGAAGCTCGCCGCGGAACGGCTCCTGAAAGAGGCGAGCGCGGCCGGGGTGGTCAGGGGGATCAGCCTGCGGCTGGCCACCGTCTTCGGTCCCGGTCGGGGGCCGCGGGCCCGCGACCGCGGCATCGTCACCACCATGGCGCGGCGGGCGCTCGCCGGGGAGCCGCTGACCATGTGGCACGACGGCTCGGTGCGCCGCGACCTGATCTACGTCAACGACGTCGCGCGCTCCTTCCTGGCGGCGCTCGACCATCCCGACCCGCTGGCCGGCCGGCACTGGCTGGTCGGCACCGGGAGCGGCCAGCCGCTCGGCCGCGTCTTCTCGATGATCGCCGAGTCCGTCGCCGCCCACACCGGCCGTCCGCCGGTGCCGGTCGTCACGGTGACGCCCCCGGGCGACGCCCCGCACACGGACTTCAAGAGCCTGACGCTCGATCCCTCCCGGTTCCGGGAGGCCACCGGGTGGGAGGCCACCGTGGCGCTGCCCGAGGCGCTGGACCGCACCGTCGCGGGCCTGGCCGCGAACCCCTGA	MRLAATPDDRPLITVLGASGFVGSAVTAALARRRCRVRAVARRPGAPVRPGAAEMEWCAADLTDTAQLARALAGSDAVLHLLLNDGGWRAAENDPGSERLNVGVMRALLEELAARDGRRPPALVVYAGAASQIGVPPDGPIDGSEPDAPLARYDRQKLAAERLLKEASAAGVVRGISLRLATVFGPGRGPRARDRGIVTTMARRALAGEPLTMWHDGSVRRDLIYVNDVARSFLAALDHPDPLAGRHWLVGTGSGQPLGRVFSMIAESVAAHTGRPPVPVVTVTPPGDAPHTDFKSLTLDPSRFREATGWEATVALPEALDRTVAGLAANP	MVIKLKNKKNDYSKLERKLYMYIVAIVVVAIVFVLYIRSMIRGKLGDWILSILENKYDLNHLDAMKLYQYSIRNNIDIFIYVAIVISILILCRVMLSKFAKYFDEINTGIDVLIQNEDKQIELSAEMDVMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSIIGYLSLLDEAPDMPVDQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKTHIDLYYMLVQMTDEFYPQLSAHGKQAVIHAPEDLTVSGDPDKLARVFNNILKNAAAYSEDNSIIDITAGLSGDVVSIEFKNTGSIPKDKLAAIFEKFYRLDNARSSDTGGAGLGLAIAKEIIVQHGGQIYAESNDNYTTFRVELPAMPDLVDKRRS	86.20	gnl|BL_ORD_ID|1809|hsp_num:0	1907			786	927	vancomycin; teicoplanin
BGC0000082.1|Kijanimicin_16 # 28839 # 30092 # -1 # ID=1_16;partial=00;start_type=TTG;rbs_motif=AAGGA;rbs_spacer=6bp;gc_cont=0.742	BGC0000082.1|Kijanimicin_16 	28839	30092	-	Loose	700	47.3654	oleI	22.46	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	TTGCGCGTCCTGTTCACCCCCGTCGCCGCCACGACCACGCCCCTGTTCCACATGGTGCCGCTGGCCTGGGCCTGCCGAGCGGCAGGACACGAGGTGCGCTTCGCCACGCCACCGGAGCTCACCGGGGAGATCGTCGCCGTCGGGATGCCCGCGGTCGAGGTCGGCCACGGCTACAAGATCATGGATGGTGTGCTGCGGTCGCGTGGCGGCCGGCGCGTGATCGAGGCGCCCGCCGACCGGTGGACCGACAGCGGCCTGGTGGGCTCCGCCGACGAGCCCGCCACGGCGCCCCCGGCCGACGAGCACGCCGACCTGCGGAACGCGGCCATGGTCCCGCTGGTCGAGGCCGCCACCAGGATGGCGCCGGACCTGCTGCGGTACACCGAGCACTGGCGGCCGGACCTGGTGGTCACCGACTCGATGGTGTTCGCGGCCCCGCTGGTCTCGGCGCTGCGGGGCGTTCCGCTGGTCCGGCAGACCTGGGGCCCCGACGTGATGCGCATGATCAGCCAGCCGTTGCAGGGCCGGGCCGCCGACGGCGACGTGCGCGCCCAGTGGCCCCGCGGGCTCCCCGAGCTGTACGACCACTACGGGGTGGAGGTCCGCAACGACTACCCGCTCCGCACCGTCGACCCCTGGCCCACCAGCCTCCAGTTCCCCGACCTGAGCGGGCGGCTGCCCATGCGGTTCGTCCCGTACAACGGCACGGCGACCGTCCCCGAATGGACGCTCGACCGTCCCGGACGGCCCCGGATCTGCGTCACGTGGGGCACCTCGACCGCCGCGCTCGGCGGTGACGAGGCGTTCGTGCTGCCCAGGGTCGTCGCCGCGCTCGCCGACCTCGACGTGGAGGTCGTCCTCGCCGTCAGCCACGACGACCTGGCGAAGCTCGGCCCGCCGCCGGGCAACGCGCGCGTCGCCGCGAACGTCCCCCTGCACCTGTTCGTGGAGACCTGCGACGCCATCGTCCACCAGGGCGGCAGCAGCTCGCTGCTGACCGCGGCCTGCCACGGCCTGCCCCAGGTCATGATCCCCCAGACGGCCGACAACCCGTTCAACGCGGCCAACTTCGCCGCCAGCGGCGCGAGCGTCACGCTCGACGCGGCCGAGGCGGGGACCGAGGAGATCGGGGCCGCCGTCACCCGGGTGCTCACCGAGCACACCTACCGGGCGGCGGCCGAGAAGGTCCACGCCGAGATCGCCGCGATGCCCTCGCCCGCCGAGATCGTCCGCGCCCTCGAAGCCCTGGTCTGA	MRVLFTPVAATTTPLFHMVPLAWACRAAGHEVRFATPPELTGEIVAVGMPAVEVGHGYKIMDGVLRSRGGRRVIEAPADRWTDSGLVGSADEPATAPPADEHADLRNAAMVPLVEAATRMAPDLLRYTEHWRPDLVVTDSMVFAAPLVSALRGVPLVRQTWGPDVMRMISQPLQGRAADGDVRAQWPRGLPELYDHYGVEVRNDYPLRTVDPWPTSLQFPDLSGRLPMRFVPYNGTATVPEWTLDRPGRPRICVTWGTSTAALGGDEAFVLPRVVAALADLDVEVVLAVSHDDLAKLGPPPGNARVAANVPLHLFVETCDAIVHQGGSSSLLTAACHGLPQVMIPQTADNPFNAANFAASGASVTLDAAEAGTEEIGAAVTRVLTEHTYRAAAEKVHAEIAAMPSPAEIVRALEALV	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	98.35	gnl|BL_ORD_ID|1684|hsp_num:0	1824			207	1167	oleandomycin
BGC0000082.1|Kijanimicin_17 # 30133 # 31326 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=6bp;gc_cont=0.743	BGC0000082.1|Kijanimicin_17 	30133	31326	-	Loose	700	48.9062	oleI	25.47	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGCATCCTGTTCACCCCGCTCCCTTACCCGACCCACCTCTTCCAGCAATGTCCGCTGATCTGGGCCGCCCGCGTCGAGGGGCACGACGTGCGGGTGGCCTCGCAGCCGATCCTCACCCCGACGACCGTCGGTCTCGGGCTGCCCGCGGTGGAGGTCGGCGGCGGCTACGACTTCCTGAACGCCGTGGCGACGCTCCGCACCGGCAACCGGTTCCAGCCCGGCGACCTGGAGGCGCTGTCCCCCGAGGAGCGGGACCGGCTCCGGGACGAGCGGTTCGTCCCCGTGATCGAGCTGGCCGCCAGGATGGCGCCGGACCTGCTGGCGTTCGCCGGGCGCTGGCGCCCGGACCTGATCGTCACCGACCCGATCGTGCTCGCCGCCCCCCTGGTCGCCGCGGCCCTGGACATCCCGATCGTCCGCAAGATCTGGGGGCCCGACATCCTGTCCGGCCACCCGCTGCAGGGGCAGCCCTTCGACGGCACCGAACGCGACACCTGGCCCGCCGGGCTGGTCGAGCTGTTCGACCGGCACGGGGTGGAGGTCCGCAACGACTACGTCCGCCACACCGTCGACCCGTGGCCGTCCAGCCTCAAGCAGATCGGCGCGCCCGGCCGCCTGCCGGAGCGGTTCATCCCCTACAACGGCGCGGGCGCCGTCCCCGAGTGGGTCCTCGAACCCCCCGAGCGTCCCCGCGTGTGCGTCACCTGCGGCACCACCAACAGCGTGTTTGGCAGCGACCCCGACCTGCTGCCGCGCACCGTCGGCGCGCTCGCCCCGCTCGACGTCGAGGTGGTGGTCGCGGTCAACGGCACCGACCGGGCGAAGGTCGGCCCGCTGCCCGGCAACGCGCGGATCGCCGAGAGCCTGCCGCTCAACCTGCTGCTGCCGAGCTGCGCGGCGATCGTCAACCAGGGCGGGGCCGGTTCGGTGCTGACGGCGGCCAGCCTCGGGATCCCCCAGGTGCTCATCCCGGAGACGGGCGAGACGCCGATGATCTCGCACACCTACGCCGACGGCGGCGCCGCCGTCGTCCTGGCGCCCACGGCCGGCGCCGACGCCATCGCCTCCGCCGTGACCGCCGCCGCCACCGACGAGGCGATGCGGGAGGCGGCCCGCAGGATGCGCGCCGAGATCGCCGCGATGCCCGCGCCCGCCGAGGTCGTCCGCACCCTCCAGGAACTGACCGCCTGA	MRILFTPLPYPTHLFQQCPLIWAARVEGHDVRVASQPILTPTTVGLGLPAVEVGGGYDFLNAVATLRTGNRFQPGDLEALSPEERDRLRDERFVPVIELAARMAPDLLAFAGRWRPDLIVTDPIVLAAPLVAAALDIPIVRKIWGPDILSGHPLQGQPFDGTERDTWPAGLVELFDRHGVEVRNDYVRHTVDPWPSSLKQIGAPGRLPERFIPYNGAGAVPEWVLEPPERPRVCVTCGTTNSVFGSDPDLLPRTVGALAPLDVEVVVAVNGTDRAKVGPLPGNARIAESLPLNLLLPSCAAIVNQGGAGSVLTAASLGIPQVLIPETGETPMISHTYADGGAAVVLAPTAGADAIASAVTAAATDEAMREAARRMRAEIAAMPAPAEVVRTLQELTA	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	93.63	gnl|BL_ORD_ID|1684|hsp_num:0	1824			270	1209	oleandomycin
BGC0000082.1|Kijanimicin_18 # 31487 # 32086 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.737	BGC0000082.1|Kijanimicin_18 	31487	32086	+	Loose	400	31.9574	nalC	31.53	3000818	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTCGCCCACGGTTCGGGAAAGCAAGATCGCGGCCGTCCGCCGCACGGTGAGCCAGGCCGCGCTCGGCCTGGCGGTCGAGCGCGGATGGGAGAACGTCCGGGTCGAGGACATTGCGGCCAGGGCGGGGATGTCCACGCGCTCGTTCGGCAACTACTTCCGCAGCAAGAACGAGGCGCTGTACGCGGCCGACCTCGACCGGTCGGCGGCGATCCGGGAGTACCTGCGGGAACGGCCGGACGACGAGCCGCTGTGGGAGGCGGTCGTCAACGCCACCCTGGACGCGTTCATGGCCGGGGACGCGCTCGACCGCGACCTGGTCAGCAAGGTGCGGTTCGCCGTCGCGGCCTCGCCGCTGGGCGGCGAGTACCTCAAGGTGCACGCCGCGCGGGAGGCGGCGCTGGCGGCGGGCGTCGCCGAGCGTCTCGGCGTGGACGTGACCACCGACGTCTACCCGCGGCTGATGGCCGCGGCCGTGGTCGGCGCGGTCCGGGTGGCGATCGAGTTCTGGATCGACTCGGGGCAGGACGCCCCGCTGTCCGACGCCATCCGCGCCGCGCTGGAGAAGGTCGCCGCCGGGCTTCCCGAACCGCCCCGCTGA	VSPTVRESKIAAVRRTVSQAALGLAVERGWENVRVEDIAARAGMSTRSFGNYFRSKNEALYAADLDRSAAIREYLRERPDDEPLWEAVVNATLDAFMAGDALDRDLVSKVRFAVAASPLGGEYLKVHAAREAALAAGVAERLGVDVTTDVYPRLMAAAVVGAVRVAIEFWIDSGQDAPLSDAIRAALEKVAAGLPEPPR	MNDASPRLTERGRQRRRAMLDAATQAFLEHGFEGTTLDMVIERAGGSRGTLYSSFGGKEGLFAAVIAHMIGEIFDDSADQPRPAATLSATLEHFGRRFLTSLLDPRCQSLYRLVVAESPRFPAIGKSFYEQGPQQSYLLLSERLAAVAPHMDEETLYAVACQFLEMLKADLFLKALSVADFQPTMALLETRLKLSVDIIACYLEHLSQSPAQG	93.43	gnl|BL_ORD_ID|2127|hsp_num:0	1670			45	357	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; panipenem; trimethoprim-sulfamethoxazole
BGC0000082.1|Kijanimicin_19 # 32122 # 33975 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=13bp;gc_cont=0.748	BGC0000082.1|Kijanimicin_19 	32122	33975	-	Loose	300	27.7202	tet(44)	28.12	3000556	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGACGATCCGGCCGGTCGCCCGGGAACGGCGGCCCACCCTGTACTTCCTCCGGGAGATCCGGGCGGTCGCGCCGGTCCACCTCGACACCGAGGTGGACATGACCCGGATCAGGGAGCACCGGACGGCCGCGCGCGAGGCGGGCCGCCACTACTCCTGGGTGAGCTACGTGCTGCACGCGGCGAGCCGCGCCCTCGCGGCCCACCCGGAGGCCAACGCCGCGTTCGGCGGGCGGTTCCGCCCGAGGGTCGCCCGGTTCCCCTCGGTCCACGGCAAGTTCACGATGGACCACACCGTGAACGGGCGGCGCGTGGTGCTGTCGGCCGTCATCCCCCACCTCCAGGTGGCCGGGCTGGACGAGATCCAGCGGCAGGTCGACCACTACACGCGCGGCGACGCCGAGCGGATGCCGGAGTTCGCCGGGGCCCGGCTGATCCGCCGGCTGCCCCGGCCGGTCGGCGCCGCCGCCTACCGGTCCCGGATCCGCCCGCTCCGCACCCGCGCCACCGCGATCGGGACCTTCACGGTCACCTCGCTGTCCCACAGCGCGGTCGACGGGTTCCACTCCACCGGCGGCACCACCGTCACCCTCGGCCTCGGCCGCGTCGCCGACCGCCCCGTGGTGCGGGACGGCGCGGTGACGGCCGCGCCCGTCATGCGGCTGAACCTCACCTTCGACCACCGTGTGATCGACGGCGCCGAGGCGGCCGACCTGCTCACCGACATCAGAACGGCCCTGGAGGACTTCCGGGAGGACACCGCCGCCGGGGACACCGGCACCAACGACGTCGGCGAGCTCAAGCGGTTCGTGCTGGCCCACACCCGGGGGCAGAACGTCCCCCACCACGAGGAGGTGCTGGCCCGTGTCCGCACCGACGCCGACGGCGACGGGTCGTGGACGGCCGAATGGTCCCGGTCCGCGCGGGCCCTGGAACGCCACGGGCGGCTGCTGGACGCCTGTCGCCACCACTCGATGGCCCGGTTCCCGTTCGTGGACGGCCCCGCCCGGCGCAGGGCGCTGGAGGAGACCGTCCGGACGTTCGACCAGTGGCGCCGCGCGGACGGGGACATCGAGCGGCTGGAGGTCGACCTGCCCGCCGGGCGCGTCGCCGCCTGGGCGACCGGGCTGTCCGACGGCGTGCGGCGGCCGGTGATGCTCGTCAGCGGCGGCATCGTGACCGTCAAGGAGCAGTGGGCTCCCACCCTGGCCGCCATCCGCCGCCTCGGCATGGCCGGGATCGTCACCGAGATGCCCGGCGTGGGCGAGAACACCCTGCCGTACGACGAGCAGAGCTGGACGATGCTGTCCCGCCTGCTCGACCACGTCGCCGACCGGGCCGACGTGGCGAACTCCCACGCGCTCGCCCTGAGCTTCAGCGGCCACCTGGCGATGCGCTGCGCGCTGGAGGACGGCCGGATCCGGTCGGTGCTCACGGCCGGGGCCCCCGTCCACGACTTCTTCACCGACCGGGACTGGCAGGCCGCCCTGCCGAGGCTCACCGTGGACACCCTGGCGCACCTCGTGGGCGAGAAACCCGAGGACGCGCTCGACCGGCTGCGGGGGTGGGCGCTGCGCCCCGAGCAGCTCCGCGCGCTCGACGTTCCGGTCCGCTACGTCGCCTGCGAGCGCGACGAGATCATTCCGGGGTCGGACGTCGCCCTGCTCCGCGAGCACGTCCGCGACATCGAGATCCTCACCCACGACGACGTGCACGGCGCCCCCGCCCACGCCGCCGAGACGCAGCTCTGGCTGATCCGGTCGCTGCTCCGGCTCCGCGGCGGGAAGGCCCCCACGGCCATCACCATCGGCCTGCTGTACCGGCTGGCCCGGCTGCGCGCCGCCGCACCGGGGTGA	MTIRPVARERRPTLYFLREIRAVAPVHLDTEVDMTRIREHRTAAREAGRHYSWVSYVLHAASRALAAHPEANAAFGGRFRPRVARFPSVHGKFTMDHTVNGRRVVLSAVIPHLQVAGLDEIQRQVDHYTRGDAERMPEFAGARLIRRLPRPVGAAAYRSRIRPLRTRATAIGTFTVTSLSHSAVDGFHSTGGTTVTLGLGRVADRPVVRDGAVTAAPVMRLNLTFDHRVIDGAEAADLLTDIRTALEDFREDTAAGDTGTNDVGELKRFVLAHTRGQNVPHHEEVLARVRTDADGDGSWTAEWSRSARALERHGRLLDACRHHSMARFPFVDGPARRRALEETVRTFDQWRRADGDIERLEVDLPAGRVAAWATGLSDGVRRPVMLVSGGIVTVKEQWAPTLAAIRRLGMAGIVTEMPGVGENTLPYDEQSWTMLSRLLDHVADRADVANSHALALSFSGHLAMRCALEDGRIRSVLTAGAPVHDFFTDRDWQAALPRLTVDTLAHLVGEKPEDALDRLRGWALRPEQLRALDVPVRYVACERDEIIPGSDVALLREHVRDIEILTHDDVHGAPAHAAETQLWLIRSLLRLRGGKAPTAITIGLLYRLARLRAAAPG	MKIINIGILAHVDAGKTTLTESLLYTSGAILELGSVDKGTTRTDTMFLERQRGITIQAAVTSFNWNDYKINIVDTPGHTDFITEVYRSLSVLDGAILVISAKDGVQAQTRILFHALQKMNIPTIIFINKIDQDGINLNNIYQNIKEKLSNDIIVMQNVTLTPEISIKNIIDLDDWDPVISKNDKLLEKYIVGEKLTIQELMYEEYRCVKKGSLFPIYHGSARNNIGTQQLIEAISNLFCSEMNENDSELCGRVFKIEYTDHKQRLVYLRLYSGTLHLRDTIILPEKKKVKLTEIYIPSNGEMIQTKTVCSGDIFIIPNNTLRLNDIIGNEKLLPCNVWNDKTVPILRTRIEPIKIEEREKLLDALTEIADTDPLLRYYVDTITHEIIISFLGTVQLEVICSLLIEKYHINIRIEDPTVIYLEKPLQKADYTIHIEVPPNPFWASIGLSITPLPIGSGIQYESKVSLGYLNQSFQNAVREGINYGLEQGLYGWEVTDCKICFEYGVYYSPVSTPSDFRFLAPIVLEQTLKKAGTQLLEPYLSFILFTPQGYFSRAYKDAQKHCAIIETSQSKNDEVIFTGHIPVRCINEYRNTLTLYTNGQAVFLTELKDYQIATCEPVIQSRRPNNRIDKVRHMFNKKEN	96.41	gnl|BL_ORD_ID|1197|hsp_num:0	1171			1728	1914	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000082.1|Kijanimicin_20 # 33972 # 34199 # -1 # ID=1_20;partial=00;start_type=TTG;rbs_motif=GAGGA;rbs_spacer=6bp;gc_cont=0.697	BGC0000082.1|Kijanimicin_20 	33972	34199	-	Loose	600	24.2534	oleC	33.33	3003748	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	TTGACGACCATCGACGACTTCCTGCTCCTGGTCCGCGACGAGATCGGCCTGACGGTCGGGCCCGAGCACGCCGAACTGCCGCTGGACCAGGTCCCGGGCTGGGACTCGATGCACCTGCTGTCCCTGCTGTCGGCGCTGGAGCGCACGACCGGACGGCCGGTGTCGCTGCCGGACGTGCTGGAGGCCCGGAACCTGCACCAGATCCACGAGGTGGTGACGCGGGCATGA	MTTIDDFLLLVRDEIGLTVGPEHAELPLDQVPGWDSMHLLSLLSALERTTGRPVSLPDVLEARNLHQIHEVVTRA	MTVRGLVKHYGETKALDGVDLDVREGTVMGVLGPNGAGKTTLVRILSTLITPDSGQATVAGYDVVRQPRQLRRVIGLTGQYASVDEKLPGWENLYLIGRLLDLSRKEARARADELLERFSLTEAARRPAGTYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVKAMVGDGVTVLLTTQYMEEAEQLASELTVVDRGRVIAKGGIEELKARVGGRTLRVRPVDPLQLRPLAGMLDELGITGLASTTVDTETGALLVPILSDEQLTAVVGAVTARGITLSSITTELPSLDEVFLSLTGHRASAPQDAEPARQEVAV	23.08	gnl|BL_ORD_ID|2050|hsp_num:0	2264			210	327	oleandomycin
BGC0000082.1|Kijanimicin_22 # 36079 # 37107 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GAGGA;rbs_spacer=5bp;gc_cont=0.734	BGC0000082.1|Kijanimicin_22 	36079	37107	-	Loose	1700	26.1794	LpeB	35.29	3004100	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACGTGTACCTTCACTCGGCCGGCACGGTGCTGCCCGGCCCGCCCGTGGACATCCCGACCCTGGCCAAGAGGTTCGGCCTGCCCTCCGTGTGGGAGCAGTGGGTGGACTCCTTCATCGACACCCCGGTCCGGCACTACTCGGTCGACCTGGACTCCGGGGAGACCCGCTTCTCCCTGACCGACCTGGCCACGACCGCCGGGGAACGCGCGCTCGCGGCCGCCGGGACCGCCCCGGACCGGATCGACCTCATCGTGATGGGCACCTCCTCGCCCGACATGCTCATGCCCGCCACCGTCAACGTCGTCGCCGACCGGCTGGGCGTCGACGACGTGGCCACCTACCAGCTCCAGTCGGGCTGCGCGGGCGCGGTCCAGGCGCTGGACGTCGCGCGGCGGCTGCTGCGCTCCGGCGAGCACCGGACCGCGCTGGTGCTCGGCGCCGACTCGTGCGCCAGGCACCTCGACCTCACCGTGGACGTCAGCGCCCTGCCGCCGGGCGAGCAGGTCAACGGCGTGCTGTTCGGCGACGGCGCGGGAGCGGCGGTGCTCGGCACCAAGCCGGGCGACAACGGGATCGCGCTCCGCTGGACGCGCGTGCGCTGCGTCGGGCGCGGACGGGAACCCGGCCAGACCCTGAACTGGTTCGGCGCGGCCGACCGGCACGTCGACCGGCCCGCCGCCGTCGAGGACTACCAGGCGGTGCAGGAGGCGGTGCCGCCGCTGGCCGCCGCGACGCTCGACGAGGTCCTCGACGCGCTCGACTGGGACCGCGGAGAACTGGACTACGTGCTGCCCCCGCAGCTCTCGGGGCGGATGACCGACGCGATCCTCGCCCGGCTCGACGTCCCGGACGCCCGCGAGGTCAGCTGCGTCCGGGAGACCGGCAACACCGGCAACGCGCTGCCGTTCTTCCAGCTCGAACGGCTGCTGCCCCACATGATCACCGGGGATCGGGCGGTCGGCGTGGCGATCGAGTCGAGCAAGTGGATCAAGGCGGGTTACGCGCTGGAGAAGGTGGGCCCATGA	MDVYLHSAGTVLPGPPVDIPTLAKRFGLPSVWEQWVDSFIDTPVRHYSVDLDSGETRFSLTDLATTAGERALAAAGTAPDRIDLIVMGTSSPDMLMPATVNVVADRLGVDDVATYQLQSGCAGAVQALDVARRLLRSGEHRTALVLGADSCARHLDLTVDVSALPPGEQVNGVLFGDGAGAAVLGTKPGDNGIALRWTRVRCVGRGREPGQTLNWFGAADRHVDRPAAVEDYQAVQEAVPPLAAATLDEVLDALDWDRGELDYVLPPQLSGRMTDAILARLDVPDAREVSCVRETGNTGNALPFFQLERLLPHMITGDRAVGVAIESSKWIKAGYALEKVGP	MKLTSYFIKHPVITIILNAMIVVLGLLCLYNLSVREYPDINFPTITVSASYPNASPDLVETAITNVLEDRLAGIEGLETITSQSSAGYAQITLMFRSGTSMDRALSTTQDAVGVAKALLPPEVRSPTVERQRKSNGLPFIGISLESTSKDFGELTHYANLNLKNVFRSVQGVASVEVWGQPYTYNITLQPEKLFSFGVNVDEIVNALAKNRISLPAGNYRNKIPSTLNSELKTREDYENLLIKANSKHPILLKSLANVALETDNSQMRVRVNGHAGVVLSINKANEANPIEVSKEIRKVIKGLQQGLPKDLKINTIIDQSDFINASIKNIRSAIGEAIFLVLIIVFLFLRNIKATIIPLITIPISLLGSLLFLKLFGFSINLMTLLAMVLAIGLVVDDAIIVLENIWRHIESGLSPLDAALKGAREIGFAIIAMTFTLSSVYLPIAFIQGMLGQLFVEFAVALAGSVFISGIVALTLSPLMCANLLSASSKNWWPQFDNALEKLTKHYSNILQFILKHQKITLLTALISVVACFGFYNLISHETAPKEDRGLIGIYIPPVAGEDIGMLDNKTGKLEKKLDAIPEANNRLTFIGDWGGSIVLPLKPHAQRHRSANQIVEKLRPSFNHFPSMDPHVWSWDTGLPGVDDAGSGSELTLVISTPDHFRQLFDETEKLKSVLDKSKLFAAVNYDLRLDTMGYNIDLDYNQLAKLGLTANQVAKTIEVFFSGDKSQTFEKDGVVYNISIKGDSSPWTLNELYLTTNEGKSVSLGAITKMQPKAQPATLDHYQQMRSTTLHVQLHKGDSMAKAIEKLWGTTKEVMPQHYKLTWIGAAKAFHESSNSMLFLFFLSLAFIYAILCTQFENFTDPFIILFTVPLACSGALLFTYLFGQSLNIYTQVGLITLIGLISKHGILIVEFANKLHKDGASLPEAIQKSAALRLRPILMTTGAMVFGAIPLVLSHDAGSESRHAIGTVLISGLGLGTLFTLFVLPAVYNIIKSKLIDMQKTGGKKRCSKE	33.73	gnl|BL_ORD_ID|2387|hsp_num:0	2759			156	294	erythromycin; spiramycin; azithromycin
BGC0000082.1|Kijanimicin_23 # 37164 # 38636 # -1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=GAGGA;rbs_spacer=7bp;gc_cont=0.763	BGC0000082.1|Kijanimicin_23 	37164	38636	-	Loose	550	286.96	Nocardia farcinica rox	40.97	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGCCCCATGACGTCATCATCGTCGGCGCCGGCCCCGTCGGGCTCATGCTCGCCTGCGAACTCCGGCTGGCCGGAACGGAGGTCGTCGTCCTGGAGGGCCGCGCCGCGCCGCCCGGGCACGCGCCCGGCGTGGCCGTCAACGGAGGCGTCGTCGAGCTCCTGGAGATGCGCGGGCTGATGGACGACTGCCGTCCCGACGGCTTCGAGTTCCCGATGGCCCACTTCGCGCACGTCTGGCTCGATCCCGGGCGGCTCGCCGACCGCCACCCGTACAACTTCTCGCTGCCCCACACCCGGCTGATCCACCACCTCGCCGAACGCGCCCGGGCGCTGGGCGCGGACCTGCGCTTCGGCCACCGCGTCCGCGACCTGGCCCAGGACGCGGACTCCGTCGAGGTCCGGACCGACGGCCCGGACGGCGAGCGCACGACGCGCGGCCGGTACCTGGTCGGCTGCGACGGCGCGCGCAGCGCGGTCCGCCGGGCGGCGGGCATCGGCTTCCCCGGACACGAGGAGCCGTTCCACGGGATCGTCGCCGACCTCCGGATCGACCCCGACCACGTCCTCAACCAGCACCTCGGCGCGAAGGAGCACCCCGCCGGGCTGTTCGCGGTGAGCCCCGTCGCGCCCGGGACCGTCCGGGTGCTGACGGCCCTGTTCGGCGTCGAACCCCCGAGCCGGGACGGCGCCCCCTCGCCCGACGAGGTCCGCGACTGCGTCCGCCGCGTCGCGGACGTCGCGTTCACCGGCGGCGAACCGCTCTGGTCGGCCCGCTGGTCCAACGAGACGCGGCTCGCCGAACGCTACCGCGCGGGCCGGGTGTTCCTGGCGGGAGACGCCGCGCACGTCCACTTCCCCCTCGGCGGCCAGGCCCTCAGCACCGGCCTGGACGACGCGGTGAACCTCGGCTGGAAACTCGCCGCCGACCTCGCCGGGCAGGCCCCCGCCGGGCTGCTCGACACCTACGCGACCGAGCGCCGCCCCGTCGGGGAACGGGCCTGCCGCACGACGCGCGCGCAGGTGGCGCTGCTGCATCCGCTGACCGAGCTCCGCGAGGTCTTCGCCGAGCTCGTGACGTTCCCCGACGTCAACGAGTACCTGGTCACGATGGTCGGCGGCACCGACACCCGGTACCGGTTCACCGACGACGGCTCCGCCCACCCGCTGCTCGGCCGCCGGATCCCGGGGATCGCGGCCGCCGCCCGGTCCGTCCCCGACCTGGCCGCGGCGTGGGCGTCCGGCCGGGGCGTGCTGCTCGACATGGGCGACGGCCCCGACACCCGGTTCGACCTCACCGGCTGGACCGACCGGGTGGCCCTGGTCCGGTCCAAGCCGCTTCCCGGCGTCGACGCCGAGGCGCTGCTGCTCCGGCCCGACGGCCGCGTCTGCTGGGCGACGCGCGGCGGGGACGGCGACGACGGTCTCGCCGAGGCCCGCGCGGCGTGGTTCGGCGGCCCGGCCACCACGGATTAG	MPHDVIIVGAGPVGLMLACELRLAGTEVVVLEGRAAPPGHAPGVAVNGGVVELLEMRGLMDDCRPDGFEFPMAHFAHVWLDPGRLADRHPYNFSLPHTRLIHHLAERARALGADLRFGHRVRDLAQDADSVEVRTDGPDGERTTRGRYLVGCDGARSAVRRAAGIGFPGHEEPFHGIVADLRIDPDHVLNQHLGAKEHPAGLFAVSPVAPGTVRVLTALFGVEPPSRDGAPSPDEVRDCVRRVADVAFTGGEPLWSARWSNETRLAERYRAGRVFLAGDAAHVHFPLGGQALSTGLDDAVNLGWKLAADLAGQAPAGLLDTYATERRPVGERACRTTRAQVALLHPLTELREVFAELVTFPDVNEYLVTMVGGTDTRYRFTDDGSAHPLLGRRIPGIAAAARSVPDLAAAWASGRGVLLDMGDGPDTRFDLTGWTDRVALVRSKPLPGVDAEALLLRPDGRVCWATRGGDGDDGLAEARAAWFGGPATTD	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	103.59	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	1410	rifampin
BGC0000082.1|Kijanimicin_24 # 38626 # 43038 # -1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=GAGGA;rbs_spacer=9bp;gc_cont=0.776	BGC0000082.1|Kijanimicin_24 	38626	43038	-	Loose	750	27.7202	tet(X6)	46.88	3005056	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGGAGAAGGAAGACAAGCTCACCGAGTACCTCCGGTGGACGACGGCGGAGCTGAAGGAGACCCGCCGGCGGCTCGCCGACCTGGAGGCCGCCCAGCGGGAGCCGATCGCGATCGTCGCGATGGGCTGCCGGTACCCGGGGAACGTCCGGTCGCCGCGGGACCTGTGGCGGCTCGTCGCGGAGGGCGTCGACGCGATCTCGCACTTCCCGGCGGACCGGGGCTGGGACCTCGACGCTCTCTACGACCCCGATCCCGAGCGGGAGGGCACCTGCTACACCCGCGAGGGCGGCTTCCTGTACGACGCGGCCGAGTTCGACCCCGGCTTCTTCGGGATCAGCCCGCGCGAGGCGCTGGCGATGGACCCGCAGCAACGCCTGCTGCTGGAGACGAGCTGGGAGACGTTCGAGAACGCCGGGCTCGACCCCGAGACGCTGCGCGGCAGCCGCACCGGCGTCTTCACCGGCGTCATGTACGACGACTACGGGGCGCGGCTCATGCAGCACACGCCGAAGGGGTTCGAGGGATACCTCGGCACCGGAAGCGCCACCAGCGTCGCGTCCGGGCGGATCGCCTACACCTTCGGGCTCGAAGGCCCCGCCGTCACCATCGACACCGCCTGCTCGTCGTCGCTGGTCGCGATGCACCTGGCGGCGCGGGCGCTGCGCGCCGGGGACTGCGAGCTCGCGCTGGCCGGCGGCGTGACCGTCCTGGCCACCCCCGGCGTGTTCGTGGACTTCAGCAGGCAGCGCGGGCTGGCCCCCGACGGGCGCTGCAAGTCGTTCTCCGCCGCCGCCGACGGCACCGGGTGGAGCGAGGGCGTCGGGCTGCTGCTGCTCGAACGCCTCTCCGACGCGCGGCGCAACGGCCACCCGGTACTGGCGGTGCTGCGCGGATCGGCCGTCAACCAGGACGGCGCCTCCAACGGCCTCACCGCCCCCAACGGCCCGTCCCAGCAGCGCGTGATCCGCCAGGCCCTCGCCGACGCGGAGCTCCGGCCGGGCGACGTCCACGTGGTGGAGGCGCACGGCACCGGCACCGTCCTCGGCGACCCCATCGAGGCCCAGGCGCTCATCGCCGCCTACGGGCAGGACCGGCCCGCCGACCGGCCACTGTGGATCGGCTCCGTCAAGTCCAACATCGGGCACACCCAGGGCGCCGCCGGGGTCGCCGGAGTGATCAAGATGGTGGAGGCCATCCGCAACGGCGTGCTGCCCGCGACGCTGCACGCGGACGAGCCGTCCCCGCACGTCGACTGGACGGCCGGGAACGTCGCGCTGCTCACCGGGGCCCGCCCCTGGCCGGACTCCCCGCGCCGCGCGGCCGTGTCCTCGTTCGGCGTCAGCGGCACCAACGCCCACGTCATCCTGGAAGGGGCGCCGGAGGAGGCGCCGGAGCCCCCGCCGACGCCGGAGCCGGCGCCGGAGCCCGCCCCGGACCGGCCCGTCGCCCTGCTGGTCTCCGCCCGCGACGAGGGCGCGTTGCGGGACGCGGCGCGCGACCTGTCCGCGCTGCTCGACGCCGACCCCGCCCCGCGCCCCCTCGACGTGGCGTACTCCCTGGCCACCACGCGGACCGCCATGCCGCACCGCGCCGTGGTCGTCGGGTCGGGCCGCGCCGAACTCGTCCGGAACCTGGACGCGCTGGCCGGAAACGACCTGCTGCCCGGCCAGGTGGTCGTGGACGAGGCCGCGCCCGGGCCGGGCGGCGTGGCGTTCCTGTTCACCGGCCAGGGCAGCCAGCGGGCGGGCATGGGCCGCGCGCTCGCCGCGGCGCAGCCGGTGTTCGCCGACGCCCTGGCGGCGGTGTGCGCCGAGTTCGACCGGCACCTCGACCGGCCGCTGCGGCCCCTGCTGTCGGCGGCGAAGGGCGAGCCGGACGCCGAGCTGCTGCACCGGACGCAGTACGCCCAGCCCGCGATCTTCGCGGTGGAGACGGCGCTGGTCCGGTTGCTCGACCACTGGGGCGTGCGGCCGGACATCGTTCTCGGGCACTCGGTGGGCGAGCTGGTCGCCGCGCACGTCGCCGGGGTGCTCGACCTCGCGGACGCCGCCGCGCTGGTCGCCGCGCGGGCCAGGGCCATGCAGCGGGCCCGCCCCGACGGCGCCATGATCTCCATCGAGGCGGCTGAGACGGAGGTGATGGAGACGCTCGCCGGGCACGCCGGCCGGCTCACGGTCGCGGCGGTGAACGGACCCCGCGCCACCGTGGTCTCCGGCGACGCCGACGCCGCCGAGGCCGTCGCCGCCCACTGGCGGGACCGGGGCCGCCGGGTCCGGCGGCTCGCCGTCAGCCACGCCTTCCACTCCCCCCACATGGACGACGTCCTGGACGGGTTCCGCGAGACCGCCGAGCGGGTGCGGTTCGCCGAGCCCTCGATCGCCCTGGTGTCCAACCTCACCGGCAAGCTCGCGGACCCGGCCGACCTGTGCTCCCCCGGCTACTGGGTGGAGCACGTCCGGCGGCCGGTGCGGTTCGCCGACGGCGTCCGCGCCCTCCGCGCCGCCGGAGCGGCCTGCCTGCTGGAGGTCGGCCCCGACTCCGTCCTCACCGCGATGGCACGGGAGTGCCTGCGCGACGAGGACGACGGCGGACGGCCGCCGACCCTCGCGCCCCTGATGAACGCCCGGCGCCCCGAGCCGCAGACCGCGCTCCTGGCGCTGGCCAGGGCGCACGCGGCGGGCCACCCGGTCGACTGGGCCGCCGGGTTCGAGGGCACCGGCGCCGCCCGCGTCGCGCTGCCGAACTACCCGTTCCAGCGTCGCGCCTACTGGCTCGACCCCGACACCGACGGCGGCCCGGGAGAGCGTTCGCCCCTGGAGAGCCGGTTCTGGGCGGCCGTCGACGACCAGGACGCCGGGCCGCTGGCCGACGCGCTCGGGCTGTCGGCCCCGCAGCGCGCCGCCCTCGCCGAACTCGTGCCCGTGCTGGCCGACCACCGGCGGCGGGCGCGCCGGCACCACCGGACGGTGTGGCGGCCCGTCGCCGACGTCCCCGCCGCGCGGCCGTCCCGGCGCCCGCTCCTGCTGGTCCCCGAGCACGGCGGCGACCCGGTGCGGCAGGTGGTCGACGCGGTCGGCGACGCCGCCGACCGGATCGTCGTCCCGGCGTCCGTGACCGACGAGGACGGGCTCGCCGCGCTCGTGCGCGCCGGGAACACCGTCGGCGGGGTGGTGTCGCTGCTGGCCCTCGCCGACGGGGCCCCCACCGCCGCCCTGCCGGGCGCGCTGGACCGGGCCGGGGTGGACGCCCCGCTCTGGGTACTGACCCGCGGCGCGGTGGCGGCCGGGCGGCTCGACCCGCCCGCCGCGCCGGAGCAGGCGGCTTTCTGGGCTCTCGGCAGGTTCCTGGCCGAGCGGCACCCCCGCCGCCGGATCAGGCTGGTCGACCTGCCGCACGGGTGGGACGACCCCACGCGGCGGCGGCTCACCGCGCTCCTCCACGGCGACCCCGCCGACACGCACCTGGCGCTGCGCGGACCGGGCCTGTTCACCCCGCGCCTGGTGCGCGTCGCCCCGCCCGGCGACGGCCCCGAGGCCCCCTGGCGGCCCGAGGGCGCGGTCCTGGTCACCGGAGGCGCCACCGGGCTGGGCGGGCACGCCGCCCGCTGGCTGGCCGAGCACGGCGCCGACGTGACGGTCGCCTCCCGCGACCCCGCCGACCGCGACGCGCTCACCCGCCTGGTCGCCGAGCGGCCCCCCACGGCCGTGGTGCACGTCGTCGACGGCGCCCTCGACGCCGCCGCCGCGACCGCCGCGATCGCCGTGGTCGACGAGGTCACGGCGCACCTCGACCTGTCCGCGTTCGTGCTGTGCGCGGAGACGGGGACGTTCGGCGGCGACCCGGTGTCCGCCCACCTGTGCATGGAGGCGCTCGCCCGGCGACGCCGGGAACGCGGCGGACCCGCGCTGGCGCTCACGTTCGGGCCGCTGCCACCGGCCGCCGCCGTCGAGGCGCTCGCGTTCGCGTCCCACGCCGACGTCGCGGCCGTGGCGGTCGCCGACCTCACGCCGCGGACCGCCCCACGGCTCCGGTCCGACCGGGTCTGCGGCGAACTGCCCGAGTTCCGGGACGCGGCCGCTCCCCCGGCCGCCCACGCCGCGCGGACGCTCCTCGACCGGCTCGCGGACGCGGGCCCGGACGAACGCGCCGCGATCCTGCTGGAGGCCGTGCGCGTCCAGGCCGCGGACGTCCTGGGCGTCGACCCGGCCGACGGCCTCGACCCGGACGCCGACCTGCTCGCCCTCGGCCTGTCGTCGTTCGCCGCGCTCGAACTGAGCACCCGGATGCGCGCGGCGGGCCTCGACGTGTCACCGGGCCAGGTCTTCGACCATCCCACCCCCGCCCGGCTCGCCGCGTCCATCGACCCGGCGGCCACCGACCACCGCCCCGGAGGAAACCCCCATGCCCCATGA	MEKEDKLTEYLRWTTAELKETRRRLADLEAAQREPIAIVAMGCRYPGNVRSPRDLWRLVAEGVDAISHFPADRGWDLDALYDPDPEREGTCYTREGGFLYDAAEFDPGFFGISPREALAMDPQQRLLLETSWETFENAGLDPETLRGSRTGVFTGVMYDDYGARLMQHTPKGFEGYLGTGSATSVASGRIAYTFGLEGPAVTIDTACSSSLVAMHLAARALRAGDCELALAGGVTVLATPGVFVDFSRQRGLAPDGRCKSFSAAADGTGWSEGVGLLLLERLSDARRNGHPVLAVLRGSAVNQDGASNGLTAPNGPSQQRVIRQALADAELRPGDVHVVEAHGTGTVLGDPIEAQALIAAYGQDRPADRPLWIGSVKSNIGHTQGAAGVAGVIKMVEAIRNGVLPATLHADEPSPHVDWTAGNVALLTGARPWPDSPRRAAVSSFGVSGTNAHVILEGAPEEAPEPPPTPEPAPEPAPDRPVALLVSARDEGALRDAARDLSALLDADPAPRPLDVAYSLATTRTAMPHRAVVVGSGRAELVRNLDALAGNDLLPGQVVVDEAAPGPGGVAFLFTGQGSQRAGMGRALAAAQPVFADALAAVCAEFDRHLDRPLRPLLSAAKGEPDAELLHRTQYAQPAIFAVETALVRLLDHWGVRPDIVLGHSVGELVAAHVAGVLDLADAAALVAARARAMQRARPDGAMISIEAAETEVMETLAGHAGRLTVAAVNGPRATVVSGDADAAEAVAAHWRDRGRRVRRLAVSHAFHSPHMDDVLDGFRETAERVRFAEPSIALVSNLTGKLADPADLCSPGYWVEHVRRPVRFADGVRALRAAGAACLLEVGPDSVLTAMARECLRDEDDGGRPPTLAPLMNARRPEPQTALLALARAHAAGHPVDWAAGFEGTGAARVALPNYPFQRRAYWLDPDTDGGPGERSPLESRFWAAVDDQDAGPLADALGLSAPQRAALAELVPVLADHRRRARRHHRTVWRPVADVPAARPSRRPLLLVPEHGGDPVRQVVDAVGDAADRIVVPASVTDEDGLAALVRAGNTVGGVVSLLALADGAPTAALPGALDRAGVDAPLWVLTRGAVAAGRLDPPAAPEQAAFWALGRFLAERHPRRRIRLVDLPHGWDDPTRRRLTALLHGDPADTHLALRGPGLFTPRLVRVAPPGDGPEAPWRPEGAVLVTGGATGLGGHAARWLAEHGADVTVASRDPADRDALTRLVAERPPTAVVHVVDGALDAAAATAAIAVVDEVTAHLDLSAFVLCAETGTFGGDPVSAHLCMEALARRRRERGGPALALTFGPLPPAAAVEALAFASHADVAAVAVADLTPRTAPRLRSDRVCGELPEFRDAAAPPAAHAARTLLDRLADAGPDERAAILLEAVRVQAADVLGVDPADGLDPDADLLALGLSSFAALELSTRMRAAGLDVSPGQVFDHPTPARLAASIDPAATDHRPGGNPHAP	MTLLKHKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL	388.89	gnl|BL_ORD_ID|4802|hsp_num:0	3797			36	129	tetracycline; minocycline; oxytetracycline
BGC0000082.1|Kijanimicin_25 # 43118 # 48496 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=7bp;gc_cont=0.735	BGC0000082.1|Kijanimicin_25 	43118	48496	-	Loose	1800	28.4906	mdtB	31.25	3000793	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACACGCCCGACGAGAAGGTCGTCGAAGCGCTGCGCACGTCGCTGCTGGAGAACAAGCGGCTGCGGCGGCGGCTCCAGCAGCGGGCCGAGGCCGCGACCGAGCCCGTCGCGATCGTGGGCATGGCCTGCCGCTACCCCGGGGACGTGCGGTCGCCCGACGACCTGTGGCGGCTGGTCACCGAGGGCCGGGACGCGATCACCGGGTTCCCCGCCGACCGCGGCTGGACGCTCGACGACCTCTACGACCCCGACCCGGACGCGCAGGGCAAGTCGTATGTGCGCGAGGGCGGCTTCCTGCACGACGCGGCCGACTTCGATCCCGGCTTCTTCGGGATCAGCCCCCGCGAGGCGCTGGCGATGGACCCGCAGCAACGCCTGCTGCTGGAGACCGCCTGGGAGACGTTCGAGAACGCCGGGCTCGACCCCGAGACGCTGCGCGGCAGCCGCACCGGCGTCTTCACGGGCGTGATGTACGGCGACTACGCGACGCGGCTGCGCCGGATGCCGGAGGGCCTGGAGGACCAGGTGGTCACCGGTAGCGCGGGCAGCGTCGCATCGGGACGGATCTTCCTACGTCTACGGTTTCGAGGGCCCGCGGCTCCCTTGGACACCGCCTGCTCGTCGTCGCTGGTCGCGCTGCACCTGGCCGTCCAGGCGCTCCGCAACGGCGAATGCGACCTGGCGCTGGCGGGCGGCGTCACCGTGATGGCCACCCCGATCGCGTTCACCGGCTTCAGCCGACAGCGCGGCCTCGCCCCCGACGCGCGCTGCAAGTCGTTCGCCGCGGCGGCCGACGGCACCTCGTGGGGGGAGGGTGTCGGGCTGCTGCTGGTCGAACGCCTGTCGGACGCCCGGCGCAACGGCCACCAGATCCTCGCGGTGGTGCGGGGCTCGGCCGTCAACCAGGACGGCCAGAGCAGCCAGCTCACGGCCCCCAACGGCCCCTCGCAGCAGCGGGTGATCCGGCAGGCGCTGGCCAACGCCGGTCTGACCCCCTCCGAGGTGGACGCGGTCGAAGCGCACGGCACCGGAACCCCGCTCGGCGACCCCATCGAGGCGCAGGCCGTCATCGCCACGTACGGGCAGGACCGCGACCGGCCGTTGTGGCTCGGCTCCATCAAATCCAACATCGGCCACACCCAGGCCGCCGCCGGAGTCGCCGGAGTCATCAAGATGGTGCAGGCCATGCGGCACGGAGTGCTGCCGTGCACCCTGCACGTGGACGAGCCGACCCCGCACGTGGACTGGGACGAGGGCAGGGTGGCCCTGCTCACCGAGGCCCAGCCCTGGCCGGGCCCGTCCCGCCGCGCCGCCGTCTCCTCGTTCGGCGTCAGCGGCACCAACGCCCACGTCATCCTGGAACAAGCCCCCGAGCCGGACCCGGAGCCCGCAGAGCGGGAAAAGCACACCGGCCCGATGGCATGGCTGCTGTCGGCCCGGACCGAAGCCGCTCTGCGAGATCAGGCCGAACGCCTGCTGGAACACCTGGAAGCCAACCCCGACCTGGACCCGGCGGCGGTCGCCGCCACCCTCGCCACACGCACCGCGTTCCCGCACCGCGCCGCCGTCATCGGCGACGACCTGAAAGATCTCATCGAGCCCCTGACCGCACTGGCCGCCGGTCTCCCCCACAACCGGCTCGTCGAGGGAACCGCGACGGCGGGCAAGACGGTGTTCGTGTTCCCCGGCCAAGGCTCCCAATGGGCCGGAATGGGCCTGGAACTGATGGAGTCCTCCCCGGTGTTCGCCGAACACCTGCGAGCTTGCGACGAAGCATTGCGCCCGCACACCGGCTGGTCACTGCTTGACGTGCTGGGCGACGAGACAGCCCTGGAACGCGTTGATGTCGTCCAACCCGCACTGTTTTCGATCATGGTGTCGCTGGCCCGGCTCTGGCAACACCACGGCGTCCACCCCGACGCCGTCATCGGCCACTCCCAAGGCGAAATCGCCGCCGCCCACATCGCCGGAGCCCTCAGCCTGAACGACGCCGCCAAGATCGTCGCACTGCGCTCCCAAGCCATCCACACCCTGACAGCCAACGGCGCGATGGCCGCCATCCCCCTACCCGCCGACCAGATCCCCACCAGCGACACCATCTCCATTGCCGCCATCAACTCCCCCACCACCACCATCGTCTCCGGCGACACCGACGCCGTGGCCTCCCTGGTCGCCGCTCATCCTGGGGCCAAGACCATCCCGGTGGACTACGCCTCCCACTCACCCCACGTCCAACCCCTCCACGACCACCTACTGGACATACTGAGCGACATCACCCCCACCACCCCCGACATCCCCATCCACAGCACCGTTAGTGACATCACGACCAACACCCCCTTCGACGCCCGCTACTGGTACGACAACCTGCGCAACACCGTCCAGTTCCACCCCACCCTCACCACCCTGCTGCACACCGGACACACCCGTTTCATCGAAATCAGCGCCCACCCCGTCCTGACCACCGCCATCCAGGACAACCCCGACGCCATCGCCATCGGCACCCTGCGCCGCAACCACGGCACCCCCACCCAACTCCTCCACGCCCTGGCCACCGCCCACACCCACGGCATCACCACCAACCCCCTCCACCCCACCAACCCACACACCCCACTGCCCACCTACGCCTTCCAACACCAGCGCTATTGGTTGGAGGCCACGACCGGGGCGGGTGTCGACGACGTCGCTTCAGCGGGGCTGGAGGAGTCGGCGCACCCGCTGCTCGCCGCCCTCGTCGAGCTGCCCGAGGGCCGGGGGCTCGCGGCGACCGGTCGCGTCGGAACGGACACCCACCCATGGCTGGCCGGGTACCTGGTCCAGGGCACGGCGGTGCTCCCGGCGGTCGCGGTCCTCGACCTGGTGCTGTCCACCGGGCGGCATCTCGGTCTCCACCATCTTGAGGAACTGACCCTGGACGGTCCGATCGTGCTGCCGGAGGACGGCGGGGTGGATCTGCGCGTGCAGGTGTCGGGCCCGGACGACGCCGGGAGGCACACGGTCGGCGTTCACACGCGGTCGGACGGTGAATGGTCCCGGCGCGCCACCGGAGTGCTGGGCGCGGGGGCGGGCGCGGGCGCCGCCGAGACGGCCGGGAACGCCGTCCAGGCCCCGGGCGGGGCGGGTCTCGAACGGCTGGCCCGGCGGCTCGACGCGGCGGGCTACGAGCACGACGGCGTGTACAGGAGCGTGCGCGGGTTCGCCACCGGCGCGGGCGGTGCCGTCCATACCCGGACGGCCCTTCCGGACGGCGTCGGCGCGGACGGGTTCGGGTTCCACCCGGCGTTGCTGGCCGCCGCCCTCGACGGGGCGTTGGCGGAGGCGTCGGCGGAGGCGGAGACCCCGTTCCCCGTCCGGTTCGCCGACGTCCGGTCGCACGCGACCGGCGCCGTCGAGGCCACTGTCCGGTGTTCCGCCGGGGAGGACGGCTCCGTGTCCGTCGCGCTGCTGGACGGCGCGGGCACGCCCCTGCTCACGATCGGCGCGGTCGTCTCCCGGCCGCTCCGCGAGGAGGACCTCACGTCCGCGCCGGGCGGGCCGCTCCACTCCCCGCTGGCGCTGGAGTGGACGCCGCTGTCCCCCGTGCGGGTCGTCGGCGCGCCGCGCGGCGACCTCGCCGACCTGCTGGCCGCTCCGGCCGGCACGGGCGTGCCCGGCGTGCTCACCCTGGCGGTCCCGCCGAGCGACGGGTCCGGTCCGGCGGCCGCGCACGCCACCGCCGAACGGGTGCTGCGGATGATCCAACAGTGGTTGGAGCAGGACCGGTTCGCCGACTCGCGGCTGGTCGTGCTGACCCGGCGCGCCGTCTCCACCGGTCCCGGCGACCCGGTCGCCTATCTTCCGGCCGCCGCCGTCTGGGGCCTGGTGCGGTCCGCCCAGAACGAGCACCCCGACCGGCTCGTCCTGCTCGACCACGACGGCACCGGCTCCTCGGACCGGGCCGTCGACGCGGCCCTCGGCACCGGTGAGCCGCAGCTCGCCCTCCGCGACGGCGTGTGCCTGGTCCCCCGCCTCACGCCCACCGCCGGGGCCGACGGTGACGCACCCGCCCTCGATCCCGAGGGGACCGTCCTGGTCACCGGCGGCACCGGCACCCTCGCCGCGCACGTCGCCCGCCACCTCGTCACCCGGTACGGGGCGGGCCGTCTCCTGCTCGTCAGCCGGCGCGGCCCCGACGCGCCGGGCGCGCAGGAACTGCGCGCCGAGCTGACCGGCGCGGGCGCCGAGGTCACCGTCGCCGCCTGCGACGTCAGCGACCGCGACGACCTGGCCGCCCTGCTCGCCGCCATCCCCGCCGAGCACCCCCTCACCGCCGTCGTCCACACCGCCGGGGTCCTCGACGACGCCGTCCTCACCAACCTCACCCCGCAGCGGCTGCACCGCGTTCTCCGGCCGAAGGTGGACGCGGCCTGGCACCTGCACGAGCTCACCCGCGACCTACCGCTGACCGCGTTCGTGCTGTTCTCCTCCGCCGCCGCAACCCTGGGCACCCCAGGACAAGCCAACTACGCCGCCGCCAACGCCTACCTCGACGCCCTCGCCCACCACCGCCACACCCACACCCTCCCCGCCACCAGCCTCGCCTGGGGACTGTGGACCGACACCAGCGAGATGACCGGAAACCTGAACGAGGGCGACCTCGACCGGCTCTCCGCCACCGGGTTCCGGCCGCTGTCGGCTCCCGAAGCGCTCGACCTCTTCGACGCCGCGTTCCACGACGCCCGCGACCCCCACCTCGTCCTCGCGCGGACCGACCGGGGCGCGATCCGGCGGCACGCGCAGGACGGCACGCTGCCGGTGCTCTTCGAACGGCTCGCCCCCGCCCGGCTGCGGCAGGCCGGTGCGGAGGGCGCGGCGCTGACCGAGCGGCTGCGCGGACTGGACGCGCAGCGGCGCGGGCAGGTGCTGCTCGACGTGGTCCGCGCGCACGTCGCGGCCACCCTGGGGCACGGGTCCGCCGCCGACGTCGCGCCCGGGCAGGCGCTCAAGGACCTCGGTTTCGACTCCCTCACCGCCGTCATGCTGCGCAACCGGCTGGCGGCCGCGACCGGCGTCCGGCTCGCGACCACGCTGGTCTTCGACCACCCCACCGTCATCGCGATCGCCGAGCATCTCAACGAGCGGTTCGGCGACGGCGCGGACGGCGCCACCCCCCTCCAGGCCGAGCTGGAACGGCTGGAGGCGGCGGTGGCCGACGCCGACCTGGACGACGCGGGCCGGGACCGGTTCGAGGCCCGGCTGCGGGCGCTGCTGCTGCGGGTCACCGAGTCGCGGGCGGAACGGGACGCGCCCGTCGACGACGACCTGGCGTCGGTCAGCGACGACGAGCTGTTCGAGGTGCTCGACGAGGAGCTCGGCCTGTCCGGGACCGACCAGCGATGA	MDTPDEKVVEALRTSLLENKRLRRRLQQRAEAATEPVAIVGMACRYPGDVRSPDDLWRLVTEGRDAITGFPADRGWTLDDLYDPDPDAQGKSYVREGGFLHDAADFDPGFFGISPREALAMDPQQRLLLETAWETFENAGLDPETLRGSRTGVFTGVMYGDYATRLRRMPEGLEDQVVTGSAGSVASGRIFLRLRFRGPAAPLDTACSSSLVALHLAVQALRNGECDLALAGGVTVMATPIAFTGFSRQRGLAPDARCKSFAAAADGTSWGEGVGLLLVERLSDARRNGHQILAVVRGSAVNQDGQSSQLTAPNGPSQQRVIRQALANAGLTPSEVDAVEAHGTGTPLGDPIEAQAVIATYGQDRDRPLWLGSIKSNIGHTQAAAGVAGVIKMVQAMRHGVLPCTLHVDEPTPHVDWDEGRVALLTEAQPWPGPSRRAAVSSFGVSGTNAHVILEQAPEPDPEPAEREKHTGPMAWLLSARTEAALRDQAERLLEHLEANPDLDPAAVAATLATRTAFPHRAAVIGDDLKDLIEPLTALAAGLPHNRLVEGTATAGKTVFVFPGQGSQWAGMGLELMESSPVFAEHLRACDEALRPHTGWSLLDVLGDETALERVDVVQPALFSIMVSLARLWQHHGVHPDAVIGHSQGEIAAAHIAGALSLNDAAKIVALRSQAIHTLTANGAMAAIPLPADQIPTSDTISIAAINSPTTTIVSGDTDAVASLVAAHPGAKTIPVDYASHSPHVQPLHDHLLDILSDITPTTPDIPIHSTVSDITTNTPFDARYWYDNLRNTVQFHPTLTTLLHTGHTRFIEISAHPVLTTAIQDNPDAIAIGTLRRNHGTPTQLLHALATAHTHGITTNPLHPTNPHTPLPTYAFQHQRYWLEATTGAGVDDVASAGLEESAHPLLAALVELPEGRGLAATGRVGTDTHPWLAGYLVQGTAVLPAVAVLDLVLSTGRHLGLHHLEELTLDGPIVLPEDGGVDLRVQVSGPDDAGRHTVGVHTRSDGEWSRRATGVLGAGAGAGAAETAGNAVQAPGGAGLERLARRLDAAGYEHDGVYRSVRGFATGAGGAVHTRTALPDGVGADGFGFHPALLAAALDGALAEASAEAETPFPVRFADVRSHATGAVEATVRCSAGEDGSVSVALLDGAGTPLLTIGAVVSRPLREEDLTSAPGGPLHSPLALEWTPLSPVRVVGAPRGDLADLLAAPAGTGVPGVLTLAVPPSDGSGPAAAHATAERVLRMIQQWLEQDRFADSRLVVLTRRAVSTGPGDPVAYLPAAAVWGLVRSAQNEHPDRLVLLDHDGTGSSDRAVDAALGTGEPQLALRDGVCLVPRLTPTAGADGDAPALDPEGTVLVTGGTGTLAAHVARHLVTRYGAGRLLLVSRRGPDAPGAQELRAELTGAGAEVTVAACDVSDRDDLAALLAAIPAEHPLTAVVHTAGVLDDAVLTNLTPQRLHRVLRPKVDAAWHLHELTRDLPLTAFVLFSSAAATLGTPGQANYAAANAYLDALAHHRHTHTLPATSLAWGLWTDTSEMTGNLNEGDLDRLSATGFRPLSAPEALDLFDAAFHDARDPHLVLARTDRGAIRRHAQDGTLPVLFERLAPARLRQAGAEGAALTERLRGLDAQRRGQVLLDVVRAHVAATLGHGSAADVAPGQALKDLGFDSLTAVMLRNRLAAATGVRLATTLVFDHPTVIAIAEHLNERFGDGADGATPLQAELERLEAAVADADLDDAGRDRFEARLRALLLRVTESRAERDAPVDDDLASVSDDELFEVLDEELGLSGTDQR	MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSETVRTAITGANVNSAKGSLDGPSRAVTLSANDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGANIISTADSIRQMLPQLTESLPKSVKVTVLSDRTTNIRASVDDTQFELMMAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTLSVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDPAVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEKTLNLPVDITTQFQGSTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPTAGVGALLALLIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLIVSQVLTLFTTPVIYLLFDRLALWTKSRFARHEEEA	172.31	gnl|BL_ORD_ID|757|hsp_num:0	820			1308	1500	novobiocin
BGC0000082.1|Kijanimicin_27 # 69155 # 87880 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=15bp;gc_cont=0.755	BGC0000082.1|Kijanimicin_27 	69155	87880	-	Loose	750	87.8113	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	31.18	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGACGGATGTGAGGGAGCCGGAGCTCGTGTTCTCAGCGTCGAACGAACCGATCGCCATCGTCGGGCTGTCCTGCCGGCTGCCCCAGGCGCCGGATCCGGCGGCGTTCTGGCGGCTGCTGCTCGACGGGCGCAGCGCCGTCACCGAGACGCCGCCCGGTCGCTGGACCGGCGCGGAGGGGACCGCCGGGCTCCGGCACGGCGGGTTCCTGGACGACGTCGACCGGTTCGACGCGGCGTTCTTCGACGTCTCCCCCCGCGAGGCCGCGAGCATGGACCCGCAGCAGCGGCTGATGCTGGAGCTCGCCTGGGAGGCCGTCGAGGACGCGATGATCGCGCCCGCGACGCTGGCGGGCGGGCGCACCGGCGTCTTCGTCGGCGCCATCGGCGACGACTACGCCGCGCTGATGCGCCGGCACGGCCCCGAGGGCGGCACCCGGCACTCGCTGGCCGGGACCCTCCGCGGCATCATCGCCAACCGCGTCTCCTACACGCTCGGCCTGCGCGGCCCGAGCCTCACCGTGGACGCCGCGCAGGCGTCGGCGCTGGTGGCCGTGCACCTGGCGTGCGAGAGCATCGCGTCGGGCGAGTCGGCCATGGCGCTCGCCGGCGGCGTCAACCTGAACCTCGACACCGGGACCGCCCTGGAGACCGAACGGTTCGGCGGCCTGTCGCCGGACGGCCGCTGCCACACCTTCGACGCCCGCGCCAACGGCTACGTGCGCGGCGAGGGCGGCGCGTTCGTCCTGCTCAAGCCGCTGTCCCGCGCGCTGGCCGACGGTGACCGGGTGTACTGCGTGATCCGCGGGAGCGGGGTGAACAACGACGGCGCCACCGACGGCCTCACCGTGCCGGACGCCGACGCCCAGCGCGAGGTGATCCGGCTCGCCTGGCGGCGGGCGGGGCTGGAGCCCGGCGCCGTCCAGTACGTGGAGCTGCACGGGACCGGCACCAGGGTCGGCGACCCCGTGGAGGCCGCGTCGGTCGGAGCGGCGCTCGGCGCGGCCCGCGCGGACGGGCCGGTGCACGTCGGCTCCACCAAGACCAACGTGGGTCATCTCGAGGGCGCGGCGGGGATCGTCGGGCTCGTCAAGGCCGCGCTGTGCGTGCGGCACCGGATGATCCCGGCGAGCCTGAACTTCGAGACGCCGAACCCGGAGATCGACCTCGCGGCGCTCAACATCGAGGTGCGCACGGCCCCCGGGCCCTGGCCCCGTCCCGACGCCCCCCTGGTGGCGGGGGTCAACTCGTTCGGCATGGGCGGCACGAACTGCCATGTGGTGGTCGCCGAGCCCCCGGCCGCCGAGCCGGAGCCGGGCGCGGCCGCCGAGCCGGAGCCGGGCGCGGCCGCCATGCCGGTCGTCCCGTGGGTGCTGTCGGCGCGGGATCCGGGAGCCCTCCGCGACCAGGCCGCCGCGCTGCGCGCCGCGGCCGCGGACCTCGATCCGGTCGACACCGGATGGTCGCTGCTCACCACCCGGTCCTCCTTCGAGCACCGCGCCGTGGTCCTCGGCGCGGACCGCGACGGCCTGCTGCGCGGCCTGGCGGAGGCCGCCGCCGGGGAGGAGGCGGCCGGGCTGGTCACCGGCCGGGCCGCCGAGCACGGCGGGACGGTGTTCGTGTTCCCCGGGCACGGCACCCAGTGGCCGGGGATGGGCCTGGACCTGCTGGAGACCTCCCCGGTGTTCGCCGAACACCTACGAGCCTGCGACGCGGCACTGCGACCCCACACCGGCTGGTCACTCATCGACGTCCTGCACAACACGCCCGACGCCCCCCAACTCGACCGCGTCGACATCGTCCAACCCGCCATCTTCGCCCTCACCGTCTCCCTGGCCCGCCTCTGGCAACACCACGGCGTCCGCCCCGACGCCGTCATCGGCCACTCCCAAGGCGAAATCGCCGCCGCCCACATCGCAGGCGCCCTCTCCCTCCAGGACGCCGCCAAGATCATCACTCATCGTGGCCGCGTCGCCGCGACCATCGCCGGGACCGGCGGCATGGTCGCCGTCCCCCTGCCCCCCGACCAGGTCACCGCGGACCTCGCCGACCACCCCGGGCTCACCGTCGCGGGGATCAACTCGCCGCGCAGTACGGTCGTCTCCGGCGACCTGGAGGCCGTGCGACGTCTCCTCGCCCACTACAAGGAACGCGGCGTCGACGCGCGCGCGGTCCCGATCGGCTACGCCTCCCACTCCCCGCACATCGATCCGCTCCGCGACCGGCTCCTGGCCGCCTTCGCCGACATCACGCCCCGCACGCCCCAGATCCCCTTCCACTCCACCGTCCGCCCCGGGACCACCCCCGTCCTGGACGCGGAGTACTGGTTCGACAACCTGCGCGCGCCCGTCCGGTTCCACGCCGCCGTCACCGCCCTCCACGACGCCGGGCATCACCGGTTCGTCGAGGTCAGCCCGCATCCGGTCCTCACCGCGCCCGTCCAGGACGGCACCGGCGCGACCGCGATCGGCACCCTGCGGCGCAACCGGCCGGGCTGGCGGGCGTTCGTCACCGCGCTGGCCCGCCTGCACGTGACGGGTGGGGAGGTCGACTGGGCCGTGCTCTTCGAGGGGCGCCGCCCTCGCCGCGTACCGCTGCCGACCTATCCGTTCCAGCGGCGGCGTCACTGGTTCCCCTCCGGAGGCGAACGGCACGAGGCCGAGTCGCGAGAGGCCGCGTCGCGAGAGGTCGCCGCCCCCAAGGAGCCGGGCGTCCCCGAACCGTCCCCGGCGTCCTCGCCGCTGGCCGGGCTGCCGGAGGCGGAACTGCGGCGGACGCTGCTGGACCTGGTCCGCAAGCGCGCGGCCGTCGTCCTCGAACACCCCGACGACTCCGGCATCGACACGGGACGATCGTTCAAGCAGCTCGGCTTCGACTCGCTGCTCGCGGTGGAGCTGCGGAACGCGCTGGCCGCCGCGACGGGCCTCGACCTGCCGGCCTCGCTGCTGTTCGACCATCCGACGCCCACGGCCCTCACCGGGTACCTGCACGACCGGATCACCGGGTCCGCCGGCACGCGGCCGCTGGAGGCCGCGCCGCCGCGCCGGACCACCGGTGGCGCGGACGACCCGATCGCCATCGTCGGCATGGCCTGCCGGTTCCCCGGCGGGGTGCGGACGCCCGAGCAGTTGTGGCGGCTGGTGGAGACCGGGACGGACGCGATCTCGGACTTCCCCGACAACCGCGGCTGGGACCTGAACGCCCTGTTCGACCCCGACGCGGAGGCGTCGGGCACGTCCGCGGTGCGCCGGGGCGGTTTCCTGCCCGACGCCGACCTGTTCGACCCGGCGTTCTTCGGCATCAGCCCGCGCGAGGCGCTGGCGATGGACCCGCAGCAGCGGCTGCTGCTGGAGGTCTCGTGGGAGGCGCTGGAGCGGGCGGGTGTCGATCCGCTGTCGCTGCGCGGCGGCCGCGCCGGGGTGTTCGTCGGGGCGATGGCCCAGGAGTACGGGCCCCGCCTGTCCGACGCCGCCGACGGGCTGGAGGGGTTCCGGCTCACCGGCACGTCGGTGAGCGTCGCCTCCGGCCGGATCGCCTACACGCTGGGGCTCCAGGGCCCGGCGTTCACCGTGGACACCGCGTGCTCGTCGTCCCTGGTGGCGCTGCATCTGGCCGTCCGGGCGCTGCGCGACGGCGAGTGCCCGCTCGCCGTCGCGGGCGGGGTGAACGTGATGGCCTCGCCCGGCATCTTCGTCGAGTTCAGCCGCCAGCAGGGGCTGTCACCCGACGGCACGTGCAAGGCGTTCGCCGACGCCGCCGACGGCACGGGCTGGTCCGAGGGCGTGGGGATGGTGGTCCTCGAACGGCTCTCGGACGCCCGCCGCAACGGCCACCGGGTGCTCGCCCTGATCCGCGGGTCGGCGATCAACTCCGACGGCGCGAGCAACGGGCTGACCGCGCCGAACGGGCCGTCCCAGGTGCGGGTGATCCGGCAGGCGCTCGCCGACGGCGGGCTGTCCCCGGCCGACGTGGACGCCGTCGAGGCGCACGGCACCGGCACCAGGCTCGGCGACCCGATCGAGGCGCAGGCCCTCATCGAGGCCTACGGGCGGGACCGTCCGGCGGACGCCCCGCTGTGGCTGGGGTCCCTGAAGTCGAACATCGGGCACGCGCAGGCCGCGGCCGGGATCGGCGGCCTGATCAAGATGGTGATGGCGCTGCGCCACCGGTCGCTGCCCCGCACCCTGCACGTGGACGCGCCCACCCGCCGGGTGGACTGGTCGGCGGGGGCGGTCCGGCTGCTGGCCGAGGCGCGGCCCTGGCCCGGCACGCCGGTTCGGCGGGCGGCGGTGTCGTCGTTCGGCATCAGCGGCACCAACGCCCACCTGGTGCTGGAGCAGGCCCCCGAGAGCGACGTGCCCGCCGACGACGGGCGGGCGGCCGATCCCGGTGCGGCGACCCTGCCGTGGCCGGTGTCGGCCCCGAACGAGCAGGGGCTGCGGGACCGGGCGGCGCAGCTGCTCCGCCACCTCGACTCGGTCCCGGACGCCGTCCCCGACGACATCGGCGTGGCGCTGGCCACCACCCGTTCGGCGTTCGCCCACCGCGCGGTCGTCACCGGCGGCGACCGCGCCGCGCTGCGCGCCGGGTTGGAGGCGCTGGCGAACGGCGTGCCCGCCCCGAACGTCACGCTGGGCACGGCGCGGGACCGCGGCGGGGTCGTGTTCGTCTTCCCGGGGCAGGGCTCGCAGTGGGCCGGGATGGCCGCCGAGCTGGCGGCGTCCTCGCCGGTGTTCCGCGCCGAGGCGCTCGCCTGCGCCGACGCGCTCCAGCCGCATCTGGACTGGCCGGTGCGCGACGTGCTGCTCGGCCGCCCCGGGGCTCCGGGGCTGGACCGGTCCGACGTGGTGCAGTGCACGACGTTCGCGGTCGTGGCGGGGCTGGCGGCGGTGTGGCGCGCGGCGGGGGTCGAGCCCGACGCCGTCGTGGGCCACTCCCAGGGGGAGATCGCCGCCGCGTACGTGTCCGGCGCGCTGACGCTGGCGGACGCCGCCCGGGTGGTCGCGCTGCGCAGCACGGCGCTGCTGTCCCTGGCGGGCACCGGCGGCATGGTGACGGTGTCGGCCTCCCCGGACGAGACGGAGGCGCTGCTCGGCCGCTGGGCGGGGCGGCTGTCGGTGGCGGCGTCGAACGGGCCCGCGTCCACCGTGGTCGGCGGCGACCCGGAGGCGCTGGAGGAGCTGCTGGCGCACTGCGAGGCCCGCGGGGTCTGGGCCAGGCGGGTGCCCGTCGACTACGCCTCGCACTCCCCGCACATGGAGGCGCTCCGGGAGGAGCTGACCGGGAGGCTGGCGCCGGTCTCCGGCCGCGCCCCCCGCATCGCCTTCCACTCCACCGTCGAGGGCGTCCGCCACGGGACGTTCCGGACCGACGGCGAGTACTGGTACCGGAACCTGCGGCACCGGGTGGAGTTCGCTCCGGCCGTCCGGGACCTGGCGGCCGCGGGGTTCGACACGTTCGTCGAGGTGAGCCCGCACCCGGTGCTGACCACGGCGATCGAACAGACCCTGGAGGAGGCCGGGGTCGAGCACGCCGTCGTGGTCGGGTCGCTGCGGCGGGACGACGGCGGCCGGGGACGGTTCACCGCCTCCCTCGCCCACGCGCACGCCCACGGCGTCGCCGTGGACTGGCCGGCCGCCCTGGCGGACCTGCCGGCGCGGCCCGTCGACCTGCCGACCTACCCGTTCCGGCGGCAGCGCTACTGGATCGGGCCGGGCACCGGCGGCGAGAACACGATCGGGCACCCCTTCCTGCACACCGTGACGGACCTCGCCGACGGCGACGGGCACGTGTTCACCGGGAGGCTGTCGCCGTCGGCGCGTCCGTGGCTGGCCGACCACGCCGTGCGGGGGGCCGCGCTGCTGCCCGGCACCGCATTCCTGGACATGGTCGCGCGCGCCGGGGAGGAGCTGGGGTACGGCTCGGTCGAGGAGCTGACCCTTGAGGCCCCGCTGCCGATCCCCGCGGACGGCGACGTCCGGCTCCAGGTCGTCGTGGGCGCCGCCGACGGGTCGGGGCGCAGGCCGGTGAGGCTGTTCTCGCGGACCGCCGAGGAGGGGTGGACGCGGCACGCCACGGGATTCGTCTCGGCGGAGGCTCCCGCCGCCGTGGACGTCCCCCCGGACGAGGCGTGGCCGCCGCCGGGGGCGACCGAGCTCGACGTCGACGAGCTGTACGACGGTCTCCGGGAACACGGGTACGAGTACGGGCCGGCGTTCCGCAACGTCCGGGCCGCGTGGCGGCTCGGCGACGACCTGTACGCCGAGGTGGCCCTCCCGGCGGAGCTGCGGGCGGAGGCGGACCGGGGGCCGGTGCATCCGGCGCTGCTGGACGCGGCGCTGCATCCGCTCGGCGCGACCGGGCTCCTCCGGGAGGACGCGGAGGGGCTGCTGCTGCCCTTCTCCTGGACCGGGTTCTCGGCACCGTCCGCGGGCGCCGGCACGGTGCGGGCGCGGCTCACCCCGTCCGGGGCCGACGCGGTCTCCCTCGTCGTCACCGACGACGCCGGCGCGGTCGTCGCGGCGGGCTCCCTCGCCCTGCGGCCGACCGCCGTCGAGCGCCTCGCCCCCGCCCGGACCGTCCGGAACCTCTACGGCGTCGAGTGGCGGCCGCTGCCGCTCGGCGTCCCGGGCGACGGGCGATGGGCCGCGCTCGGCGACGCCGCGCTCGACGTCGCGCGCGCCGCCGGGCTGCCCGCCGACGCCTACCCCGACCTCGCCGCGCTGCGCGAGGCGGTCGCGGGCGGCGCCGCGGCCCCCGCCCTGGTCCTCGCGGGCCCCGCCGCCGGGGACGGCGTGCCGCCCGACGCGGCGGCGCACGCGACCGCCGGGCGGACGCTCGCCCTGCTCCAGGAATGGCTCGCCGACGAACGCCTGGACGCCGCGCGGCTGGTCGTCGTCACCCGGGACGCGGTGGCCGCCGTCCCCGGCTCCGACGTCCCGTCCCCGGCGGACGCCGCGGTGTGGGGGCTGGTCCGGTCGGCGCAGACCGAGCATCCGGGCCGGTTCGTCCTGCTCGACCTGGACGGCGACGCGGCGTCCGCGCGGGCGGTCGCGGCCGTCGCCGCGAGCGGCGAACCGCAGACGGCCGTCCGCGCCGGGGAGGCGCGGGTGCCGCGGCTGGCCCCGGTCACCACCGCCGGTCCGGACGCGACCGGTCCGGCGCTCGACGGCACCGTGCTGCTCACCGGCGGCACCGGGCGGCTCGGCCGCCTGGTCGCGCGGCACCTGGTGCGCGACCGCGGGGCGCGGCACCTGCTGCTGGTCAGCCGCCGGGGCGACGCCGCCGACGGGGCCACCGAACTCGCGGCCGAACTGCGCGCCCTGGGCGCCGAGGTGGCCTTCGCCGCCGCCGACGCGGCCGACCGGGCGGCGCTGCGCGCGGTGCTCGACGCCGTCCCCGCCGACCGGCCGCTCCGCGCCGTCGTGCACCTCGCGGGCGTCCTCGACGACGGCGCCGTCACCTCCCTCACCCCGGAACGGACCGGCGCGGTGCTGCGGCCGAAGGCGGACGCGGCCTGGCACCTGCACGAGCTCACCCGCGACCTGCCGCTGGCCGCGTTCGTGCTGTTCTCCTCCGCGATCGGCACGGTCGGCGGACCGGGGCAGGCCAACTACGCCGCCGCCAACGCCTTCCTGGACGCCCTGGCCGAACGGCGTCGCGCGGAGGGGCTCGCGGCCGTGTCGCTCGCCTGGGGCCTGTGGTCCGAGGCCAGCGGGATGACCGGGCACCTCACCGAGTCCGACCGCGCGCGGCTGCGCCGGTCCGGCATCGCCGCGATGGACACCGGCGAGGCGCTCGCGCTGCTCGACGCCGCGCTGGCCGCCGACCGGCCCGTCGTGGTGCCGGCCAGGCTCGACCTGGCCGCGCTGCGCGCCGGGCACGGCCCCGACGAGGTGCCCGCGCTCTTCCGGCGACTGCTGCCCCGCACCGGCGGAGCGGCCCCGCGCGCCGCCGCCAGGGGGGCGGCGTCGGCCCGGCGGCTGACCGCGCTGCCCCCGGCCGAACGGGAGGCCGCGCTCCTCGATCTCGTCCGCGCCGAGGCGGCCGGGGTGCTCGGCCACGACGACCCCGGCACGGTCGAACCGGACCGGGCGCTCCGCGAGCAGGGCCTCGACTCCCTCACCACCGTCGAGCTCCGCAACAGGATCGGCGCGGCGACCGGGCTGCGGCTGCCCGCCACGGTCGTGTTCGAGCATCCGACGGTGACCGCGCTGGCCCGGCACCTCGGCGAGAAGCTCACCGGGGCGGGCGGCGCGGACCGGGCCGCGGCCACCGGCGTCCAGAGCGACGAGCCGATCGCGATCGTGGGCATGGCGTGCCGTTACCCCGGCGGGGCGACCTCACCGGAGGCCCTGTGGCGGCTGGTCGCCCAGGGAGTCGATGCCATCGGGGAGTTCCCCACCGACCGGGGCTGGGACCTGGAGGGCCTCTACGATCCCGACCCCGACCATCCCGGTACCAGCTACACCCGTCACGGCGGCTTCCTGTACGACGCCGCCGACTTCGACCCCGAGTTCTTCGGCATCAGCCCCCGCGAAGCCCTGGCCACCGACCCCCAACAACGCCTCCTCCTGGAAACCGCCTGGGAAACCCTCGAAAACGCCGGAATCAACCCCCACACGCTGCGCGGCAGCCACACCGGCGTCTTCACCGGCGTCATGTACGACGACTACGGCAACCGGCTCATGCAGGACTCCCCCGACGGGTTCGAAGGGTTCCTGATCGCCGGGACCCAGACCAGCGTGGCGTCCGGGCGGGTGTCCTACGTCCTCGACCTGGCCGGACCGGCGCTGACCGTCGACACCGCCTGCTCGTCCTCGCTGGTCGCCCTGCACCTGGCGATCCAGGCGCTCCGCAACGGCGAATGCGACCTCGCGCTGGCCGGCGGCGCGACGATCATGGCGACGCCCGGGCCGTTCATCGAGTTCAGCCGGCAGCGCGGCCTGGCACCGGACGGACGTTCCAAGTCGTTCTCCGCCGCCGCCGACGGCGCGGCCTGGAGCGAGGGCGTCGGACTCCTGCTGGTCGAACGACTCTCCGACGCCCAGCGCAACGGCCACCGCGTGCTCGCCGTCGTCCGAGGCTCGGCCGTCAACCAGGACGGCGCGTCCAACGGGCTCACCGCGCCCAGCGCCGCGGCGCAGCGCCGTGTGATCCGGCAGGCGCTGACCAACGCCGGGCTGTCCCCCGCCGACGTGGACGCGGTCGAGGCGCACGGCACCGGCACCACCCTCGGCGACCCCATCGAAGCCGAAGCCATCCTCGCCACCTACGGACAGAACCGCGACCGGCCGTTGTGGCTCGGCTCCATCAAATCCAACATCGGCCACACCCAAGCCGCCGCAGGCGTCGCCGGAATCATCAAAATGGTGCAGGCCATGCGACACGGAGTCCTGCCCCGGACGCTGCACGTGGACGAGCCGACCCCACACGTGGACTGGGACACCGGACACGTCGAACTACTCACCCACAACCACGACTGGCCGACCGGCGACCGCCCCCGCCGCGCGGGCGTCTCCTCCTTCGGCATCAGCGGCACCAACGCCCACGTCATCATCGAGGAACCCCCCGCGGCCGAACCGGACGCGACCGGCGGGACCGAGGAGCGGCCCGGCCCGGTGGCGTGGACGCTGTCGGCCAGGACCGGGACGGCGTTGCGGGACCAGGCCGGACGCCTGCTGGAGCACCTGGAGGCCGACCCCGGCCTGGACCCGGCGGCGGTCGCCCGCACGCTGGGCTCCCGCGCCGTCTTCGCGCACCGCGCGGGCGTCGTCGGCGACGACCCGGACGACCTGCGTTCCGGGCTGGCGGCGCTCCGGGACGGCGTTCCGGCCGCGAACCTCGGCCAGGGCGTCGAGATGCCCGGAAAGACCGTGTTCGTGTTCCCCGGGCACGGCACCCAGTGGCCGGGGATGGGCCTGGACCTGCTGGAGACCTCCCCGGTGTTCGCCGAACACCTACGAGCCTGCGACGCGGCACTGCGACCCCACACCGGCTGGTCACTCATCGACGTCCTGCACAACACGCCCGACGCCCCCCAACTCGACCGCGTCGACATCGTCCAACCCGCCATCTTCGCCCTCACCGTCTCCCTGGCCCGCCTCTGGCAACACCACGGCGTCCACCCCGACGCCGTCATCGGCCACTCCCAAGGCGAAATCGCCGCCGCCCACATCGCCGGAGCCCTCTCCCTCCAAGACGCCGCCAAGATCATCGCGTTGCGCGGGCAGGTCTGCCGGACCATCGCGGGCACCGGCGGGATGATCGCCGTCCCGCTGCCCGTCGAGCGGGTCGAGGCCGACCTGGAACCTTACGGCGGCGCCCTGTCGGTCGCGGGCGTCAACTCGCCGCGCGGCACGGTCGTCTCGGGCGACCTCGACGCCGTCGACCGGCTGCTCGCCGAATACCGGCGGCGGAACGTGGACGCCAAACCCGTCCCCATCGGTTACGCCTCGCACTCGCCCCACATCGAACCGCTCCGCGACCGCATGCTGGAGGCGCTCGCCGACATCGAGCCGCAGGAGCCCGCCATCCCCGTGCACACGACGGCGGGCGCCCCCGAGGACGGCGTCCGGTTCGACGCGGCGTACTGGTACGCCAACCTCCGGAACCCGGTGCGGTTCCACCGGGCCGTCGCCGCGCTGCTGGAGACCGGGCACCTCCGGTTCGTCGAGGCGAGCCCGCACCCGGTGCTGACCGCCTCGATCCAGCACACGGCCGAGGCCACGGGCGCGGAGGCCGTGGCGGTCGGGACGCTGCGCCGCGGCCGGGGCGACCGGTCCCAGCTGCTCGCCGCGCTGGTCCGCGCCCACACGCACGGCGTCGACGTCGACTGGACGACCGTCCACCCCGGGGACCGGCGGGTGCCGCTGCCCGCCTACGCCTTCCAGCACCGGCCCTACTGGCTCCACCCCGCCGACCGCGCGCGCGGCGGTGCGGACACCGGACACGCGCTGGTCAGCGCGGCGACCGAGCTTCCCGAGGGCAACGGTCACATCCTCACCGGCCGGATCTCCACCGCCACCCACCCGTGGCTGGCCGACCACGCCGTCCTCGGCACCGTGCTGCTGCCCGGGTCCGCGTTCCTCGACCTGGCCCTGCGCGCGGCGATCGAGGTCGGCGGCGACCGGGTCGACGGGCTCACCCTGGAGAACCCGCTGACGCTGCGCGGAGACGCCCCCGTCGAACTGCACGTCGGTGTCGGCGCGCCCGACGGGCCGGACGGCGGCCACCGCACCGTGACGATCCACTCGCGCCCGGCGGACCGGCCGGGCGAGCCGTGGACCCGGCACGCCACCGGCACGATCGCCGCGTCCGCCGGCGACCGCCCGGGCGGCGTCGGCGAGGCGTGGCCGCCGCTTGGCGCGACCCCCGTCGACCTCACCGGCGCCTACGACCGGCTCGACGCCGACGGGTACGAGTACGGACCGGTCTTCCAGGGGCTCCGGGCCGCGTGGCGACACGGCGACGAGATCTTCGCCGAGGTCGCGCTGCCGGAGCACGAGCACGCGGCGGCCCGCCGCTTCTGCCTGCACCCCGCGCTGCTGGACGCCGCGCTGCACGGCATCGTGCTCGGGCTGCTCGGCGAACGGGAGCGGGCCACGCTGCCGTTCGCCTGGACCGGGGTGGCGCTCCACGCGGTGGGCGCGAGCGGCCTGCGGGTCCGCCTGCGCCCGGTCGGAGCCGACGAGGTCGCCCTGGACGTCGCCGACACGACCGGCGCTCCCGTCGCCACCGTCGAGTCGCTGACCCTGCGGACGGTCGCCCCCGAACGGCTCCTCGGCGGGGACCGGCGCGGGCCGACGCCGTACCACCTGGACTGGACGGCCCTGGCCCCGGCCGCCGCGGAGCCGCCGCACGTTCCGCCGCCGGACGCCGACCCCCGGGAGCTCACCGGCCCGCTCCCGGACCCGGTCCTCGTCGACTGCTCCGCACCGGACGGCGGCAACGGCCCCGAGGCCGCGCACGCGCTCGCCGAACGGGCCCTGGAGCTGACGCGGTGGTGGCTGGCCGACGAGCGGTCGGCCGCGTCCCGCCTGGTGTTCCTGACCCGGGGCGCGGTCTCCACCGGCCCCGACGACGGGACCGCCGACCCGGCCGGCGCGGCGGTGTGGGGCCTGGTCCGCTCGGCGCAACTGGAGCACCCCGGCCGGTTCGTCCTGCTGGACGTCGACGGCGACGACGCCTCGGCCCGGGCGCTGGGCGCGGCGGTCGCGTCCGGCGAGCCGCAGCTCGCGATCCGGAACGGCCGGTGTCACGCGCCTCGGCTCGCCCGGACCGCCGACGCTCCCGGCGACGCCCCGTTCGACCCCGACGGCACCGTGCTCATCACCGGTGGCACCGGCACGATCGGCGCGCTCCTCGCCCGCCACGCCGTCGCCCGGCACGGCGCGCGGCACCTGTTGCTGCTCAGCCGGCGCGGCCCCGACGCGCCGGGCGCGGAGGAGCTGCGGGCCGAGCTGACCTCGCTGGGCGCCGAGGTCACCGTCGCCGCATGCGACACCGCCCGCCGGGACGACCTCGCCCGCGTCCTCGGTGCGCTGCCGGAGGAACGTCCGCTCACCGCGGTCGTCCACGCCGCCGGGGTGCTGGACGACGCGATGCTGACCGACCTCACCCCGGAGCGGCTGCACGCGGTGCTGCGGCCGAAGGTGGACGCGGCCTGGCACCTGCACGAGCTCACCCGCGACCTGCCGCTGACCGCGTTCGTGCTGTTCTCCTCCGCCGTCGGCACGGTCGGGGCGGCGGGCCAGGCCAACTACGCCGCCGCCAACGCCTGGCTCGACGCGCTCGCCCACCACCGCCGGTCCCTGGGTCTGCCGGGCGTGTCGCTCGGCTGGGGCCTCTGGGCCGCCACCAGCGACATGACCGGCTCCCTCAGCCGGGACCAGCGCGAACGCCTGCATCGCCAGGGGCTGCGGCCCCTGTCCACCGAGCACGCGCTCGCCCTGTTCGACGCCGCCCTGGCCGCCGGGACGGCCCACCTCGTCACCGCCGACCTGGACCCGAACGCCCTCCAGGACCGCGCCGCCGACGGCACGCTGCCTCCGGTGCTGAGCGGCCTCGTCCGGCAGCGGCCCCGCCGGGCCGGTGCGGGCGGGCCGAGCGGCGCCGAACTCACCGCCCGCCTGGCCGGTCTCGCGGGCGCCGAGCAGGAGGAACTGCTCGGCGACCTCGTCCTCGGCCATGTGGCCGCCGTGCTCGGCCACTCCACGACGGCCGACGACGCCCGCGACCGGAGCTTCAAGGAACTCGGCTTCGACTCGCTCACCGCCGTCGAGCTCCGCAACCGGCTGAGCACCGCGACCGGCCTCCGGCTGCCCGCCACCCTGGCCTTCGACCACCCGACCGCCAACGCGCTGGCGCGGTTCCTCAGGGAACAGGTGACCAGCACCGGCGAACGACCCTCCGCGCCGACCGCGTCCACCATCCCGGCCGACGAGCCGATTGCGATCGTGGGAATGGCGTGCCGTTACCCCGGTGGGGCGACCTCACCGGAGGCCCTGTGGCGGCTGGTCTCCCAGGGCGTCGACGCCATCGGGGAGTTCCCCACCGACCGGGGCTGGGACCTGGAGTCCCTCTACGATCCCGACCCCGACCATCCCGGTACCAGCTACACCCGTCACGGCGGCTTCCTTTACAACGCCGCCGACTTCGACCCCGAGTTCTTCGGCATCAGCCCCCGCGAAGCCCTGGCCACCGACCCCCAACAACGCCTCCTCCTGGAAACCAGCTGGGAGACGTTCGAAAACGCCGGAATCAACCCCCACACGCTGCGCGGCAGCCACACCGGCGTCTTCACCGGCGTCATGTACGACGACTACGGCAACCGGCTCATGCAGCAGGCGCCGGAAGGCTACGAAGGGCAGCTGGGGACCGGCAGCGCGGGCAGCGTCGCGTCCGGGCGGATCGCCTACACGTTCGGGCTCGAAGGCCCTGCCATCTCGGTGGACACCGCCTGCTCGTCCTCGCTGGTCGCCCTGCACCTGGCGATCCAGGCGCTCCGCAACGGCGAATGCGACCTGGCACTGGCCGGCGGCGTCACCGTGATGGCCACACCGGGGACCTTCGTGGAATTCAGCCGCCAGCGCGGCCTGGCCCCCGACGGGCGGCCGAAGCCGTTCGCCGCCGCCGCCGACGGCACCTCGTGGGGGGAGGGCGTCGGACTGCTGCTGGTCGAACGACTCTCCGACGCCCAGCGCAACGGCCACCGCGTGCTCGCCGTCGTCCGGGGCTCGGCCGTCAACCAGGACGGCGCGTCCAACGGGCTCACGGCCCCCAACGGGCCCTCGCAGCAGCGGGTGATCCGGCAGGCGCTGGCCAACGCCGGTCTGGCCCCCGCCGAGGTGGACGCGGTCGAGGCGCACGGCACCGGCACCAGGCTCGGCGACCCCATCGAGGCGAACGCGCTGCTGACCACCTACGGGCAGGACCGCGACCGGCCGTTGTGGCTCGGCTCCATCAAATCCAACATCGGCCACACCCAAGCCGCCGCAGGCGTCGCCGGGATCATCAAAATGGTGCAGGCCATGCGACACGGGGTCCTGCCCCGGACGCTGCACGTGGACGAGCCGACCCCACACGTGGACTGGGACGCCGGACGCGTCGAACTGCTCACCGACAACCACGACTGGCCCGAACTCGACCGGCCCCGCCGCGCGGCGGTGTCATCGTTCGGCATCAGCGGCACCAACGCCCACGTCATCCTGGAACAAGCCCCCAAGCCAAAGCCGGAGCCCGCAGAGCCGGAAGAGCACACCGGCCCGATGGCATGGCTGCTGTCGGCCCGGAACGAGACGGCGTTGCGGGACCAGGCCAAGCGTCTGCTGGAACACCTAAAGGCCGACCCCGACCTGGATCCGGCGGCGGTTGCCGCCACCCTCGCCACACGCACGGCATTCCCGCACCGCGCCGCCGTCATCGGCTCCACTCTCGACGAGGCTGTCGCCGGTCTTCGCGCGCTGAGTGCGGACACACCGGCCGCGAACCTGGTCCAGGGAAGGGAAACGCCGGGCAAGACGGTGTTCGTGTTCCCCGGCCAAGGCTCCCAATGGGCCGGGATGGGCCTGGAACTGATGGAGTCCTCTCCGGTGTTCGCCGAACACCTGCGAGCCTGCGAACAGGCCCTGCGCCCTCACACCGGCTGGGCACTGACCGACGTGCTGGGCGACGAAGCTGCCCTGGAACGCGTCGATGTCGTCCAGCCCGCACTGTTTTCGATCATGGTGTCGCTGGCCCGACTCTGGCAACACCACGGCGTCCACCCCGACGCCGTCATCGGCCACTCCCAAGGCGAAATCGCCGCCGCCCACATCGCAGGCGCACTGACACTGGCGGACGCCGCCAAGATCGTCGCACTGCGCTCCCAAGCCATCCACACCCTGGCAGGCAATGGCGCGATGGCCGCCATCCCCCTACCCGCCCATCAGATCCCCACCAGCAACGGCATCTCCATCGCCGCCATCAACTCCCCCACCACCACCATCGTCTCCGGCGACACCGACGCCGTGGCCTCCCTGGTCGCCGCCCACCCCGGGGCCAAGACCATCCCGGTGGACTACGCCTCCCACTCACCCCACGTCCAACCCCTCCAAGAACAAATCCTCACCGCCCTGGCCGACATCACCCCCACCACCCCCGACATCCCCATCCACAGCACCGTCGGTGACATCACGACCAACACCCCCTTCGATGCCCGGTACTGGTACGACAACCTGCGCAACACCGTCCAGTTCCACCCCACCCTCACCACCCTGCTGAACACCGGACACACCCGTTTCATCGAAATCAGCGCCCACCCCGTCCTGACCAGCCCCATCCAGGACAACCCCGACGCCATCGCCATCGGCACCCTGCGCCGCAACCACGGCACCCCCACCCAACTCCTCCACGCCCTGGCCACCGCCCACACCCACGGCATCACCACCAACCCACTCCACCCCACCAGCCCACACACCCCACTGCCCACCTACCCCTTCCAACACCAGCGCTACTGGCTCACCCCCACCACCACACCCCAGCCCGGCCACACCACCACCGGCCACCCGCTGGTGAGCGGTGTCGTCGAGTTGCCGGGCAGTCAGGGGCTCGTGCTCACCGGGCGGATCTCCACGGCCACCCATCCGTGGCTGGCCGACCACGCCGTGCTCGGTACCGTCCTTCTTCCCGGCGCCGCCCTGGTCGACGTCACGCTGCACGCGGGTGCGCGGGTCGGTTGCGCGCGGATCGACGACCTGGTCCTGGATCATCCGCTGGTGCTGCCCGAGCAGGGGGCGGCCGACCTGCGGGTCCAGGTCAACGGTCCCGACGAGGACGGCCGCCGCGCGTTCACGGTCCATTCGCTGCCGGGCGGCGCGCAGGACGCCGACTGGGTGTGCAACGCGACGGGCCTGCTCGCTCCCGCGACGACGCCGACGGCGTCCGGGGGTGGGGCGTGGCCGCCGCCGACCGCCGCTCCGCTGCCGGTGAAGGACCTTTACGAACGGCTCGCCGACGGCGGCTACGACTACGGCCCCGTCTTCCAGGGGCTCCAGGCCGCCTGGCGGGACGGGGACGTCCTCTACGCCGAGGTCCGGCTCCCCGACGACACCGACCCCACCGGCTTCGCCGTCCACCCCGCCCTGCTCGACGCGGCGCTGCACGTCCGGCTGGCCGCCGACCCGGGCGGGGTCGCGGACGGTCTCCGGTTGCCGTTCTCCTGGTCCGAGGTCACCGTGACCGGGGGCGACGTCCGTGCGCTGCGCGTGCGGATGTCGCTGGCGGACCAGTCGACGATCGGGCTGGTCGGCATGGACGCCGAGGGGCGTCCGGCCGTCACGGTCGGGTCCCTCGCGCTGCGGCCGGTCGACCCGGCGCGGCTGGCGGCACCGCAGGCGTCTCCGCTGAACGTCGGTTGGACGCGGCCGGACCCGGCCGCGCCGCGACCGGTCGAGGCGGTCCTGCTCGGCGCGGACGTCTTCGCCACCGGGCTTCCCGTCCGCGCCGGGCTCGCGGACGTCCTGGCCGGTCCCGCGCCCGTGCCGGAGGCGGTGGTGGCCGTTCTGGCGGCGGACGGCGGCGCCGATCCCGTCGCGCGGGCCCACTCCCTGGTGGAACGGGCGCTGGCCCTGGTGCGGGAGTGGCTGGCCGAGGAGCGGGCGGCCGACTCCCGGCTGGTCGTCCTCACCCGGGGTGCGGTGGCCGCCGTCCCGGACGACGAGATCACCGATCTGCCCGCCGCGGCCGTCTGGGGCCTGGTGCGGTCCGCCCAGGCCGAGCATCCCGGCCGGTTCGTCCTGGCCGACCTGGACGGGAGCGAGGCCTCGGCGCGGTCCCTCGCGGAGGCGCTCGCGCTGGACGAGCCGCAGGTCGCGCTCCGTGACGGTGAGCCGCTGGTCGCCCGGCTGGCGCGGACGGCCCCCGCTCCCCTGGCCGACGGCCCGTTCGATCCCGACGGCACCGTGCTCGTCACCGGTGGCACCGGGGCCCTGGGCGCGCACGTCGCCCGGCACCTGGTGGCCCGGCACGGCGTCCGGCACCTGCTGCTGCTCAGCCGGCGCGGCCCCGACGCGCCGGGCGCGCAGGAGCTGCGCGCCGAGCTGACCGGCGCGGGCGCCGAGGTCACCGTCGCCGCCTGCGACACCGCCGACCGGGCGAGCCTCGCCGCCGTCCTCGCCGACGTCTCCCCCGACCACCCGCTCACCGCCGTCATCCACACCGCCGGGGTGTTGCGGGACGCCACCGTCGCCAACCTCGCGCCGGACCAGCTCCGTGAGGTCCTGCGGCCGAAGGTGGACGCGGCCTGGCACCTGCACGAACTCACCCGCGACCTGCCGCTGACCGCGTTCGTGCTGTTCTCCTCCGCGGCCGGAACCCTGGGCACCCCAGGACAAGCCAACTACGCCGCCGCCAACGCCTACCTCGACGCCCTCGCCCACCACCGCCACACCCACGCCCTCCCCGCCACCAGCCTCGCCTGGGGACTGTGGACCGACACCAGCGAGATGACCGGAAACCTGAACGCCTCCGACGTCGGCCGTCTGGGCCGGACCGGCCTGGCCCCGATGTCGGTGGCCGAGGGGCTGGCGTTGTTCGACGCCGCGCTGGCGGCCGGCGGGCACTCCCATCTGGTGCTCGCGCCGCTGGACCGGGCGGCGCTGCGTCGTCAGGCCGCGAACGGCGGGGTCCCGGCGCTGTTCCGCGATCTCGCGCCCCGGCCGTCCGGGCGGGCCCCCGAGGACGGCGGGAACGGCTGGGCCCGGCGGTTCGCCGAGGCGGCGGAGGACGAGCGCGGCGAGCTCCTGCTCGACCTGGTGCGTTCGCATGTGGCGACGGCGCTCGGACACGCGTCGGCTGAGCGGATCGATCCGGACCGCGCGCTGAAGGAGCTGGGCTTCGACTCGCTGATCGCGGTCGACTTCCGGAACCGCCTGGGCGCGGCGACCGGGCTGCGGCTGCCCGCGACGCTGGCGTTCAACCACCCGACCCCGGCGGCCGTCGCCGAGTACCTCGGGAGCCGTCTGGCGGCCGGGGATCCGGAGGGCGGGCGGGACTCGGTCCTCGCCGAGCTCGACCGGATCGAGGAGGCGCTGCGGAAGGCGTCCGACGACTCCCGGCAGGAGATCACCGAACGGCTCCGGCTGTTGCTCACCCGGCATACCGAGGAGGGTCCGGGCTCCGGCGACATCGCGGCGGCCACCGACGACGAGATGTTCAACCTGATCGACAACGAACTCGGCATCGCCTGA	MTDVREPELVFSASNEPIAIVGLSCRLPQAPDPAAFWRLLLDGRSAVTETPPGRWTGAEGTAGLRHGGFLDDVDRFDAAFFDVSPREAASMDPQQRLMLELAWEAVEDAMIAPATLAGGRTGVFVGAIGDDYAALMRRHGPEGGTRHSLAGTLRGIIANRVSYTLGLRGPSLTVDAAQASALVAVHLACESIASGESAMALAGGVNLNLDTGTALETERFGGLSPDGRCHTFDARANGYVRGEGGAFVLLKPLSRALADGDRVYCVIRGSGVNNDGATDGLTVPDADAQREVIRLAWRRAGLEPGAVQYVELHGTGTRVGDPVEAASVGAALGAARADGPVHVGSTKTNVGHLEGAAGIVGLVKAALCVRHRMIPASLNFETPNPEIDLAALNIEVRTAPGPWPRPDAPLVAGVNSFGMGGTNCHVVVAEPPAAEPEPGAAAEPEPGAAAMPVVPWVLSARDPGALRDQAAALRAAAADLDPVDTGWSLLTTRSSFEHRAVVLGADRDGLLRGLAEAAAGEEAAGLVTGRAAEHGGTVFVFPGHGTQWPGMGLDLLETSPVFAEHLRACDAALRPHTGWSLIDVLHNTPDAPQLDRVDIVQPAIFALTVSLARLWQHHGVRPDAVIGHSQGEIAAAHIAGALSLQDAAKIITHRGRVAATIAGTGGMVAVPLPPDQVTADLADHPGLTVAGINSPRSTVVSGDLEAVRRLLAHYKERGVDARAVPIGYASHSPHIDPLRDRLLAAFADITPRTPQIPFHSTVRPGTTPVLDAEYWFDNLRAPVRFHAAVTALHDAGHHRFVEVSPHPVLTAPVQDGTGATAIGTLRRNRPGWRAFVTALARLHVTGGEVDWAVLFEGRRPRRVPLPTYPFQRRRHWFPSGGERHEAESREAASREVAAPKEPGVPEPSPASSPLAGLPEAELRRTLLDLVRKRAAVVLEHPDDSGIDTGRSFKQLGFDSLLAVELRNALAAATGLDLPASLLFDHPTPTALTGYLHDRITGSAGTRPLEAAPPRRTTGGADDPIAIVGMACRFPGGVRTPEQLWRLVETGTDAISDFPDNRGWDLNALFDPDAEASGTSAVRRGGFLPDADLFDPAFFGISPREALAMDPQQRLLLEVSWEALERAGVDPLSLRGGRAGVFVGAMAQEYGPRLSDAADGLEGFRLTGTSVSVASGRIAYTLGLQGPAFTVDTACSSSLVALHLAVRALRDGECPLAVAGGVNVMASPGIFVEFSRQQGLSPDGTCKAFADAADGTGWSEGVGMVVLERLSDARRNGHRVLALIRGSAINSDGASNGLTAPNGPSQVRVIRQALADGGLSPADVDAVEAHGTGTRLGDPIEAQALIEAYGRDRPADAPLWLGSLKSNIGHAQAAAGIGGLIKMVMALRHRSLPRTLHVDAPTRRVDWSAGAVRLLAEARPWPGTPVRRAAVSSFGISGTNAHLVLEQAPESDVPADDGRAADPGAATLPWPVSAPNEQGLRDRAAQLLRHLDSVPDAVPDDIGVALATTRSAFAHRAVVTGGDRAALRAGLEALANGVPAPNVTLGTARDRGGVVFVFPGQGSQWAGMAAELAASSPVFRAEALACADALQPHLDWPVRDVLLGRPGAPGLDRSDVVQCTTFAVVAGLAAVWRAAGVEPDAVVGHSQGEIAAAYVSGALTLADAARVVALRSTALLSLAGTGGMVTVSASPDETEALLGRWAGRLSVAASNGPASTVVGGDPEALEELLAHCEARGVWARRVPVDYASHSPHMEALREELTGRLAPVSGRAPRIAFHSTVEGVRHGTFRTDGEYWYRNLRHRVEFAPAVRDLAAAGFDTFVEVSPHPVLTTAIEQTLEEAGVEHAVVVGSLRRDDGGRGRFTASLAHAHAHGVAVDWPAALADLPARPVDLPTYPFRRQRYWIGPGTGGENTIGHPFLHTVTDLADGDGHVFTGRLSPSARPWLADHAVRGAALLPGTAFLDMVARAGEELGYGSVEELTLEAPLPIPADGDVRLQVVVGAADGSGRRPVRLFSRTAEEGWTRHATGFVSAEAPAAVDVPPDEAWPPPGATELDVDELYDGLREHGYEYGPAFRNVRAAWRLGDDLYAEVALPAELRAEADRGPVHPALLDAALHPLGATGLLREDAEGLLLPFSWTGFSAPSAGAGTVRARLTPSGADAVSLVVTDDAGAVVAAGSLALRPTAVERLAPARTVRNLYGVEWRPLPLGVPGDGRWAALGDAALDVARAAGLPADAYPDLAALREAVAGGAAAPALVLAGPAAGDGVPPDAAAHATAGRTLALLQEWLADERLDAARLVVVTRDAVAAVPGSDVPSPADAAVWGLVRSAQTEHPGRFVLLDLDGDAASARAVAAVAASGEPQTAVRAGEARVPRLAPVTTAGPDATGPALDGTVLLTGGTGRLGRLVARHLVRDRGARHLLLVSRRGDAADGATELAAELRALGAEVAFAAADAADRAALRAVLDAVPADRPLRAVVHLAGVLDDGAVTSLTPERTGAVLRPKADAAWHLHELTRDLPLAAFVLFSSAIGTVGGPGQANYAAANAFLDALAERRRAEGLAAVSLAWGLWSEASGMTGHLTESDRARLRRSGIAAMDTGEALALLDAALAADRPVVVPARLDLAALRAGHGPDEVPALFRRLLPRTGGAAPRAAARGAASARRLTALPPAEREAALLDLVRAEAAGVLGHDDPGTVEPDRALREQGLDSLTTVELRNRIGAATGLRLPATVVFEHPTVTALARHLGEKLTGAGGADRAAATGVQSDEPIAIVGMACRYPGGATSPEALWRLVAQGVDAIGEFPTDRGWDLEGLYDPDPDHPGTSYTRHGGFLYDAADFDPEFFGISPREALATDPQQRLLLETAWETLENAGINPHTLRGSHTGVFTGVMYDDYGNRLMQDSPDGFEGFLIAGTQTSVASGRVSYVLDLAGPALTVDTACSSSLVALHLAIQALRNGECDLALAGGATIMATPGPFIEFSRQRGLAPDGRSKSFSAAADGAAWSEGVGLLLVERLSDAQRNGHRVLAVVRGSAVNQDGASNGLTAPSAAAQRRVIRQALTNAGLSPADVDAVEAHGTGTTLGDPIEAEAILATYGQNRDRPLWLGSIKSNIGHTQAAAGVAGIIKMVQAMRHGVLPRTLHVDEPTPHVDWDTGHVELLTHNHDWPTGDRPRRAGVSSFGISGTNAHVIIEEPPAAEPDATGGTEERPGPVAWTLSARTGTALRDQAGRLLEHLEADPGLDPAAVARTLGSRAVFAHRAGVVGDDPDDLRSGLAALRDGVPAANLGQGVEMPGKTVFVFPGHGTQWPGMGLDLLETSPVFAEHLRACDAALRPHTGWSLIDVLHNTPDAPQLDRVDIVQPAIFALTVSLARLWQHHGVHPDAVIGHSQGEIAAAHIAGALSLQDAAKIIALRGQVCRTIAGTGGMIAVPLPVERVEADLEPYGGALSVAGVNSPRGTVVSGDLDAVDRLLAEYRRRNVDAKPVPIGYASHSPHIEPLRDRMLEALADIEPQEPAIPVHTTAGAPEDGVRFDAAYWYANLRNPVRFHRAVAALLETGHLRFVEASPHPVLTASIQHTAEATGAEAVAVGTLRRGRGDRSQLLAALVRAHTHGVDVDWTTVHPGDRRVPLPAYAFQHRPYWLHPADRARGGADTGHALVSAATELPEGNGHILTGRISTATHPWLADHAVLGTVLLPGSAFLDLALRAAIEVGGDRVDGLTLENPLTLRGDAPVELHVGVGAPDGPDGGHRTVTIHSRPADRPGEPWTRHATGTIAASAGDRPGGVGEAWPPLGATPVDLTGAYDRLDADGYEYGPVFQGLRAAWRHGDEIFAEVALPEHEHAAARRFCLHPALLDAALHGIVLGLLGERERATLPFAWTGVALHAVGASGLRVRLRPVGADEVALDVADTTGAPVATVESLTLRTVAPERLLGGDRRGPTPYHLDWTALAPAAAEPPHVPPPDADPRELTGPLPDPVLVDCSAPDGGNGPEAAHALAERALELTRWWLADERSAASRLVFLTRGAVSTGPDDGTADPAGAAVWGLVRSAQLEHPGRFVLLDVDGDDASARALGAAVASGEPQLAIRNGRCHAPRLARTADAPGDAPFDPDGTVLITGGTGTIGALLARHAVARHGARHLLLLSRRGPDAPGAEELRAELTSLGAEVTVAACDTARRDDLARVLGALPEERPLTAVVHAAGVLDDAMLTDLTPERLHAVLRPKVDAAWHLHELTRDLPLTAFVLFSSAVGTVGAAGQANYAAANAWLDALAHHRRSLGLPGVSLGWGLWAATSDMTGSLSRDQRERLHRQGLRPLSTEHALALFDAALAAGTAHLVTADLDPNALQDRAADGTLPPVLSGLVRQRPRRAGAGGPSGAELTARLAGLAGAEQEELLGDLVLGHVAAVLGHSTTADDARDRSFKELGFDSLTAVELRNRLSTATGLRLPATLAFDHPTANALARFLREQVTSTGERPSAPTASTIPADEPIAIVGMACRYPGGATSPEALWRLVSQGVDAIGEFPTDRGWDLESLYDPDPDHPGTSYTRHGGFLYNAADFDPEFFGISPREALATDPQQRLLLETSWETFENAGINPHTLRGSHTGVFTGVMYDDYGNRLMQQAPEGYEGQLGTGSAGSVASGRIAYTFGLEGPAISVDTACSSSLVALHLAIQALRNGECDLALAGGVTVMATPGTFVEFSRQRGLAPDGRPKPFAAAADGTSWGEGVGLLLVERLSDAQRNGHRVLAVVRGSAVNQDGASNGLTAPNGPSQQRVIRQALANAGLAPAEVDAVEAHGTGTRLGDPIEANALLTTYGQDRDRPLWLGSIKSNIGHTQAAAGVAGIIKMVQAMRHGVLPRTLHVDEPTPHVDWDAGRVELLTDNHDWPELDRPRRAAVSSFGISGTNAHVILEQAPKPKPEPAEPEEHTGPMAWLLSARNETALRDQAKRLLEHLKADPDLDPAAVAATLATRTAFPHRAAVIGSTLDEAVAGLRALSADTPAANLVQGRETPGKTVFVFPGQGSQWAGMGLELMESSPVFAEHLRACEQALRPHTGWALTDVLGDEAALERVDVVQPALFSIMVSLARLWQHHGVHPDAVIGHSQGEIAAAHIAGALTLADAAKIVALRSQAIHTLAGNGAMAAIPLPAHQIPTSNGISIAAINSPTTTIVSGDTDAVASLVAAHPGAKTIPVDYASHSPHVQPLQEQILTALADITPTTPDIPIHSTVGDITTNTPFDARYWYDNLRNTVQFHPTLTTLLNTGHTRFIEISAHPVLTSPIQDNPDAIAIGTLRRNHGTPTQLLHALATAHTHGITTNPLHPTSPHTPLPTYPFQHQRYWLTPTTTPQPGHTTTGHPLVSGVVELPGSQGLVLTGRISTATHPWLADHAVLGTVLLPGAALVDVTLHAGARVGCARIDDLVLDHPLVLPEQGAADLRVQVNGPDEDGRRAFTVHSLPGGAQDADWVCNATGLLAPATTPTASGGGAWPPPTAAPLPVKDLYERLADGGYDYGPVFQGLQAAWRDGDVLYAEVRLPDDTDPTGFAVHPALLDAALHVRLAADPGGVADGLRLPFSWSEVTVTGGDVRALRVRMSLADQSTIGLVGMDAEGRPAVTVGSLALRPVDPARLAAPQASPLNVGWTRPDPAAPRPVEAVLLGADVFATGLPVRAGLADVLAGPAPVPEAVVAVLAADGGADPVARAHSLVERALALVREWLAEERAADSRLVVLTRGAVAAVPDDEITDLPAAAVWGLVRSAQAEHPGRFVLADLDGSEASARSLAEALALDEPQVALRDGEPLVARLARTAPAPLADGPFDPDGTVLVTGGTGALGAHVARHLVARHGVRHLLLLSRRGPDAPGAQELRAELTGAGAEVTVAACDTADRASLAAVLADVSPDHPLTAVIHTAGVLRDATVANLAPDQLREVLRPKVDAAWHLHELTRDLPLTAFVLFSSAAGTLGTPGQANYAAANAYLDALAHHRHTHALPATSLAWGLWTDTSEMTGNLNASDVGRLGRTGLAPMSVAEGLALFDAALAAGGHSHLVLAPLDRAALRRQAANGGVPALFRDLAPRPSGRAPEDGGNGWARRFAEAAEDERGELLLDLVRSHVATALGHASAERIDPDRALKELGFDSLIAVDFRNRLGAATGLRLPATLAFNHPTPAAVAEYLGSRLAAGDPEGGRDSVLAELDRIEEALRKASDDSRQEITERLRLLLTRHTEEGPGSGDIAAATDDEMFNLIDNELGIA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	1500.24	gnl|BL_ORD_ID|1968|hsp_num:0	1943			447	1239	isoniazid
BGC0000082.1|Kijanimicin_28 # 87990 # 88391 # -1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=7bp;gc_cont=0.669	BGC0000082.1|Kijanimicin_28 	87990	88391	-	Loose	450	28.1054	aadA6/aadA10	27.78	3002622	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGTATCTGGAGAATCTCCGGGAAGTCTGCCACACGAACGTGCACATGGAGACCCGGCCGGGCGTCGGCCACCATGTGACGTTCACCGAGGAGCTGTACGACTCCGACGGCAACCTGGTGGCCACGTCCGAGGGCATGTCGGTGGTGTACGGGGACCCCGAGACCGGCGGCCTGGCGCAGCTCATCACGGCCACCGAGAAGCTCGGGGACGGCACCATCCAGTGGACCGGGACGGTGCGCCAGGAGGACCCGAACGGGACCGAGTTCGCGGTCCAGCGCATCCCCGCGATCGGGGTGAGCGGCCGTTACGCCGGAAAGACGGGCGTCCGGACGTTCAAATTCGTCGAACGGCCCGACCAGCACACCACGATCGCGGAGGCGACCATCTACATGGAGGACTGA	MYLENLREVCHTNVHMETRPGVGHHVTFTEELYDSDGNLVATSEGMSVVYGDPETGGLAQLITATEKLGDGTIQWTGTVRQEDPNGTEFAVQRIPAIGVSGRYAGKTGVRTFKFVERPDQHTTIAEATIYMED	MSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAARLDETVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAGIFEPATTDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWEGDERNVVLTLSRIWYSAATGKIAPKDIVANWAMERLPDQHKPVLLEARQAYLGQGEDCLASRADQLAAFVHFVKHEATKLLSAMPVMSKTKLDALST	48.01	gnl|BL_ORD_ID|1138|hsp_num:0	1242			471	669	spectinomycin; streptomycin
BGC0000082.1|Kijanimicin_29 # 88509 # 89753 # -1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=AAGGA;rbs_spacer=8bp;gc_cont=0.715	BGC0000082.1|Kijanimicin_29 	88509	89753	-	Loose	400	26.1794	Erm(42)	37.14	3003106	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACCGGACCGACCGACGCGACCGCTCCGGCGCGCTGCCGGGTGTGCGGCGACACCGTCGACGAGTTCCTCGACCTGGGACGGCAGCCGCTGTCCGACCGGTTCCTCACGCCCGCCGACACCGACGGGGAGTTCTTCTACCGGCTCGCCGTCGGCCGGTGCCACGCGTGCGGCATGGTGCAGCTCACCGAGGAGGTGCCCCGGCACCTGATGTTCCACGAGGAGTACCCGTACCACTCGTCGGGATCGTCGGTGATGCGCGAGCACTTCGCCAAGGTCGCCCAGCGTCTCCTCGCCACCGAGCTGACCGGGGCCGACCCGTTCGTGGTGGAGATCGGCTGCAACGACGGGATCATGCTGCGGGCGGTCCACGAGGCGGGCGTCCGGCACCTGGGGTTCGAGCCCTCGGCGGGCGTGGCCGAGGTGGCGCGCTCGCGGGGGGTGCGGGTGCGCACCGAGTTCTTCGAGAAGGCGACGGCCACCGCCGTGCGGGAGTCCGAGGGGCCCGCCGACGTCATCTACGCGGCGAACACCATGTGCCACATCCCCTACCTGGAGTCGGTGTTCCAGGGCGCCGACGCCCTGCTCGGCCCGGACGGCGTGGTCGTGTTCGAGGACCCCTACCTCGGGGACATCGTCGCCAAGACCTCCTTCGACCAGATCTACGACGAGCACTTCTACCTCTTCTCCGCCGGTTCCGTGGCGGCGATGGCCGAACGGTTCGGGTTCGAGCTGGTGGACGTGGAACGGCTGCCGGTCCACGGCGGCGAGGTGCGCTACACCCTCGCGCGCCGGGGCGCGCGGACGCCGACGGAGGCCGTCGGGCGGCTGCTCGCCGAAGAACGCGAACAGGGGCTGGACGACCTGGCGACGCTGCGGACGTTCGCGGCGAACGTCCACACGGTCCGGGACGAGCTGGTGGCCCTGCTGACGAGGTTGCGCGCGGAGGGGCACCGCGTGGTGGGGTACGGCGCGACCGCCAAGAGCGCCACCGTGACCAACTTCTGCGGGATCGGCCCCGACCTGGTCTCCTTCGTCTGCGACACGACGCCGGGCAAGCAGCACCGGCTGACCCCGGGCAAGCACCTCCCGGTCCGCCCGGCCGAGGCGTTCGCCGACCCGTATCCCGACTACGCGCTGCTGTTCGCCTGGAACCACGCCGACGAGATCATGGCCAAGGAGCAGGAGTTCCGGCAGGCCGGCGGGCGCTGGATCCTGTACGTGCCCGAGGTGCGCGTGCTCTGA	MTGPTDATAPARCRVCGDTVDEFLDLGRQPLSDRFLTPADTDGEFFYRLAVGRCHACGMVQLTEEVPRHLMFHEEYPYHSSGSSVMREHFAKVAQRLLATELTGADPFVVEIGCNDGIMLRAVHEAGVRHLGFEPSAGVAEVARSRGVRVRTEFFEKATATAVRESEGPADVIYAANTMCHIPYLESVFQGADALLGPDGVVVFEDPYLGDIVAKTSFDQIYDEHFYLFSAGSVAAMAERFGFELVDVERLPVHGGEVRYTLARRGARTPTEAVGRLLAEEREQGLDDLATLRTFAANVHTVRDELVALLTRLRAEGHRVVGYGATAKSATVTNFCGIGPDLVSFVCDTTPGKQHRLTPGKHLPVRPAEAFADPYPDYALLFAWNHADEIMAKEQEFRQAGGRWILYVPEVRVL	MNKNTKIKNKNFNIKDSQNFLHNTKLVEDLLFKSNITKEDFVVEIGPGKGIITKALSKICKAVNAIEFDSVLADKLSHEFKSSNVSIIEADFLKYNLPDHNYKVFSNIPFNITASILNKLLDSENPPLDTFLIMQYEPFLKYAGAPSYKESYKSLLYKPFFKTNILHSFSKFDFKPAPNANIILGQFSYKDFTDINLEDRHAWKDFLAFVFLEKGVTFKEKTKRIFSYKQQKIILKESRINDDSNISNWSYEFWLKMFKLYNSNMVSKDKKVLVNNSYKRMLEHESSLEKIHRNRKQNNRK	137.54	gnl|BL_ORD_ID|643|hsp_num:0	697			63	168	erythromycin; clindamycin
BGC0000082.1|Kijanimicin_30 # 89836 # 90957 # -1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=4bp;gc_cont=0.712	BGC0000082.1|Kijanimicin_30 	89836	90957	-	Loose	600	28.8758	DES-1	30.59	3004780	protein homolog model	n/a	n/a	penam	antibiotic inactivation	DES beta-lactamase	ATGACGACTCGCGTATGGGACTACCTGCTGGAGTACGAGCAGGAGAAGGCGGACCTCCTCGCCGCCGTCGAGACGGTGCTGGAGTCCGGTCAACTGATCCTCGGCAAGAGCGTGCAGGGCTTCGAGGCCGAGTTCGCGGCCTACCACGGCCTGGCGCACTGCGTCGGCGTCGACAACGGCACCAACGCCGTCAAGCTGGGCCTGGAGGCGCTGGGGATCGGCCCCGGCGACGAGGTGATCACCGTGTCGAACACCGCGGCGCCCACCGTGGTCGCGATCGACGGCGCCGGCGCCACCCCGGTCTTCGTGGACGTGCGCGAGGACGACCACCTGATGGACACCGACCAGGTCGCCGCCGCGATCACGCCGCGGACCAGGGCGCTGCTGCCGGTGCACCTGTACGGGCAGTGCGTCGAGATGGCCCCGCTGGAACGGCTGGCGGCCGAGCACGGCCTGGTCATCCTGGAGGACTGCGCGCAGGCGCACGGCGCGCGCCACCACGGCCGGACGGCCGGCACCATGGGCGACGCCGCCGCGTTCTCCTTCTACCCGACGAAGGTGCTGGGGGCCTACGGCGACGGCGGGGCGGTGGTCACCGACGACGCGGAGATCGACCGGCACGTGCGGCAGCTCCGCTACTACGGGATGGACAAGGTCTACTACGTCGTCCGGACCCCCGGCCACAACTCGCGCCTCGACGAGCTCCAGGCCGAGATCCTGCGCCGGAAGCTGCGCCGCCTCGACGCCTACATCGCGGGCCGCCGGGAGGTGGCGCNCCGGTACGAGGAGGGCCTCGGCGACCTCACCGGCCCCGGCGGGCTGAGGCTGCCCTCGGTGACGGAGGGCAACGAGCACGTCTACTACGTGTACGTGGTGCGGCACCCCCGCCGCGACGAGATCATCGAGCGGCTCAAGCGCTTCGACATCCAGCTCAACATCAGCTACCCGTGGCCGGTGCACACCATGAGCGGGTTCGCCGGGCTCGGCTACGCCACCGGGTCGCTGCCGGTCACCGAACGGCTCGCCGACGAGATCTTCTCGCTGCCCATGTACCCCTCGCTCCCCCGGGACCGCCAGGACAGGGTGATCGACGCGCTGCGCGAGGTGCTGGCGGACCTGTGA	MTTRVWDYLLEYEQEKADLLAAVETVLESGQLILGKSVQGFEAEFAAYHGLAHCVGVDNGTNAVKLGLEALGIGPGDEVITVSNTAAPTVVAIDGAGATPVFVDVREDDHLMDTDQVAAAITPRTRALLPVHLYGQCVEMAPLERLAAEHGLVILEDCAQAHGARHHGRTAGTMGDAAAFSFYPTKVLGAYGDGGAVVTDDAEIDRHVRQLRYYGMDKVYYVVRTPGHNSRLDELQAEILRRKLRRLDAYIAGRREVAXRYEEGLGDLTGPGGLRLPSVTEGNEHVYYVYVVRHPRRDEIIERLKRFDIQLNISYPWPVHTMSGFAGLGYATGSLPVTERLADEIFSLPMYPSLPRDRQDRVIDALREVLADL	MHSRSSYSRRYVLAGLCALPFASLSAGLIFNSSADAASLAAINGKTLQKKLAELEAASGGRLGVAARSSNGGKSLSYRGDERFPMCSTFKVLAVAALLRDKPGILEQRIHFAQIDIQPWSPVTEKHLEDGMTVAELCAAMLQHSDNTAANLVLAKLGGPQGLTSLARSFGDTTFRLDRWEVELNTAIPGDARDTTTPLAMCNTLNGLLCGNLLKAPARERLTGWMLGCATGAGRIPAGIPQGWRSAHKSGSGENGTANDVGVLLPPSNPGKATKPGKNKGKPLTVALYLTGSRLTGPENDKILASATRLVCAAEGLAMPLDNMY	115.12	gnl|BL_ORD_ID|2660|hsp_num:0	3580			123	357	
BGC0000082.1|Kijanimicin_31 # 90964 # 92277 # -1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.742	BGC0000082.1|Kijanimicin_31 	90964	92277	-	Loose	600	26.5646	LRA-5	37.14	3002483	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class A LRA beta-lactamase	ATGCCCCCATGGACGGCACGCCAGGACTCGACAACGGGACTCTACGCGCCGGTGACCCCGGCCGGTCGCGTCCTGCTCGACCGGTTGGCGGCGCACCTGCCGCGGATCCGGTCCACCGCGGCCGAGCACGACCGCGACGGCACCTTCCCCACCGACACGTTCGACGCGCTCCGCAAGGACGGCCTGATGGGCGCGACGGTCCCGGCCGAGCTGGGCGGGCTGGGGGTCGACCGGCTGTACGACGTGGCGGTCGCGCTGCTGGCCGTCGCGCGGGCCGACGCCTCGACGGCGCTCGCGCTGCACATGCAGCTCAGCCGGGGGCTCACGCTGGGCTACGAGTGGCGGCACGGCGACGAGCGGGCCCGGACGCTGGCCGAGCGGATCCTGCGGGGCATGGTCGCCGGTGACGCGGTCGTGTGCTCGGGCATCAAGGACCACCACACCGCCGTGACGACGCTGCGTCCCGACGGCGCGGGCGGGTGGCTGCTGTCCGGCCGCAAGACGCTGGTCAGCATGGCCCCCGTCGGCACGCACTTCGTCATCAACGCGCGGACCGACGGCACCGACGGGCCGCCGCGGCTGGCGTCCCCGGTCGTCACCCGCGACACCCCCGGGTTCACCGTGCTGGACAACTGGGACGGCCTCGGGATGCGGGCGTCGGGCACCGTGGACATCGTCTTCGACGACTGCCCCATCCCGGCCGACCACGTGCTGATGCGCGACCCGGTCGGCGCCCGCAACGACGCGGTGCTCGCCGGTCAGACGGTCAGCTCGGTCTCGGTGCTGGGCGTCTACGTCGGCGTCGCGCAGGCCGCCTACGACACCGCGGTGGCGGCGCTCGAACGCCGGCCCGAGCCGCCGCAGGCCGCGGCGCTCACCCTGGTCGCGGAGATCGACTCCCGTCTCTACGCGCTGCGCGCCACGGCGGGCTCCGCGCTGACCGCCGCCGACGCCCTGTCCGCCGACCTGTCCGGGGACATGGACGAACGCGGGCGGCAGATGATGCGGCACTTCCAGTGCGCCAAGCTCGCGGTCAACCGGCTCGCCCCGGAGATCGTCAGCGACTGCCTCAGCCTGGTCGGCGGCGCGTCGTACACGGCGGGCCACCCGCTGGCCCGGCTGCTGCGCGACGTCCAGGCGGGGCGGTTCATGCAGCCGTACGCCTACGTCGACGCCGTGGACTTCCTGAGCGCCCAGGCCCTGGGAATCGAGCGGGACAACAACTACATGAGCACCTGGGCGAAGCGCTCCGGCGGCAACGGCAAGTCAGCGGACGCGGCGGGCCCGCGGCGTCCTACACCCACGTCACGGTGA	MPPWTARQDSTTGLYAPVTPAGRVLLDRLAAHLPRIRSTAAEHDRDGTFPTDTFDALRKDGLMGATVPAELGGLGVDRLYDVAVALLAVARADASTALALHMQLSRGLTLGYEWRHGDERARTLAERILRGMVAGDAVVCSGIKDHHTAVTTLRPDGAGGWLLSGRKTLVSMAPVGTHFVINARTDGTDGPPRLASPVVTRDTPGFTVLDNWDGLGMRASGTVDIVFDDCPIPADHVLMRDPVGARNDAVLAGQTVSSVSVLGVYVGVAQAAYDTAVAALERRPEPPQAAALTLVAEIDSRLYALRATAGSALTAADALSADLSGDMDERGRQMMRHFQCAKLAVNRLAPEIVSDCLSLVGGASYTAGHPLARLLRDVQAGRFMQPYAYVDAVDFLSAQALGIERDNNYMSTWAKRSGGNGKSADAAGPRRPTPTSR	MKTIFGKRRQSAVVLITLIAILLASGQPYQSSQVRGAACLPDIIFDEPSQGPEKNEAISMLTERLSSIINAAGGDIGIAVIHVETGHTTAIQGTTQLPLYSVFKLPLAIAVLKEIEENRLQLDRKVRVTPADVAPGWTANAAMWRRPIDRTVAQLIEVSIIRSDNTSSDKLLQLVGGPAAVTHRMRALGFPNIEIVSTVREFSENRTRPNTGSAEDLARLLVQLQKGELLQPQHSALLLGFMHRATTGTERLRGSLPVGTPVADKTGTGDAGVVTNDVGIITLPKGQGHLAIAVLISGSKLSPAAQEKLIAEIARAAYDAHVSRAE	134.05	gnl|BL_ORD_ID|407|hsp_num:0	451			648	753	
BGC0000082.1|Kijanimicin_32 # 92341 # 93369 # -1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=11bp;gc_cont=0.707	BGC0000082.1|Kijanimicin_32 	92341	93369	-	Loose	1200	51.9878	arnA	24.79	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGTCATTCACTGACCGCGTGGTGGTCACCGGCGGGGCCGGGTTCATCGGGTCGCACTACGTGCGGCAGCTGGTGACCGGCGCGTACCCGGCGTTCGCCGACGCGTCCGTCGTCGTCCTCGACAAGCTGACCTACGCGGGCAACGAGGAGAACCTCGCCCCCGTCTCCGACGACCGGCGGTTCGAGCTGGTGGTCGGGGACGTCTGCGACGGCGAGCTGCTGGCCGAGGTCCTGCCGGGGGCGGACGTCGTGGTGCACTTCGCCGCCGAGTCCCATGTGGACCGCTCGATCGTCGGCTCGACCGACTTCATGCAGACCAACGTGCTGGGCACCCACAGCGTGTTCCAGGCGTGCCTGGACGCCGGGGTGAAGCGGGTCGTCCAGGTGTCCACCGACGAGGTCTACGGCTCGATCGAGGCCGGTTCGTGGACCGAGGACGAGCCGCTCGAACCGAACTCGCCCTACTCGGCGTCCAAGGCCGCCGCCGACCTCGTCGCCCGGTCGTTCTACCGGACCTACGGGCTGCCGGTGTGCGTGACCCGGTGCTCGAACAACTACGGCCCCTACCAGTACCCCGAGAAGATCATTCCGCTGTTCATCACCAACCTGCTGCTGGGGGAGCCGCTGCCGCTGTACGGCGACGGCGGCAACGTCCGGGACTGGCTGCACGTGGACGACCACTGCCGCGCCGTCCAGCTCGTGGTGGAGGGCGGGCGGCCGGGCCACGTCTACAACATCGGCGGCGGGACCGAGCTCACCAACCGCGAGCTCACGGCGCGGCTGCTGAAGGAGACGGGCGCGGACTGGTCCGCGGTCCGGAACGTCCCCGACCGCCCGGGACACGACCAGCGCTACTCGGTCGACTGGACGAAGATCAGCGCCGAGCTGGGCTACCTGCCGCGCGTCGGCCTGGAGACGGGGCTGGCCGAGACGGTCCGCTGGTACGTCGAGAACCGGTCCTGGTGGGAGCCGCTGCGGGAGAAGGCCGAGCGGGCCCGCGACGGATCCCCGGCCAGGGCGGCCGTCTGA	MSFTDRVVVTGGAGFIGSHYVRQLVTGAYPAFADASVVVLDKLTYAGNEENLAPVSDDRRFELVVGDVCDGELLAEVLPGADVVVHFAAESHVDRSIVGSTDFMQTNVLGTHSVFQACLDAGVKRVVQVSTDEVYGSIEAGSWTEDEPLEPNSPYSASKAAADLVARSFYRTYGLPVCVTRCSNNYGPYQYPEKIIPLFITNLLLGEPLPLYGDGGNVRDWLHVDDHCRAVQLVVEGGRPGHVYNIGGGTELTNRELTARLLKETGADWSAVRNVPDRPGHDQRYSVDWTKISAELGYLPRVGLETGLAETVRWYVENRSWWEPLREKAERARDGSPARAAV	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	51.66	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1986	polymyxin B
BGC0000082.1|Kijanimicin_33 # 93356 # 94252 # -1 # ID=1_33;partial=00;start_type=GTG;rbs_motif=GAGG;rbs_spacer=8bp;gc_cont=0.688	BGC0000082.1|Kijanimicin_33 	93356	94252	-	Loose	500	27.7202	Vibrio cholerae varG	24.56	3004289	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	Subclass B1 Vibrio cholerae varG beta-lactamase	GTGAAGGGGATCATTCTGGCCGGGGGAACAGGAACGCGTCTCCATCCGCTGACCGTCGCCCTCTCCAAACAATTGCTTCCGGTTTACGACAAGCCCATGATCTACTATCCGCTCTCCACGCTCATGCTGGGCGGCGTTCGGGACATTCTCATCATTTCCACGCCGGCGGACCTGCCGATGTTCCGCCGGGTGCTCGGCGACGGCGGCGACCTGGGCCTGCGGTTCTCCTACGCCGTGCAGCCGCGGCCCGCCGGGATCGCCGACGCCTTCCGGGTCGGCGCGGACTTCATCGGCTCCGATCCGGTCTCCCTCATCCTGGGCGACAACATCTTCCACGGCCGGGAGCTGCCGGGCACGCTGGCCGAGAGCATGGTCGACGTCGACGGCTGCACGCTGTTCGGCTACACGGTGCCCGACCCGCGGCCCTACGGCGTGGTGGAGAAGGACGCCGACGGCCGTCTGGTCGGCATCGAGGAGAAACCGGCCCGGCCGCGCGGCTCGGAGATCGTGACGGGGCTGTACGTCTACTCCAACGACGTGGTCGAGATCGCCCGCCGGATCGCCCCGTCGGCCCGCGGCGAACTGGAGATCACCGATGTGAACCGCGTCTACCTCGACCAGGGCCGGGCGCGGCTGCGGTCCCTGGGCGAGGACTGCACGTGGCTGGACGCCGGCACCTACGACGGCCTGCTGGACGCGGCGCGGTTCGTGCGGGAGGAGCAGCTCCGGGGGCCCCGGATCGGCTGCCTGGAGGAGATCGCGCTCCACCGGGGCTACATCGACGCGGACGCCTGCCACGCCCTCGGCCGCAGGCAGAAGAACTCGGGCTACGGCCGGTACGTGATGAGGATTTCAGGCAAGAGCGACCAAGGCGGTTCGAGACATGTCATTCACTGA	MKGIILAGGTGTRLHPLTVALSKQLLPVYDKPMIYYPLSTLMLGGVRDILIISTPADLPMFRRVLGDGGDLGLRFSYAVQPRPAGIADAFRVGADFIGSDPVSLILGDNIFHGRELPGTLAESMVDVDGCTLFGYTVPDPRPYGVVEKDADGRLVGIEEKPARPRGSEIVTGLYVYSNDVVEIARRIAPSARGELEITDVNRVYLDQGRARLRSLGEDCTWLDAGTYDGLLDAARFVREEQLRGPRIGCLEEIALHRGYIDADACHALGRRQKNSGYGRYVMRISGKSDQGGSRHVIH	MFVSHLSFPHLIEERKMKLSTLALAPITAALLTFNASAKGHDHDNQRAIFFPGETVQDTVKVEVEPSATQSLKLGQKINNLYERQFDNSQATVQKLGKNTYWIGVNYYNATVVVNEDSVLLIDPLGDGRIDALFKGVQSITNKPITTIMYSHYHLDHLGGGNQLVDLIKKNYPKVDKIRVIASQTVADKINQHAEVGENGVKTPKVPAPNDIYDLTKPQTVQFGSMKIKMMAPKGSGHTPDNTMILIPSDRVLHFADMINPDQLPFYNFAGAEHFHGYEEDLQSLLSKPLSKQWDFINGGHGNIGSKQDVKDLLEYIADIRTEVGKQLEVAPYTPVLSDGNHFVWFKRWQDEITNNVHTALANKYGHMYGFDSGVVETHAAMILADMIDH	76.41	gnl|BL_ORD_ID|2428|hsp_num:0	2842			171	336	meropenem
BGC0000082.1|Kijanimicin_34 # 94372 # 94911 # -1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.769	BGC0000082.1|Kijanimicin_34 	94372	94911	-	Loose	800	25.0238	tet(31)	38.24	3000476	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCGACGCGCCGCGCTGAACCGCCCCACGGCCTGCTCGACCCCGACCGGGACGCCCCCGACCCGGGCGGCCTCCGGCGCGTGCTGGGGCACTTCGCCACCGGCGTCGCCCTGGTCACCGGGCTCGACGCGGGGAAGCCGGTGGGGCTGCTGGTCAACTCCTTCACCTCCGTCTCCCTGGAACCGCCGCTGATCGCGTTCTGCGTCGCGCACACCAGCTCCAGCTGGCCCCGGCTGCGCGCGGGAGGGCGGCACTGCGTCAGCTTCCTCGCCGCCGACCAGCGGGAGCAGGCGCACCGGCTCGCCGCGTCGGGCGACGCCAAGTTCCGCGGACTGGCGTGGTCGCCCTCGCCGTCCGGGCTGCCCCTGCCCGACGGCGCGCTGGCCTGGCTGGAGTGCGCGGTCGAGGCCGAGCACCCGGCGGGCGACCACGTCATCGTGGTCGCCCGGGTGCACCGCATGGGCCGGTCCGGGGCCGTGCCGCACCCCGGGCCGCTGGTGTTCTACCGCGGCGGCTACGGGCGGTTCACCACCGAATAA	MATRRAEPPHGLLDPDRDAPDPGGLRRVLGHFATGVALVTGLDAGKPVGLLVNSFTSVSLEPPLIAFCVAHTSSSWPRLRAGGRHCVSFLAADQREQAHRLAASGDAKFRGLAWSPSPSGLPLPDGALAWLECAVEAEHPAGDHVIVVARVHRMGRSGAVPHPGPLVFYRGGYGRFTTE	MIGKLIMMNRYITIALLITFLDATGMGLIMPVLPTLLEEFSVKESIATHYGFILAIYALMQVIFAPILGQLSDKFGRKPVLILSLIGAVCDYTLLSFSSALWMLYLGRMIAGISAATGAVAASMVADHTKKAERTKWFGKLGAAFGAGLIAGPAIGGFIGQYSAHFPFIIAAILNAIALIMVIILFPKEQSRPKEIEQDQSKIHEKTTINAPLIHILKPVLLLLMLFFTVQLIGQIPASTWVLFTEYRFEWNTFNIGLSLAGLGLMHIIFQAFVAGYIASRWKNETVFILGFILDASAFLLLAFISQVWLVIPTLILLAGGGIALPALQGLISIKTADEHQGKIQGIMVSLTNITGIIGPPIFAFSFAKTVTNWDGTLWLIGAVLYSILLGLYFLYQKIRAYKQLKSQTA	43.66	gnl|BL_ORD_ID|594|hsp_num:0	640			1023	1122	tetracycline
BGC0000082.1|Kijanimicin_35 # 94935 # 96086 # -1 # ID=1_35;partial=00;start_type=GTG;rbs_motif=GAGG;rbs_spacer=4bp;gc_cont=0.721	BGC0000082.1|Kijanimicin_35 	94935	96086	-	Loose	580	27.335	SHV-196	26.19	3005229	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	GTGATCAACGTAACCCAGCCCAGCATCGGCGCGGAGGAACTGNCCGCCGTGGGCGAGGTCTTCGACAGCAAGTGGCTCGGGTCCGGCCCGCGGACCCAGGAATTCGAGGAGCAGTTCGCCCGGTTCCTCGGGGTGCCGGCCGAGAACGTGCTGTTCCTCAATTCGGCGACCTCCGGCCTCTTCCTCACGGTCGAGCTGCTCGGCATCGGGCCGGGCGACGAGGTCGTGCTGCCGTCGAACGGGTTCGTCGCCAACGCCAACTCCGTGGTGGACGCCGGGGCCCGCCCGGTGTTCTGCGACGTGGGCGACGACCTCAACCCCCGGGTGGAGGACGTGGCCGCCGTGCTCACACCGCGCACCAGGGCGGTGGTGATCCTGCACTACGGCGGCTATCCCGGCGAGGTGGAGAAGATCGCCGCGCTGTGCGCCGAACGCGGCGTGGCGCTGGTGGAGGACGCGGCCGTGTCGATCGCGTCCAGCGTGCACGGCCGGATGTGCGGCACGTTCGGGGACTTCGGCGTGTGGAGCCTGGACGCCCGCAAGGTCATCACCACCGGCGACGGCGGCATGCTGTACGTGCGGGACCCCGAGACCGCGCGCCGCGCGCGGCGGCTGGCCTACCACGGGCTGGAGGACCGCAGCTCGTTCACCACCGCCGCCAGGTCGCCGCACCTGTGGTGGAGCTTCGACATCGAGGACGTGGGCCGCCGCCTGATCGGCAACGACATCACCGCGGCGATCGGCCAGGTGCAGCTCGGCAAGCTCGCCGGGTTCGTGGCGCGGCGCCGCGAGATCGCCCGGCGGTACGACGCGGCGCTGGGCGACGTCCCGGGCATCCGGATCCCGCCGCCACTGCCGGACGGGCACGCCTCGACGCACTACTTCTACTGGGTGCGGTTCGACAGCACCGCCATCCGGGACGGGGTGAGCGAGGACCTGCTCGCCAGAGGCATCTACACCTCCTACCGCTACTACCCCCTGCACCGGGTCCGGCGGTACGGCGCCACCGACGCCGTGCTGCCGCGGACGGACGAGGTGTCGGACACCGCCCTGCTGCTTCCGGCGCACCAGTCGCTGCTCGACGAGGAGGTCGACCGGGTGGCGCGGGAGGTGGTCAGGGCGGTCGAGGCCCGGCGTGACCCGGCCGCCTGA	MINVTQPSIGAEELXAVGEVFDSKWLGSGPRTQEFEEQFARFLGVPAENVLFLNSATSGLFLTVELLGIGPGDEVVLPSNGFVANANSVVDAGARPVFCDVGDDLNPRVEDVAAVLTPRTRAVVILHYGGYPGEVEKIAALCAERGVALVEDAAVSIASSVHGRMCGTFGDFGVWSLDARKVITTGDGGMLYVRDPETARRARRLAYHGLEDRSSFTTAARSPHLWWSFDIEDVGRRLIGNDITAAIGQVQLGKLAGFVARRREIARRYDAALGDVPGIRIPPPLPDGHASTHYFYWVRFDSTAIRDGVSEDLLARGIYTSYRYYPLHRVRRYGATDAVLPRTDEVSDTALLLPAHQSLLDEEVDRVAREVVRAVEARRDPAA	MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAEIGAALIEHWQR	133.92	gnl|BL_ORD_ID|2937|hsp_num:0	3951			639	846	
BGC0000082.1|Kijanimicin_37 # 97138 # 98313 # -1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=9bp;gc_cont=0.766	BGC0000082.1|Kijanimicin_37 	97138	98313	-	Loose	700	58.151	oleI	28.67	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGGGTTCTGTTCACCTCGGCCACCTTCGCATCGCACCTCTACCCGCTCGTCCCCCTGGCGTGGGCGTTCCGCGCGGCGGGGCACGAGGTCCGGGTGGCCGTCCAGCCACCTCTCCTCGGCGAGGTGACCGCGGCGGGCCTGCCCGCCGTCGAGGCCGGGGGCGACCTGGACTTCATCGTCGAGCTGAAGCAGGCCGTCGGCAGTGCGCTGGCGGAGTCCGGGGGCGCGCCACCGACCCTGGAGCAGATCATGGTCCCGCACGTGCGGGCCGCCGCGGCCGTCGCGGCCGACCTGGTCCCCTTCGCCCGGCGCTGGGCCCCGGACCTGGTGGTCGCCGATCCCGCCGCGTTCGTCGCGCCGGTGGTCGCCCGGGCCGCCGGGGCGCCGCTGGCGCTGAACACCTGGGGGCCGATGCCGGCCGACCTGTGGTCGCACCTGACGTCCGAGCGCGCGGTGCGCGAGAACTGGCCGAAGACGCTGGTCGCGTTCCTCGACGAGTGGGACGCGCCGCTCGGGCCCGACTACGCGGCGTACTGCGTGGACCCGTGCCCGGACGAGCTGCTCGCGGTCCGGATGCCGAACCGGTACCCGGCGCGGTTCGTGCCGTACGGCCGGGCCGCCGTCGCGCCGTCCTGGCTGGCCGAGCCCGCGGGACGGCCCCGGGTGTGCATCACCTGGGGCACCACCAACGGCGCGTTCCTGGGGGCCGACGCGCTGGCCGCGCCGCTGACGATCATCGACGCGCTGACCGCGCTGGACGTGGAGGTGGTGGCGGCGCTCGGCAAGGCCGGTGCCGAGCTGCTCGGCGACCGCCGCGAACGGGTCCGGGCGGTCGACTGGATGCCGCTGTCGACGCTGCTGCCGACCTGCGACGCGCTCGTCAGCCAGGGCGGTCCCGGCACGGTCCTGGCCGCCGTCGCGCACGGGGTGCCGCAACTGGTCGTGCCGTCCATCAGCGCCCAGCCGCTGGGCGCCGAGCTGCTGGCGGCGAGCGGGGCGGGCCTGTCGCTCACCCCCGGGGAGCTCACCGCCGAGTCGGTCACCGCGGCGATGTCGGAGCTGCTCACCGGGGCGTCCGTCCGCGACGCCGCCCGGACGCTGGGCGAGCGGAACGCCGCCCGGCCCTCCCCGGCCGAGATCGCCAGGACGCTGGAGGCTCTGGTCCGGGGGTAG	MRVLFTSATFASHLYPLVPLAWAFRAAGHEVRVAVQPPLLGEVTAAGLPAVEAGGDLDFIVELKQAVGSALAESGGAPPTLEQIMVPHVRAAAAVAADLVPFARRWAPDLVVADPAAFVAPVVARAAGAPLALNTWGPMPADLWSHLTSERAVRENWPKTLVAFLDEWDAPLGPDYAAYCVDPCPDELLAVRMPNRYPARFVPYGRAAVAPSWLAEPAGRPRVCITWGTTNGAFLGADALAAPLTIIDALTALDVEVVAALGKAGAELLGDRRERVRAVDWMPLSTLLPTCDALVSQGGPGTVLAAVAHGVPQLVVPSISAQPLGAELLAASGAGLSLTPGELTAESVTAAMSELLTGASVRDAARTLGERNAARPSPAEIARTLEALVRG	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	92.22	gnl|BL_ORD_ID|1684|hsp_num:0	1824			714	1149	oleandomycin
BGC0000082.1|Kijanimicin_38 # 98397 # 99395 # -1 # ID=1_38;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.711	BGC0000082.1|Kijanimicin_38 	98397	99395	-	Loose	550	27.7202	APH(2'')-Ie	25.0	3002634	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2'')	ATGGAGAATCCGGCGAACGCCAATCCGATCCGGGTCGGAGTGATCGGGTGCGCCGACATCGCGTGGCGGCGAGCGCTGCCGGCGCTGGAGGCCGAACCGCTCACCGAGGTCACGGCCATCGCCAGCCGGCGGTGGGACCGGGCCAAACGGTTCACCGAGCGGTTCGGCGGCGAACCGGTGGAGGGCTACCCGGCGCTTTTGGAACGTGACGATGTCGACGCGGTGTACGTCCCGCTGCCCGCCGTGCTGCACGCCGAGTGGATCGACCGGGCGCTCCGGGCGGGCAAGCACGTGCTGGCGGAGAAGCCGCTCACCACCGACCGCCCGCAGGCCGAACGGCTGTTCGCGGTGGCCCGGGAACGGGGGCTGCTGCTGATGGAGAACTTCATGTTCCTCCACCACCCCCAGCACCGGCAGGTCGCGGACATGCTGGACGAGGGCGTCATCGGCGAGATCCGCTCGTTCGCCGCCAGCTTCACGATCCCGCCGAAGCCGCAGGGCGACATCCGCTACCAGGCCGACGTGGGCGGCGGGGCACTGCTGGACATCGGCGTGTACCCGATCCGCGCCGCCGGTCTGTTCCTCGGCGCGGACCTGGAGTTCGTGGGCGCGGTGCTGCGGCACGAGCGGGACCGGGACGTGGTGGTCGGCGGCAACGCGCTCCTGACCACCCGCCAGGGCGTGACCGCGCAGCTCACCTTCGGGATGGAGCACGCCTACACCAACAACTACGAGTTCCGGGGCAGCACCGGCCGGCTGTGGATGAACCGCGTCTTCACTCCCCCGGCGACCTACCAGCCCGTCGTCCACATCGAACGGCAGGACCACGCCGAGCAGTTCGTCCTGCCCGCGCACGACCAGTTCGCCAAGAGCATCCGCGCCTTCGCCCAGGCGGTCCTCAGCGGCGAGCACCCGCGGGAGTGGTCGGAGGACTCGCTGCGCCAGGCGTCCCTGGTCGACGCCGTCCGGACGGGGGCGCGCGACATCTACTTCCCCTGA	MENPANANPIRVGVIGCADIAWRRALPALEAEPLTEVTAIASRRWDRAKRFTERFGGEPVEGYPALLERDDVDAVYVPLPAVLHAEWIDRALRAGKHVLAEKPLTTDRPQAERLFAVARERGLLLMENFMFLHHPQHRQVADMLDEGVIGEIRSFAASFTIPPKPQGDIRYQADVGGGALLDIGVYPIRAAGLFLGADLEFVGAVLRHERDRDVVVGGNALLTTRQGVTAQLTFGMEHAYTNNYEFRGSTGRLWMNRVFTPPATYQPVVHIERQDHAEQFVLPAHDQFAKSIRAFAQAVLSGEHPREWSEDSLRQASLVDAVRTGARDIYFP	MTTYTFDQVEEAIEQLYPDFTINTIEISGEGNDCIAYEINGNFIFKFPKHSRASINLLNEVTVLKTIHNELSLPIPEVVFTGMPSEMCQMSFAGFTKIKGVPLTPLLLKNLPKQSQDQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGHQMKKVDDFYRDILDNEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYMMKEKYWSFEKIIYGKEYGYMDWYEEGLNEIRSIKIK	110.30	gnl|BL_ORD_ID|119|hsp_num:0	137			723	867	amikacin; kanamycin A; tobramycin; gentamicin A; gentamicin
BGC0000082.1|Kijanimicin_40 # 100109 # 100840 # -1 # ID=1_40;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.663	BGC0000082.1|Kijanimicin_40 	100109	100840	-	Loose	400	33.113	vanR gene in vanA cluster	31.03	3002919	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGGAGGTCCTGCTGCGCACCCTCCTGATCCGCAACGGACAGGTGGTGTCCCTGGACCAGCTCACGCAGGAGCTGTGGGGTGAGACGCCCCCGGTCCGGGCCGGCGCCTCCCTGCACGTCTACGTGTCGCAGCTTCGCAAGGTCCTCAACAAGTTCAGCCTGAACAGCGACGTGATCACCACCCGCGCCCCCGGATACATCCTGAACCTGGGGCGGGACGAGCTCGACCTCAACCTCTTCCTGTCCCTGTCGGAGAAGGGGCGGCTGCAGCTGAGCATGCACGACCACGCCGCCGCGGCCGAGACCCTGACCAAGGCGCTGGAACTCTGGCGCGAACCGGTGCACGCCTCCTCCTACGAGGGGCCGATCATCCGGGAGTTCGCCAACTGGACCGAGGAGTTCCGGGTCGAGTGCGTCGAACTGCTGGCCCGGGCGCTGCTGGCCTCCGACCAGACCAGCGAGGCGATCCGCATTCTCTACTCCCTGATCTCCGAATATCCGCTGCGCGAGGATCTGTACGCCTTTCTCATGGAGGCGCTCAGCCGGTCCGGGCGGCGGGCGGACGCGCTGGAGGTCTACCGGACGGCGCGGAACCGCATCCGCGACGAACTGGGTCTGGAACCGTGCAAATTCCTGCAGGAGACCCAGGAACTGGTACTGAACGACCGGATGGACGAGCTCAGGATCATGCGTTCCCGGCATGACGGGAGCATGTGGGCGCGCGCCATGTGA	MEVLLRTLLIRNGQVVSLDQLTQELWGETPPVRAGASLHVYVSQLRKVLNKFSLNSDVITTRAPGYILNLGRDELDLNLFLSLSEKGRLQLSMHDHAAAAETLTKALELWREPVHASSYEGPIIREFANWTEEFRVECVELLARALLASDQTSEAIRILYSLISEYPLREDLYAFLMEALSRSGRRADALEVYRTARNRIRDELGLEPCKFLQETQELVLNDRMDELRIMRSRHDGSMWARAM	MSDKILIVDDEHEIADLVELYLKNENYTVFKYYTAKEALECIDKSEIDLAILDIMLPGTSGLTICQKIRDKHTYPIIMLTGKDTEVDKITGLTIGADDYITKPFRPLELIARVKAQLRRYKKFSGVKEQNENVIVHSGLVINVNTHECYLNEKQLSLTPTEFSILRILCENKGNVVSSELLFHEIWGDEYFSKSNNTITVHIRHLREKMNDTIDNPKYIKTVWGVGYKIEK	105.19	gnl|BL_ORD_ID|750|hsp_num:0	722			489	663	vancomycin; teicoplanin
BGC0000082.1|Kijanimicin_41 # 101524 # 101871 # -1 # ID=1_41;partial=00;start_type=ATG;rbs_motif=GAGGA;rbs_spacer=5bp;gc_cont=0.672	BGC0000082.1|Kijanimicin_41 	101524	101871	-	Loose	2090	25.0238	mdsB	35.29	3000790	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACAAGGTCAGGGGACAGTCGGCGGCCGAAGACGACGCAACGCCGCAACCACCGGGTGGGGCCGCTGCGCTTCAACGACGAAGAGCTGCGCGCCGTGAGGCAGGCGGCGGACAAGGCGGGGCTCTCCCTGGGCGCGTACGCGACCGAGGCGGTGGTCAGGGCCGCGTACGCCGAACTGAACGGCACGCCCAGCGAAAGCGAACGCCTGGAGGCGCTGCGCGATATCCAGATCGGCCTGGCGCGCCTTCTGAAAAATCCCCACCAAACAGGGCCCGGTGATCCGCTGGACCGGCTCACCGGAACGCTCACCGAAATTCTCGACACCATTCAGCGCGACAGACGCTGA	MTRSGDSRRPKTTQRRNHRVGPLRFNDEELRAVRQAADKAGLSLGAYATEAVVRAAYAELNGTPSESERLEALRDIQIGLARLLKNPHQTGPGDPLDRLTGTLTEILDTIQRDRR	MKFTHFFIARPIFAIVLSLLMLLAGAIAFLKLPLSEYPAVTPPTVQVSASYPGANPQVIADTVAAPLEQVINGVDGMLYMNTQMAIDGRMVISIAFEQGTDPDMAQIQVQNRVSRALPRLPEEVQRIGVVTEKTSPDMLMVVHLVSPQKRYDSLYLSNFAIRQVRDELARLPGVGDVLVWGAGEYAMRVWLDPAKIANRGLTASDIVTALREQNVQVAAGSVGQQPEASAAFQMTVNTLGRLTSEEQFGEIVVKIGADGEVTRLRDVARVTLGADAYTLRSLLNGEAAPALQIIQSPGANAIDVSNAIRGKMDELQQNFPQDIEYRIAYDPTVFVRASLQSVAITLLEALVLVVLVVVMFLQTWRASIIPLVAVPVSLVGTFALMHLFGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHISQGKSPGEAAKKAMDEVTGPILSITSVLTAVFIPSAFLAGLQGEFYRQFALTIAISTILSAINSLTLSPALAAILLRPHHDTAKADWLTRLMGTVTGGFFHRFNRFFDSASNRYVSAVRRAVRGSVIVMVLYAGFVGLTWLGFHQVPNGFVPAQDKYYLVGIAQLPSGASLDRTEAVVKQMSAIALAEPGVESVVVFPGLSVNGPVNVPNSALMFAMLKPFDEREDPSLSANAIAGKLMHKFSHIPDGFIGIFPPPPVPGLGATGGFKLQIEDRAELGFEAMTKVQSEIMSKAMQTPELANMLASFQTNAPQLQVDIDRVKAKSMGVSLTDIFETLQINLGSLYVNDFNRFGRAWRVMAQADAPFRMQQEDIGLLKVRNAKGEMIPLSAFVTIMRQSGPDRIIHYNGFPSVDISGGPAPGFSSGQATDAIEKIVRETLPEGMVFEWTDLVYQEKQAGNSALAIFALAVLLAFLILAAQYNSWSLPFAVLLIAPMSLLSAIVGVWVSGGDNNIFTQIGFVVLVGLAAKNAILIVEFARAKEHDGADPLTAVLEASRLRLRPILMTSFAFIAGVVPLVLATGAGAEMRHAMGIAVFAGMLGVTLFGLLLTPVFYVVVRRMALKRENRVDSHDQQA	10.90	gnl|BL_ORD_ID|1269|hsp_num:0	1385			1401	1554	chloramphenicol
BGC0000082.1|Kijanimicin_42 # 102602 # 103531 # -1 # ID=1_42;partial=00;start_type=GTG;rbs_motif=GAGG;rbs_spacer=6bp;gc_cont=0.687	BGC0000082.1|Kijanimicin_42 	102602	103531	-	Loose	570	26.5646	ARL-5	41.94	3004738	protein homolog model	n/a	n/a	penam	antibiotic inactivation	ARL Beta-lactamase	GTGAGGTCTTCCGCGCGTTGTGCGGTGGCCGTGGCGCTCGCCGCGCCCATGGTCGCCGTGCCGGTGGCGACCGCCCACGCCGAGCCCGCCGTCTCCGCCAAGGCGGGGCCGTCGGGGGTCTACGCCAAGTCGGCGCTGCTGCTCGACGTCGGCGCCAAGAAGGTCCGGTGGAGCCGGTCGCCCCACACCAAGCGGCGCATCGGCAGCATCACCAAGGTGATGACGGCCTATGTGGTCATCAAGTCCGGCAACCTGGACCGCAAGATCACCGTTCAGCGCAAGCACGTCGACTACCTGCGCGGCAACGGCGCGGGCGGCAGCTCGGCCGGGCTCGTGGTCGGCGACCGGCTCACGGTGCGGCAGCTGCTGCGCGCCCTGATGCTGCCGTCGGGGTGCGACGCGGCCTACGTGCTGGCCGACGCCTACGGGCCCGGCTGGAAGGGCTTCGTCGCCAAGATGAACAAGACGGCCCGCGGCCTGAAGATGACCAACACGAAGTACGCCAACTTCGACGGCATCGACTGGAAGGGGGCCACGATGTACTCGACGGCCTACGACCAGACCAGGCTCGCCGCCGCCGCGATGAAGCTCAAGGAGTTCCGCTCCGTCGTCGGCACCAGGTCCTACCGGGTGCCGCCGACCAGCACCACGCACATCTACAACTGGACGAACACCAACGCCCTGCTCGGCAAGTACAAGGGCATGACCGGCGTCAAGACCGGCTTCACCAACATGGCGGGCGCCTCGTTCATGTTCGGTGCCAAGCGGGGCGGTCGTGAGCTGGTCGGGATCGTCCTGAACAGCGGCAGCGGCAGCTACAAGAGCCGCCGCTTCACCGACGCCTCCAAGATCCTCAACTGGGGCTTCGGGGTCCGCTCCGCCGACCTGCCGGTCATGTCGCGGAGCCTGGACGACGGCCGCTTCGACTAG	MRSSARCAVAVALAAPMVAVPVATAHAEPAVSAKAGPSGVYAKSALLLDVGAKKVRWSRSPHTKRRIGSITKVMTAYVVIKSGNLDRKITVQRKHVDYLRGNGAGGSSAGLVVGDRLTVRQLLRALMLPSGCDAAYVLADAYGPGWKGFVAKMNKTARGLKMTNTKYANFDGIDWKGATMYSTAYDQTRLAAAAMKLKEFRSVVGTRSYRVPPTSTTHIYNWTNTNALLGKYKGMTGVKTGFTNMAGASFMFGAKRGGRELVGIVLNSGSGSYKSRRFTDASKILNWGFGVRSADLPVMSRSLDDGRFD	MKKFFTIFVLLCVCFAYTTASASAQDLTKLEHKNDATVGVYGINTATGKTYSHNADTRFAYASTFKAITSGLLLQQSSPEALNKTVTIKESDIVAYSPVTEQYVGKTMTLRQLISAAMLQSDNTASNVIMEQLGGLDQISSRLQALGDTTTNPQRYEPELNNYDPQSTADTSTPRATAHSLQQLLTTDAVAPQQRKFLQNLMFNNETGDSLIKKGVPDSYKVGDKSGQGTTYGTRNDVALIYPKHQTKPIVLVVFTKHKQQDAKPQDALVAQAARQAIQQLD	109.57	gnl|BL_ORD_ID|2536|hsp_num:0	3553			309	402	
BGC0000082.1|Kijanimicin_43 # 103802 # 104389 # 1 # ID=1_43;partial=00;start_type=ATG;rbs_motif=AAG;rbs_spacer=7bp;gc_cont=0.679	BGC0000082.1|Kijanimicin_43 	103802	104389	+	Loose	2300	26.9498	evgS	22.4	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGTGACTCGTCGGTGCCAGACTGGCTCCTGCCCCCGCCGGGCGGGTTCACCGCTGATGACTTTCTGCGGATGCGCGGACTTCCCCGGCACACGGAGTTGATCGACGGGAGTCTCGTCTTCGTGAGTCCGCAGGAGAAATGGCACGGCAGAGTGATCAATCTGCTGCTCGCCGAACTGGACCGGCAGGCGCCGGACGGGCTCCGGGCGGACCGGGAGATGGCGGTCAGGCTGGCCAGGCGGCAGATGCCGGAACCGGACGTCCTGATCGTGACCGCCGAGGCGTACGACCGCGAGGACCCGTCCACCCACTACTTCGCCGACGACCTCGTGCTCGCCGTCGAGGTCGTCTCGCCGGACTCCGAGGACCGGGACCGCGACACCAAACCGCGAAAGTACGCCGCCGCCGGCATTCCTCACTACTGGCGGGTGGAGAAGGTCAACGGCCAGACGGTCGTGTACGTCTACGAACGCGACCCCGCCACCGGTGGCTACGGCGTCGCGGGCATCCATCGCGACCGGTTGAAGGTGGCCGTGCCGTTCGACATCGGCATTGATCTCTCTGTCGCCGGGCGGCGGGTGCGTTAG	MGDSSVPDWLLPPPGGFTADDFLRMRGLPRHTELIDGSLVFVSPQEKWHGRVINLLLAELDRQAPDGLRADREMAVRLARRQMPEPDVLIVTAEAYDREDPSTHYFADDLVLAVEVVSPDSEDRDRDTKPRKYAAAGIPHYWRVEKVNGQTVVYVYERDPATGGYGVAGIHRDRLKVAVPFDIGIDLSVAGRRVR	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	16.29	gnl|BL_ORD_ID|1214|hsp_num:0	1318			57	420	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0000082.1|Kijanimicin_44 # 104386 # 105006 # -1 # ID=1_44;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.747	BGC0000082.1|Kijanimicin_44 	104386	105006	-	Loose	200	26.1794	vanH gene in vanA cluster	25.0	3002942	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	GTGACGGCCGGCTCCCTTGCCGCGCTGGTGGCCCTGGGCGCGTTCCACGGTCTGAACCCGGGCATGGGCTGGCTGTTCGCGGTGGCCCGGGGCCTCCAGGAACGCGACCGCTCGCGCGTGCTGCAGTCGCTGCCCGCCATCGCGGCGGGCCACGCGGCGTCGGTGGGCGCGGTGGCGATCCTGGTCGGCCTGACCCGCTCGGTCGTGACGACGCGCGCCATCGCGGTCGGCGGCGGCGCGGCGCTGGTGGCGTTCGGCCTGTGGCGCCTGCTGTCGCGCCGCCACTTCCGCTGGGTCGGCATGAAAATCTCGCTGTGGCAGCTGGCGGCCTGGTCGTTCCTGATGTCCTCGGCCCACGGCGCGGGCCTGATGCTGCTGCCGGTCCTGACCGGCGCCCCCGCGCCGCCCGGCCACGACCACGGCCTGACGGCGGGCCTGTCCGCGGGGCTGTTCGTGACGGGCGTCCACACCCTGGCGATGTTCGCGACGGCGGGGACGATAGCCGTCCTGGTCTACGAGGTGGTCGGCCTGACGATCCTCCGCCGGGCCTGGCTGAACATGGACCGCCTGTGGGCCGCGGCCCTGATCGGAGCCGGGACCACCACCCTCCTCACCGCCTAA	MTAGSLAALVALGAFHGLNPGMGWLFAVARGLQERDRSRVLQSLPAIAAGHAASVGAVAILVGLTRSVVTTRAIAVGGGAALVAFGLWRLLSRRHFRWVGMKISLWQLAAWSFLMSSAHGAGLMLLPVLTGAPAPPGHDHGLTAGLSAGLFVTGVHTLAMFATAGTIAVLVYEVVGLTILRRAWLNMDRLWAAALIGAGTTTLLTA	MNNIGITVYGCEQDEADAFHALSPRFGVMATIINANVSESNAKSAPFNQCISVGHKSEISASILLALKRAGVKYISTRSIGCNHIDTTAAKRMGITVDNVAYSPDSVADYTMMLILMAVRNVKSIVRSVEKHDFRLDSDRGKVLSDMTVGVVGTGQIGKAVIERLRGFGCKVLAYSRSRSIEVNYVPFDELLQNSDIVTLHVPLNTDTHYIISHEQIQRMKQGAFLINTGRGPLVDTYELVKALENGKLGGAALDVLEGEEEFFYSDCTQKPIDNQFLLKLQRMPNVIITPHTAYYTEQALRDTVEKTIKNCLDFERRQEHE	63.98	gnl|BL_ORD_ID|4669|hsp_num:0	178			48	249	vancomycin; teicoplanin
BGC0000082.1|Kijanimicin_45 # 105003 # 106403 # -1 # ID=1_45;partial=00;start_type=ATG;rbs_motif=GAGGA;rbs_spacer=6bp;gc_cont=0.722	BGC0000082.1|Kijanimicin_45 	105003	106403	-	Loose	600	25.7942	DES-1	32.58	3004780	protein homolog model	n/a	n/a	penam	antibiotic inactivation	DES beta-lactamase	ATGGCGCTGTGGAAGCCCGATCCCACGTTCTACGCCTCACCCCGGGACGCGGTGAACGCGCCGCCGGAGAAGCTCGCCTACGTGGCGGCGTTCGACCGTTCGGCGGCGAGGCCCGACGCCATCGCGGTCCTGGACGTGGATCCGGCGTCGGGGTCCTACGGGTCGGTCGTGGGCTGGACGGACCTGCCCCACACCGGTGACGAGCTGCACCACTTCGGGTGGAACGCGTGCAGCAGCGCGCTGTGCCCGTACGCGCCGCACCCGCACGTGGAACGCCGCTACCTGATCGTGCCGGGCCTCCGCTCCTCGCGGATCTACGTCATCGACACCAAGGAGCAGCCGACCAGTCCCCAGATCGTGAAGGTGCTGGAGGCCGGCGAGCTGGCCGAGCGCGCGGGGTACTCGCGCCCGCACACCGTGCACTGCGGGCCGGAGGGGCTGTACGTCACCGCGCTCGGCGGCGCCAACGGCGAGGACGGCCCGGGCGGGATCGCGCTGCTGGACCACACCTCGTTCGAGGTGCTGGGCCGCTGGGAGGTGGACCGGGGCCCGCAGCGCCTGGCCTACGACGCCTGGTGGCACATCGCGCACGACGTGCTGGTCACCTCCGAGTGGGGCACCCCGTCGATGGTCGAGGACGGCGTGGACGCCGAACTGCTGCTGAACCGCCGGTACGGCCACTCCCTGCACTTTTGGGACCTGCGCAAACGCCGCCACATCCAGAGCGTGGACCTGGGCGACGAGCACCAGATGGTCCTGGAGCTGCGCCCGGCGCACGACCCGACGAAGCAGTACGGCTTCGTCGGCGTCGTCGTGAGCGTGGAGGACCTGTCGGCCTCGGTCTGGGTGTGGCACCGCGACGGCGGCCGCTGGGCGGCGAAGAAGGTCATCACGATCCCCGCCGAACCGGCCGACGCCGCCGCGCTGCCGCCGGTGATCCGGCCGTTCGGCGCGGTCCCGCCGCTGGTCACCGACATCGACCTGTCGGTGGACGACCGGTGGCTGTACGTCTCCTGCTGGGGCACCGGCGAGCTCAGGCGCTACGACGTGTCCGACCCGTTCCACCCGGTGGAGGCGGGTTCGGTCCGCATCGGCGGCATCGTGAACCGCACCCCCCGNCCGGCCCGCCCCGACCTGCCCCTGTCCGGCGGGCCGCAGATGGTGGAGGTCAGCCGCGACGGNAGGCGNGTCTACGTCACCAACAGCCTCTACGGCTCGTGGGACGACCAGTTCTACCCCGACGGCGTGGGCGCGTGGATGGCCAAGCTCGACGCGACCCCCGACGGTCTCACCTTCGACGAGCGCTTCTTCCCCCACGACGACGACTGGCGCGGCCTGCGCCCGCACCAGACCCGCCTGCAGGGCGGCGACGCCTCCTCCGACTCCTACTGCTACCCGTGA	MALWKPDPTFYASPRDAVNAPPEKLAYVAAFDRSAARPDAIAVLDVDPASGSYGSVVGWTDLPHTGDELHHFGWNACSSALCPYAPHPHVERRYLIVPGLRSSRIYVIDTKEQPTSPQIVKVLEAGELAERAGYSRPHTVHCGPEGLYVTALGGANGEDGPGGIALLDHTSFEVLGRWEVDRGPQRLAYDAWWHIAHDVLVTSEWGTPSMVEDGVDAELLLNRRYGHSLHFWDLRKRRHIQSVDLGDEHQMVLELRPAHDPTKQYGFVGVVVSVEDLSASVWVWHRDGGRWAAKKVITIPAEPADAAALPPVIRPFGAVPPLVTDIDLSVDDRWLYVSCWGTGELRRYDVSDPFHPVEAGSVRIGGIVNRTPXPARPDLPLSGGPQMVEVSRDXRXVYVTNSLYGSWDDQFYPDGVGAWMAKLDATPDGLTFDERFFPHDDDWRGLRPHQTRLQGGDASSDSYCYP	MHSRSSYSRRYVLAGLCALPFASLSAGLIFNSSADAASLAAINGKTLQKKLAELEAASGGRLGVAARSSNGGKSLSYRGDERFPMCSTFKVLAVAALLRDKPGILEQRIHFAQIDIQPWSPVTEKHLEDGMTVAELCAAMLQHSDNTAANLVLAKLGGPQGLTSLARSFGDTTFRLDRWEVELNTAIPGDARDTTTPLAMCNTLNGLLCGNLLKAPARERLTGWMLGCATGAGRIPAGIPQGWRSAHKSGSGENGTANDVGVLLPPSNPGKATKPGKNKGKPLTVALYLTGSRLTGPENDKILASATRLVCAAEGLAMPLDNMY	143.83	gnl|BL_ORD_ID|2660|hsp_num:0	3580			303	546	
BGC0000082.1|Kijanimicin_4 # 3095 # 4273 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=4bp;gc_cont=0.731	BGC0000082.1|Kijanimicin_4 	3095	4273	-	Loose	390	26.1794	MexZ	40.43	3003709	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCGCCGAGACCTTCGCCCAGATGCCGTCGCTCGCCGACGGCGGCGCCGAGACGCTGGCCTGGATGCGGCGGATGCGTGACGAGCAGCCGCTCTGGGTGGACGCCGCCAACATGCACCACGTCTTCCGGTACGCCGACGTGCAGGCGGTGATGTCCGACCCCGCGCGGTTCTCCTCCAACATCGGCCGGATCCTGCCCGGCCACGACCCCGAGCAGATCAGCGCCAACCTGCCCTGGCTGGACCCCCCGGACCACCGGCGGCTGCGGCAGCTCGTCAGCCAGGCGTTCGCCCCGAAGACGGTGGTCGGCCTGCGGCCGCGGATCACCGAGATCGCCGCGGGCCTGCTGGCCGCCGTGCCGGACGGCGAGTTCGACTTCGTCGAGCGGGTGGCGTACCCGCTGCCGGTGATCGTCGTCGCCGAGCTGCTCGGCCTGCCCCCGGCCGACCGCGCGTTCTTCCGGGACTGCGCCGACCGGCTGCTGGGCGTCGGCGACGCCGGGTCGGCGGAGGCGGGCAGCGCGGCCATCGCGGAGGCGAACAGGGAGCTCCGGGAGTACCTCACCGCCGAGGCCGGGCGGCAGCGCGGAAGCCGGTCCGACGGCCTGATCGCGGCGCTCACCGCCGCCGAGCTCGACGGTCAGCGGCTGAGCGACGTGCAGGTCGCCACCATCGCCGGGCTGCTGCTCACCGCCGGTCACATCACCACCACGATGGTGCTCGGGAACGCCCTGCTGTGCCTGCGGGACAACCCCGAGGCCGAGGCGCGGACGCGCGCGGACCGTTCCCTGGTGCCCGCCGCGCTGGAGGAGGTCGTCCGGCAGCGGCCGCCGTTCCCCCGCGTCGTCCGGGTCAGCACGCAGGACGTGGCGATCGCGGGAGGCGTGATCCCGGCCCAGCGGCTCGTCGTGGCCTCGACGCTCTCGGCCAACCACGACGAGCGGCAGTTCCCGGACCCGGAGCGGTTCGACATCGACCGGCATCCCAACCGGCACATCGGGTTCGGCCACGGCATCCACTTCTGCCTCGGCGCCCCGCTGGCCCGGGCGGAGACCCAGATCATGCTCGACCTGCTGTTCGACGAATTCGCCGAGCTGCGGGTCGTCGGGGAGCCGGTCCACAATGAGTCCGAGTATTTCGGAACCAGGAAGATGACGGTCTTCGCGCGCCGCTCGTGA	MAAETFAQMPSLADGGAETLAWMRRMRDEQPLWVDAANMHHVFRYADVQAVMSDPARFSSNIGRILPGHDPEQISANLPWLDPPDHRRLRQLVSQAFAPKTVVGLRPRITEIAAGLLAAVPDGEFDFVERVAYPLPVIVVAELLGLPPADRAFFRDCADRLLGVGDAGSAEAGSAAIAEANRELREYLTAEAGRQRGSRSDGLIAALTAAELDGQRLSDVQVATIAGLLLTAGHITTTMVLGNALLCLRDNPEAEARTRADRSLVPAALEEVVRQRPPFPRVVRVSTQDVAIAGGVIPAQRLVVASTLSANHDERQFPDPERFDIDRHPNRHIGFGHGIHFCLGAPLARAETQIMLDLLFDEFAELRVVGEPVHNESEYFGTRKMTVFARRS	MARKTKEESQKTRDGILDAAERVFLEKGVGTTAMADLADAAGVSRGAVYGHYKNKIEVCLAMCDRAFGQIEVPDENARVPALDILLRAGMGFLRQCCEPGSVQRVLEILYLKCERSDENEPLLRRRELLEKQGQRFGLRQIRRAVERGELPARLDVELASIYLQSLWDGICGTLAWTERLRDDPWNRAERMFRAGLDSLRSSPYLLLADA	186.67	gnl|BL_ORD_ID|4693|hsp_num:0	2223			486	609	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; chloramphenicol; arbekacin; norfloxacin; ofloxacin; gentamicin
BGC0000082.1|Kijanimicin_39 # 99457 # 100065 # -1 # ID=1_39;partial=00;start_type=ATG;rbs_motif=AAGGA;rbs_spacer=7bp;gc_cont=0.688	BGC0000082.1|Kijanimicin_39 	99457	100065	-	Loose	390	24.6386	MexZ	41.67	3003709	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCGGTATCGAGATCGAGGAGATGTCGGTCGCGGGGGCCTTCCGGATCAGGCCGACGCAGATTCCGGACCGGCGAGGCAGATTCTACGAGTCGTGGCGGTTCAGCGAGTTGCTGCAACAGGCCGGTCACCCCTTCGAGATCCGTCAGGTGAACTACTCGGTGTCCCGGAAGAACACGCTCCGGGGAATTCACGGCACCACCATTCCGCCGGGGCAGACGAAACTGGTCACCTGCGTCCGGGGCGCCGCGCTGGACGTGGCGGTCGACCTGCGGGTCGGGTCGCCGACGTTCGGCCGGTTCGACGTGACGCTCCAGGAGGCGGGGAGCGGGATCGGCGTCTATCTCGCCGACGGCATCGGGCACGCCTTTCTCGCCCTCACCGACGACACGTGCATGAACTACCTCTGCGGCGCCGAGTACGTGCCCGGCACCATGATCGATGTCCAGGCGCTCGATCCGGCGCTGGGCATCCCCTGGGAACTGGACGGCCCGCCGATCATGTCCGACAAGGACGCGGCCGCGCCGACCCTCGCCGAGGCGGCCGAACGCGGGCTGCTCCCGACCTACGAGCAGGCGCGGGCGGCACGGGCCCCGCACCTTCTCTGA	MSGIEIEEMSVAGAFRIRPTQIPDRRGRFYESWRFSELLQQAGHPFEIRQVNYSVSRKNTLRGIHGTTIPPGQTKLVTCVRGAALDVAVDLRVGSPTFGRFDVTLQEAGSGIGVYLADGIGHAFLALTDDTCMNYLCGAEYVPGTMIDVQALDPALGIPWELDGPPIMSDKDAAAPTLAEAAERGLLPTYEQARAARAPHLL	MARKTKEESQKTRDGILDAAERVFLEKGVGTTAMADLADAAGVSRGAVYGHYKNKIEVCLAMCDRAFGQIEVPDENARVPALDILLRAGMGFLRQCCEPGSVQRVLEILYLKCERSDENEPLLRRRELLEKQGQRFGLRQIRRAVERGELPARLDVELASIYLQSLWDGICGTLAWTERLRDDPWNRAERMFRAGLDSLRSSPYLLLADA	96.19	gnl|BL_ORD_ID|4693|hsp_num:0	2223			369	441	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; chloramphenicol; arbekacin; norfloxacin; ofloxacin; gentamicin
